
<html lang="en"     class="pb-page"  data-request-id="9d073c0a-4f43-4fcc-9092-0c18931eccf9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-4;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm401551n"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Heat Shock Protein 70 Inhibitors. 1. 2,5′-Thiodipyrimidine and 5-(Phenylthio)pyrimidine Acrylamides as Irreversible Binders to an Allosteric Site on Heat Shock Protein 70" /></meta><meta name="dc.Creator" content="Yanlong  Kang" /></meta><meta name="dc.Creator" content="Tony  Taldone" /></meta><meta name="dc.Creator" content="Hardik J.  Patel" /></meta><meta name="dc.Creator" content="Pallav D.  Patel" /></meta><meta name="dc.Creator" content="Anna  Rodina" /></meta><meta name="dc.Creator" content="Alexander  Gozman" /></meta><meta name="dc.Creator" content="Ronnie  Maharaj" /></meta><meta name="dc.Creator" content="Cristina C.  Clement" /></meta><meta name="dc.Creator" content="Maulik R.  Patel" /></meta><meta name="dc.Creator" content="Jeffrey L.  Brodsky" /></meta><meta name="dc.Creator" content="Jason C.  Young" /></meta><meta name="dc.Creator" content="Gabriela  Chiosis" /></meta><meta name="dc.Description" content="Heat shock protein 70 (Hsp70) is an important emerging cancer target whose inhibition may affect multiple cancer-associated signaling pathways and, moreover, result in significant cancer cell apopt..." /></meta><meta name="Description" content="Heat shock protein 70 (Hsp70) is an important emerging cancer target whose inhibition may affect multiple cancer-associated signaling pathways and, moreover, result in significant cancer cell apopt..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 18, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401551n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401551n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401551n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401551n" /></link>
        
    
    

<title>Heat Shock Protein 70 Inhibitors. 1. 2,5′-Thiodipyrimidine and 5-(Phenylthio)pyrimidine Acrylamides as Irreversible Binders to an Allosteric Site on Heat Shock Protein 70 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401551n" /></meta><meta property="og:title" content="Heat Shock Protein 70 Inhibitors. 1. 2,5′-Thiodipyrimidine and 5-(Phenylthio)pyrimidine Acrylamides as Irreversible Binders to an Allosteric Site on Heat Shock Protein 70" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0013.jpeg" /></meta><meta property="og:description" content="Heat shock protein 70 (Hsp70) is an important emerging cancer target whose inhibition may affect multiple cancer-associated signaling pathways and, moreover, result in significant cancer cell apoptosis. Despite considerable interest from both academia and pharmaceutical companies in the discovery and development of druglike Hsp70 inhibitors, little success has been reported so far. Here we describe structure–activity relationship studies in the first rationally designed Hsp70 inhibitor class that binds to a novel allosteric pocket located in the N-terminal domain of the protein. These 2,5′-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides take advantage of an active cysteine embedded in the allosteric pocket to act as covalent protein modifiers upon binding. The study identifies derivatives 17a and 20a, which selectively bind to Hsp70 in cancer cells. Addition of high nanomolar to low micromolar concentrations of these inhibitors to cancer cells leads to a reduction in the steady-state levels of Hsp70-sheltered oncoproteins, an effect associated with inhibition of cancer cell growth and apoptosis. In summary, the described scaffolds represent a viable starting point for the development of druglike Hsp70 inhibitors as novel anticancer therapeutics." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401551n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401551n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401551n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401551n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401551n&amp;href=/doi/10.1021/jm401551n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1188-1207</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401805h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401552y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Heat Shock Protein 70 Inhibitors. 1. 2,5′-Thiodipyrimidine and 5-(Phenylthio)pyrimidine Acrylamides as Irreversible Binders to an Allosteric Site on Heat Shock Protein 70</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanlong++Kang">Yanlong Kang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tony++Taldone">Tony Taldone</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hardik+J.++Patel">Hardik J. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pallav+D.++Patel">Pallav D. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Rodina">Anna Rodina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Gozman">Alexander Gozman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronnie++Maharaj">Ronnie Maharaj</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina+C.++Clement">Cristina C. Clement</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maulik+R.++Patel">Maulik R. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+L.++Brodsky">Jeffrey L. Brodsky</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason+C.++Young">Jason C. Young</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriela++Chiosis">Gabriela Chiosis</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Program in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Groupe de Recherche Axé sur la Structure des Protéines, Department of Biochemistry, McGill University, Montreal, Quebec, Canada H3G 0B1</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Pharmacology Program, Weill Graduate School of Medical Sciences, Cornell University, New York, New York 10021, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 646-888-2238. E-mail: <a href="/cdn-cgi/l/email-protection#d9adb8b5bdb6b7bcad99b4aab2babaf7b6abbe"><span class="__cf_email__" data-cfemail="c5b1a4a9a1aaaba0b185a8b6aea6a6ebaab7a2">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Phone: 646-888-2235. E-mail: <a href="/cdn-cgi/l/email-protection#5e3d3637312d372d391e332d353d3d70312c39"><span class="__cf_email__" data-cfemail="9dfef5f4f2eef4eefaddf0eef6fefeb3f2effa">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401551n&amp;href=/doi/10.1021%2Fjm401551n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1188–1207</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 18, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 October 2013</li><li><span class="item_label"><b>Published</b> online</span>18 February 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 February 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401551n" title="DOI URL">https://doi.org/10.1021/jm401551n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401551n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2634</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401551n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Heat Shock Protein 70 Inhibitors. 1. 2,5′-Thiodipyrimidine and 5-(Phenylthio)pyrimidine Acrylamides as Irreversible Binders to an Allosteric Site on Heat Shock Protein 70&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yanlong&quot;,&quot;last_name&quot;:&quot;Kang&quot;},{&quot;first_name&quot;:&quot;Tony&quot;,&quot;last_name&quot;:&quot;Taldone&quot;},{&quot;first_name&quot;:&quot;Hardik&quot;,&quot;last_name&quot;:&quot;J. Patel&quot;},{&quot;first_name&quot;:&quot;Pallav&quot;,&quot;last_name&quot;:&quot;D. Patel&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Rodina&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Gozman&quot;},{&quot;first_name&quot;:&quot;Ronnie&quot;,&quot;last_name&quot;:&quot;Maharaj&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;C. Clement&quot;},{&quot;first_name&quot;:&quot;Maulik&quot;,&quot;last_name&quot;:&quot;R. Patel&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;L. Brodsky&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;C. Young&quot;},{&quot;first_name&quot;:&quot;Gabriela&quot;,&quot;last_name&quot;:&quot;Chiosis&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1188-1207&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401551n&quot;},&quot;abstract&quot;:&quot;Heat shock protein 70 (Hsp70) is an important emerging cancer target whose inhibition may affect multiple cancer-associated signaling pathways and, moreover, result in significant cancer cell apoptosis. Despite considerable interest from both academia and pharmaceutical companies in the discovery and development of druglike Hsp70 inhibitors, little success has been reported so far. Here we describe structure–activity relationship studies in the first rationally designed Hsp70 inhibitor class that binds to a novel allosteric pocket located in the N-terminal domain of the protein. These 2,5′-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides take advantage of an active cysteine embedded in the allosteric pocket to act as covalent protein modifiers upon binding. The study identifies derivatives 17a and 20a, which selectively bind to Hsp70 in cancer cells. Addition of high nanomolar to low micromolar concentrations of these inhibitors to cancer cells leads to a reduction in the steady-state levels of Hsp70&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401551n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401551n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401551n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401551n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401551n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401551n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401551n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401551n&amp;href=/doi/10.1021/jm401551n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401551n" /></input><a href="/doi/pdf/10.1021/jm401551n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401551n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401551n%26sid%3Dliteratum%253Aachs%26pmid%3D24548207%26genre%3Darticle%26aulast%3DKang%26date%3D2014%26atitle%3DHeat%2BShock%2BProtein%2B70%2BInhibitors.%2B1.%2B2%252C5%25E2%2580%25B2-Thiodipyrimidine%2Band%2B5-%2528Phenylthio%2529pyrimidine%2BAcrylamides%2Bas%2BIrreversible%2BBinders%2Bto%2Ban%2BAllosteric%2BSite%2Bon%2BHeat%2BShock%2BProtein%2B70%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D4%26spage%3D1188%26epage%3D1207%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292017" title="Solvents">Solvents</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jmcmar.2014.57.issue-4/production/jmcmar.2014.57.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Heat shock protein 70 (Hsp70) is an important emerging cancer target whose inhibition may affect multiple cancer-associated signaling pathways and, moreover, result in significant cancer cell apoptosis. Despite considerable interest from both academia and pharmaceutical companies in the discovery and development of druglike Hsp70 inhibitors, little success has been reported so far. Here we describe structure–activity relationship studies in the first rationally designed Hsp70 inhibitor class that binds to a novel allosteric pocket located in the N-terminal domain of the protein. These 2,5′-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides take advantage of an active cysteine embedded in the allosteric pocket to act as covalent protein modifiers upon binding. The study identifies derivatives <b>17a</b> and <b>20a</b>, which selectively bind to Hsp70 in cancer cells. Addition of high nanomolar to low micromolar concentrations of these inhibitors to cancer cells leads to a reduction in the steady-state levels of Hsp70-sheltered oncoproteins, an effect associated with inhibition of cancer cell growth and apoptosis. In summary, the described scaffolds represent a viable starting point for the development of druglike Hsp70 inhibitors as novel anticancer therapeutics.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The heat shock protein 70 (Hsp70) family members are powerful proteins with major roles in malignancy, such as inhibition of apoptosis, induction of resistance to chemotherapy, and regulation of the stability of oncoproteins.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Specifically, Hsp70 expression blocks apoptosis at several levels, and in this respect the chaperone inhibits key effectors of the apoptotic machinery, and also facilitates proteasome-mediated degradation of apoptosis-regulatory proteins. The contribution of Hsp70 isoforms to tumorigenesis is mainly through their role as cochaperones of heat shock protein 90 (Hsp90), a heat shock protein known to regulate the transforming activities of several kinases and transcription factors. In this process, Hsp70 initiates the association of the client protein with Hsp90 through a bridging protein called HSP-organizing protein (HOP). These biological functions propose Hsp70 as an important target whose inhibition or downregulation may result in significant apoptosis in a wide range of cancer cells and also in inhibition of signaling pathways involved in tumorigenesis and metastasis. Indeed, simultaneous silencing of Hsc70 or Hsp70 expression in human colon cancer cell lines induced proteasome-dependent degradation of Hsp90 onco-client proteins, cell-cycle arrest, and tumor-specific apoptosis.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Importantly, silencing of Hsp70 isoforms in nontumorigenic cell lines did not result in comparable growth arrest or induction of apoptosis, indicating a potential therapeutic window for Hsp70 targeted therapies.</div><div class="NLM_p">The Hsp70’s are a family of highly homologous proteins composed of two functional domains: the N-terminal ATPase domain and the C-terminal client protein-binding domain.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> The unique interplay between the two domains creates a ligand-activated, bidirectional molecular switch. For example, ATP binding to the ATPase domain induces a conformational change that is rapidly propagated to the C-terminal and that results in accelerated client protein dissociation. Conversely, client protein binding to the C-terminal domain of ATP-bound Hsp70 induces a conformational change that is propagated to the ATPase domain and that results in a stimulation of the ATP hydrolysis rate. The chaperoning activity of Hsp70 is further regulated by cochaperones (e.g., Hsp40s, BAG, and Hsp110) that catalyze the interconversion between the ATP- and ADP-bound states and thus regulate chaperone function. Such structural regulation suggests that Hsp70 may be vulnerable to most strategies that interfere with its flexibility.</div><div class="NLM_p">Much effort has recently been dedicated toward the discovery of Hsp70 inhibitors, and unsurprisingly, molecules from a number of chemical classes have been reported to interact with Hsp70 through a variety of modes (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> A few, such as 15-deoxyspergualin (<b>1</b>) and pifithrin-μ (2-phenylethynesulfonamide) (<b>2</b>), are believed to target the C-terminal of Hsp70,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> whereas others, such as dihydropyrimidines (i.e., <b>3</b> (MAL3-101)),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> are thought to block J-domain-stimulated ATPase activity of Hsp70. Compounds such as myricetin (<b>4</b>)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and <b>5</b> (MKT-077)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> are proposed to interact with a pocket outside the nucleotide-binding domain, whereas apoptozole (<b>6</b>) may bind to the ATP-binding pocket of Hsp70.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of reported potential Hsp70 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The majority of these compounds were discovered in library screens that aimed to identify inhibitors of either the ATPase or the folding capacity of yeast or bacterial Hsp70<a onclick="showRef(event, 'ref2 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref2 ref7 ref8">(2, 7, 8)</a> or in the case of <b>6</b> a cell-based screen of compounds capable of inducing apoptosis.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><b>5</b> was discovered following optimization efforts<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> that had previously identified such rhodacyanine dyes as possessing anticancer activity.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In the only reported rational design approach to develop Hsp70 inhibitors, nucleotide mimetics such as the dibenzyl-8-aminoadenosine analogue <b>7</b> (VER-155008) were developed to bind into the N-terminal ATP pocket of Hsp70.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> While these molecules are reported to elicit their effects through an Hsp70 mechanism, it is likely that they also act on multiple other unrelated and as yet unspecified mechanisms. Furthermore, these molecules have been hindered by a nontractable structure–activity relationship (SAR), with subtle changes resulting in drastic changes in activity. While these molecules have been of some value as tool molecules to offer insight into the consequences of pharmacological modulation of Hsp70, they have limited potential to become useful drugs.</div><div class="NLM_p">At this point in time it is fair to say that Hsp70 has proven to be a very difficult target to drug. In contrast, Hsp90 has proven highly amenable with numerous small-molecule ATP-competitive inhibitors entering into the clinic.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In the case of Hsp90, potent small-molecule inhibitors such as geldanamycin and radicicol were known even before their precise mode of action was determined. When X-ray crystal structures showed that they bound to a clearly specified pocket (i.e., ATP pocket) and behaved as ATP-competitive inhibitors, structure-based drug design became possible. Unfortunately, no such molecules that could potentially guide and truly inspire the development of Hsp70 inhibitors exist for Hsp70.</div><div class="NLM_p">The experiences of scientists at Vernalis offer some further insight into the difficulty of targeting Hsp70 and perhaps as to why no natural product ATP-competitive inhibitor is known.<a onclick="showRef(event, 'ref18 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref20">(18, 20)</a> In the only rational approach reported to date, they designed a series of adenosine analogues to act as direct ATP-competitive inhibitors. However, despite obtaining molecules that bound Hsp70 with high affinity (<i>K</i><sub>d</sub> = 50 nM), their cellular potency was disappointing, and a number of reasons were given for this poor correlation. Hsp70 has a high affinity for ADP (<i>K</i><sub>d</sub> = 0.11–0.5 μM) and coupled with high intracellular ATP concentrations makes the prospect of competitive inhibition a daunting task. Furthermore, the binding mode of ATP is such that important polar contacts are made with its β- and γ-phosphate groups that lie buried within a polar cavity. Attempts to mimic these interactions have resulted in highly polar nondruglike molecules such as <b>7</b>, which despite potent affinity (<i>K</i><sub>d</sub> = 0.3 μM) possess weak cellular activity. Combined, these factors make the prospect of obtaining compounds with potent in vivo activity low and make a strong case against the development of reversible ATP-competitive inhibitors of Hsp70 as a viable therapeutic strategy.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">We had sought alternative strategies toward inhibiting Hsp70 which would have the potential for potent in vivo activity. Specifically, we had sought and subsequently identified another pocket, outside of the active site.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This allosteric site, located in the N-terminal domain, was not evident nor entirely predicted by the available crystal structures of Hsp70 and has been recently discovered by us through computational analyses.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We used the homology model to design ligands that could bind to this allosteric pocket.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Here we describe structure–activity investigations in this first reported allosteric pocket inhibitor class. These ligands are 2,5′-thiodipyrimidine and 5-(phenylthio)pyrimidine scaffold compounds that we show here and in the accompanying paper<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> to be amenable to extensive medicinal chemistry and to act on cancer cells through an Hsp70-mediated mechanism.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Ligand Design and Computational Analysis of Ligand–Hsp70 Interactions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There are several available crystal structures of Hsp70, but most capture a relatively closed nucleotide-binding domain.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24-27)</a> In contrast, recent NMR techniques and molecular dynamics studies suggest a model in which subdomains of the N-terminus are bridged and in a close proximity only in the ATP-binding conformation, with residues of these subdomains rearranging and the cleft opening upon ADP binding.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> To overcome these limitations of the currently available crystal structures and to investigate pockets other than the ATP-binding site, we recently developed a theoretical model of human Hsp70 (hHsp70).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This nucleotide-free structure of hHsp70 both captured the N-terminal binding cleft in a conformation that is more open than that captured by X-ray and unveiled a pocket that contains a potentially reactive cysteine residue (Cys267 in hHsp70) embedded inside the cavity (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The newly identified allosteric pocket (depicted by the green surface in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a,b) is located outside the nucleotide-binding domain and is flanked by subregions IB and IIB of the nucleotide-binding domain (NBD) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Rational design of the allosteric pocket ligands. (a,b) The homology-modeled hHsp70 structure led to the identification of a novel allosteric pocket (shown in green) located in the N-terminal domain of human Hsp70.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This pocket contains a potentially reactive cysteine residue (position shown in red lettering in panel a) and is located outside the ATP-binding site (shown in red in panel b). (c) The geometry of the N-terminal allosteric pocket of hHsp70 as predicted by SiteMap (shown in yellow) and residues lining the pocket and their relative location (depicted as colored circles) are presented. Ligands based on the 2,5′-thiopyrimidine and 5-(phenylthio)pyrimidine chemical scaffolds were designed to fit into the allosteric pocket. They adopt the conformation required for a proper fit and position functionalities toward the shown pocket residues. An acrylamide positioned toward Cys267 was also incorporated into these scaffolds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This cavity is larger and potentially more druglike than the nucleotide-binding pocket (depicted by the red surface in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b), because it contains a balanced number of hydrophilic and hydrophobic residues (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). At the lower part of the allosteric site lies mainly a hydrophilic cavity containing Lys271 and Glu268 and further apart lined by Thr13, Thr14, Tyr15, Lys56, Asp234, Asn235, Arg264, Thr265, and Arg269 (numbering as in hHsp70) (site A, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). Hydrophobic amino acids such as Leu237 and Val238 also line site A. This subpocket also contains the potentially reactive cysteine residue, Cys267, that could covalently link to a ligand containing the appropriate Cys-reactive functionality, such as an acrylamide.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Adjacent to site A, and placed in the middle, is a larger cavity comprised of both nonpolar and polar amino acid residues, such as Tyr41, Val59, Pro63, Thr66, Asp69, Phe68, Arg72, Glu231, Val260, and Arg261 (site B, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). Placed at the upper part of the binding site, and also potentially providing interactions to a small-molecule ligand, are Lys88, His89, Trp90, Pro91, and Phe92 (site C, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c).</div><div class="NLM_p">We analyzed the geometry and the environment of the computationally identified allosteric pocket to provide a starting point for the rational design of ligands (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). We concluded that ligands built around the 2,5′-thiodipyrimidine and 5-(phenylthio)pyrimidine scaffolds, both little explored chemical spaces, would adapt the necessary conformation and provide the required attachment sites for ligand functionalization (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). Each designed ligand used this pharmacophore template to attach X<sub>3–7</sub> functionalities pointed toward several amino acids lining the Hsp70 pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c).</div><div class="NLM_p last">Because our homology model may not entirely mimic the native protein structure, we included an additional binding hook, i.e., an acrylamide functionality, to probe possible covalent bond formation between the inhibitor and Cys267 upon protein binding (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). Due to the location of Cys267 deep inside the cavity, such bond formation would be possible only after the ligand was inserted into the pocket and has achieved a proper fit. By gaining affinity through a covalent linkage in addition to enthalpy, we hoped to increase the ligand’s apparent affinity for the protein in the event the fit would be less than optimal. We reasoned that if the initial ligand would be of sufficiently good fit, additional enthalpy could be gained by properly modifying the appended functionalities, such as we proceed to do here and in the adjoining paper.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of all designed compounds evaluated in this study is shown in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a> and described below. Reaction of 2-amino-4,6-dimethoxypyrimidine (<b>8a</b>) with <i>p</i>-methoxybenzyl chloride ((PMB)Cl) resulted in PMB-protected pyrimidine <b>9a</b> in 95% yield (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). This was iodinated with <i>N</i>-iodosuccinimide (NIS) to give <b>10a</b> in 98%, which was further coupled to 4,6-diamino-2-mercaptopyrimidine using CuI/neocuproine to give 2,5′-thiodipyrimidine <b>11a</b> in 65% yield. Acetylation of the amino groups was accomplished with Ac<sub>2</sub>O/DMAP at 110 °C for 2 h to give <b>12a</b> in 91% yield. Selective removal of the PMB groups occurred by heating <b>12a</b> in a 1:1 mixture of TFA/CHCl<sub>3</sub> at 62 °C for 24 h to give <b>13a</b> in 95%. Fluorodediazoniation was accomplished with NaNO<sub>2</sub>/HF/pyridine to give <b>14a</b> in 54% yield, which was then reacted with a variety of amines to yield <b>15a</b>–<b>c</b>. Deacetylation of these intermediates followed by reaction with acryloyl chloride resulted in target compounds <b>17a</b>–<b>c</b>. Derivatives <b>20a</b>–<b>c</b> were prepared following a similar route from 2-amino-4,6-diethoxypyrimidine (<b>8b</b>), which was prepared by refluxing a mixture of 2-amino-4,6-dichloropyrimidine and NaH in ethanol in 89% yield (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (PMB)Cl, NaH, DMF, 0 °C to rt; (b) NIS, MeCN, rt; (c) 4,6-diamino-2-mercaptopyrimidine or 4-amino-2-mercaptopyrimidine, neocuproine, CuI, K<sub>2</sub>CO<sub>3</sub>, DMSO, 120–130 °C; (d) Ac<sub>2</sub>O, DMAP, 110–120 °C; (e) TFA, CHCl<sub>3</sub>, 62 °C; (f) HF/pyridine, NaNO<sub>2</sub>, 0 °C; (g) amine, DMF, 90 °C; (h) NaOH, H<sub>2</sub>O, MeOH, 60 °C; (i) acryloyl chloride, Et<sub>3</sub>N, dioxane, rt.</p></p></figure><div class="NLM_p">The chemistry used to prepare <b>27a</b>–<b>d</b> is similar and shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Derivative <b>10a</b> was coupled with 4-amino-2-mercaptopyrimidine to give <b>21</b> in 92% yield. Acetylation followed by PMB removal resulted in <b>23</b>. Reaction with NaNO<sub>2</sub>/HF/pyridine gave fluoro derivative <b>24</b>, which was reacted with a variety of amines to give <b>25a</b>–<b>d</b>. Deacetylation followed by reaction with acryloyl chloride resulted in target compounds <b>27a</b>–<b>d</b>. Reaction of <b>27a</b> with <i>m</i>-CPBA at −78 °C resulted in <i>N</i>-oxide <b>28</b>. Reaction of <b>24</b> with NaOMe/MeOH followed by deacetylation resulted in <b>29</b>, which was reacted with acryloyl chloride to give <b>30</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Reaction of <b>11a</b> with acryloyl chloride followed by treatment with TFA resulted in <b>31</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOMe/MeOH, 90 °C, then NaOH, 60 °C; (b) acryloyl chloride, Et<sub>3</sub>N, dioxane, rt; (c) TFA, CHCl<sub>3</sub>, 62 °C.</p></p></figure><div class="NLM_p">Thioethers shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> were prepared from chloropyrimidine <b>32</b> or <b>38</b>. Reaction of <b>32</b> with <i>N</i>-methylpiperazine or morpholine resulted in <b>33a</b> and <b>33b</b>, respectively. Iodination of these derivatives, followed by coupling with 3-aminothiophenol resulted in <b>35a</b> and <b>35b</b>, respectively. These compounds were then reacted with a variety of unsaturated acid chlorides to give target compounds <b>36a</b>,<b>b</b> and <b>37</b>. Target compounds <b>42a</b>–<b>c</b> and <b>43</b> were prepared similarly starting from chloropyrimidine <b>38</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-methylpiperazine or morpholine, DMF, 90 °C; (b) NIS, TFA, CH<sub>3</sub>CN, rt; (c) 3-aminothiophenol or 4-amino-2-mercaptopyrimidine, neocuproine, CuI, K<sub>2</sub>CO<sub>3</sub>, DMF, 110–130 °C; (d) acid chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Biological Evaluation in the Hsp70 Inhibitor Series</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Recent studies suggest that, unlike normal cells, cancer cells express modified heat shock protein species characterized by both enhanced cochaperone recruitment and distinct post-translational modifications.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31-33)</a> Evidence also indicates that certain small molecules show preferential binding to these tumor-modified heat shock proteins.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Our goal being to develop Hsp70 inhibitors for cancer treatment, we accordingly employed here a testing strategy that used phenotypic assays to read fingerprints of Hsp70 inhibition in tumor cells rather than a classical recombinant protein-based approach (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Known Hsp70 functions used to design the biological testing of the Hsp70 inhibitors in cancer cells. Hsp90 in concert with Hsp70 maintains the transforming capacity of several oncoproteins whose aberrant activity leads to increased cell proliferation and survival. The function of the Hsp90 protein complex requires the HSP-organizing protein (HOP), involved in the formation of the active chaperone complex. Altering the formation of the Hsp90–HOP–Hsp70 complex leads to degradation of the oncoprotein via a proteasome-mediated pathway and is associated with cell growth inhibition and/or cell death. To confirm an Hsp70-mediated mechanism, it is expected that compounds will be active at similar concentrations in this battery of assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To design a tumor–Hsp70 tailored testing module, we took advantage of known biological activities mediated by Hsp70 in cancer. As mentioned, Hsp70 is both an antiapoptotic molecule<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and a transforming protein that acts together with Hsp90 to regulate the altered activity of several cancer kinases.<a onclick="showRef(event, 'ref1 ref2 ref34'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref34">(1, 2, 34)</a> Thus, our testing strategy incorporated assays that measured induction of apoptosis (i.e., the ability to activate caspase-3,7, Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and induce PARP cleavage, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) and those that read a phenotypic outcome similar to that of Hsp90 inhibitors (i.e., degradation of Hsp90/Hsp70-sheltered oncoproteins such as HER2 and Raf-1 in the proper genetic background, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) (see tests 1 and 2 in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Because a compound that interferes with nucleotide binding to the ATP-binding pocket of Hsp90, either competitively or allosterically, could result in a phenotype closely resembling Hsp70 inhibition, we also included an assay to test for possible direct binding to Hsp90 (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl1">Table 1<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X<sub>1</sub> = X<sub>2</sub></th><th class="colsep0 rowsep0" align="center">X<sub>3</sub></th><th class="colsep0 rowsep0" align="center">X<sub>5</sub>, X<sub>6</sub></th><th class="colsep0 rowsep0" align="center">X<sub>7</sub></th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (μM) growth inhibition<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (μM) caspase-3,7 activation<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">methylpiperazine</td><td class="colsep0 rowsep0" align="char" char="±">0.90 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">morpholine</td><td class="colsep0 rowsep0" align="char" char="±">12.5 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">12.1 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">piperidine</td><td class="colsep0 rowsep0" align="char" char="±">17.1 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">16.2 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 × −OC<sub>2</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">methylpiperazine</td><td class="colsep0 rowsep0" align="char" char="±">0.89 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">4.0 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20b</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 × −OC<sub>2</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">morpholine</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">10.5 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20c</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 × −OC<sub>2</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">piperidine</td><td class="colsep0 rowsep0" align="char" char="±">4.5 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">4.0 ± 2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27a</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">methylpiperazine</td><td class="colsep0 rowsep0" align="char" char="±">1.25 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">4.0 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27b</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">morpholine</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">7.2 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27c</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">piperidine</td><td class="colsep0 rowsep0" align="char" char="±">3.15 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">12.4 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27d</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">pyrrolidine</td><td class="colsep0 rowsep0" align="char" char="±">46.1 ± 15.5</td><td class="colsep0 rowsep0" align="char" char="±">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1-methylpiperazine 1-oxide</td><td class="colsep0 rowsep0" align="char" char="±">>100</td><td class="colsep0 rowsep0" align="char" char="±">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">–OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">ND</td><td class="colsep0 rowsep0" align="char" char="±">7.5 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">–NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">4.5 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36a</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">methylpiperazine</td><td class="colsep0 rowsep0" align="char" char="±">7.8 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">morpholine</td><td class="colsep0 rowsep0" align="char" char="±">46.5 ± 3.4</td><td class="colsep0 rowsep0" align="char" char="±">27.5 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42a</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">2 × −CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">methylpiperazine</td><td class="colsep0 rowsep0" align="char" char="±">ND</td><td class="colsep0 rowsep0" align="char" char="±">6.0 ± 2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">2 × −CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">morpholine</td><td class="colsep0 rowsep0" align="char" char="±">14.4 ± 2.7</td><td class="colsep0 rowsep0" align="char" char="±">15.4 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44a</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2 × −OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-(2-(2-(2-(piperazin-1-yl)ethoxy)ethoxy)ethoxy) ethanol</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">14.3 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45a</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">–OCH<sub>3</sub>, –(OC<sub>2</sub>H<sub>4</sub>O)<sub>4</sub>H</td><td class="colsep0 rowsep0" align="left">methylpiperazine</td><td class="colsep0 rowsep0" align="char" char="±">76.5 ± 21.5</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 10.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Inhibition of growth measured in Kasumi-1 acute myeloid leukemia cells. Values are the mean ± SEM.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Caspase-3,7 activation measured in MOLM13 acute myeloid leukemia cells. Values are the mean ± SEM.</p></div></div></div><div class="NLM_table-wrap" id="tbl2">Table 2<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0011.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Inhibition of growth measured in Kasumi-1 acute myeloid leukemia cells. Values are the mean ± SEM.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Caspase-3,7 activation measured in MOLM13 acute myeloid leukemia cells. Values are the mean ± SEM.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 3. <a class="ref internalNav" href="#t3fn4" aria-label="a">a</a></p></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">HER2<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Raf-1<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">cPARP<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">growth inhibition<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Hsp90 binding<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">13.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PU24FCl<a class="ref internalNav" href="#t3fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">0.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20c</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27a</b></td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27d</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">16.5</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42a</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42c</b></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">16.7</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44a</b></td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45a</b></td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">>500</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn4"><div class="footnote" id="t3fn4"><sup>a</sup><p class="last">All values are in micromolar units.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">HER2 and Raf-1 steady-state levels, PARP cleavage and inhibition of growth measured in SKBr3 breast cancer cells.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last">Binding to SKBr3 cell extracts.</p></div><div class="footnote" id="t3fn3"><sup>d</sup><p class="last">Structure and activity reported in ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">38</a>.</p></div></div></div><div class="NLM_p">HER2 is a key transforming protein in the HER2-overexpressing breast cancer cells SKBr3, and its degradation or inhibition is sufficient to inhibit the growth of these cells. Thus, in addition to testing the effect of these derivatives on HER2 expression, we also measured their activity on cell growth (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> In addition, the compounds were further tested for their ability to inhibit the growth of cancer cells of distinct genetic origin, including the P-gp/MDR-1-expressing Kasumi-1 acute myeloid leukemia cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) (see test 3 in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><div class="NLM_p">For select derivatives we probed their ability to bind Hsp70 from tumor extracts (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a) and from live cancer cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b,c) and investigated their ability to alter the Hsp70–HOP complex in cancer cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>d; see test 4 in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref5 ref6 ref32'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref32">(5, 6, 32)</a></div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Designed ligands interact specifically with Hsp70 in cancer cells. (a) Streptavidin beads were incubated with the indicated concentrations of <b>44b</b>, <b>45b</b>, and <span class="smallcaps smallerCapital">d</span>-biotin, the unbound agent was washed off, and the resulting beads carrying <b>44b</b>, <b>45b</b>, or <span class="smallcaps smallerCapital">d</span>-biotin were probed with SKBr3 cell extracts (500 μg). Hsp70 isolated on the beads was probed by Western blot (WB). A representative blot is presented (top). Blots were quantified by densitometry and values, in relative luminescence units, graphed against the concentration of added biotinylated Hsp70 inhibitor (bottom). Results from three independent experiments were graphed to determine the relative binding affinity (<i>K</i><sub>d</sub>) of <b>44b</b> and <b>45b</b> using equations as implemented in the GraphPad Prism software. Key: points, mean; bars, SD. (b) Cells were treated with the indicated concentrations of <b>44b</b> for 6 h prior to lysing and precipitation of protein complexes on streptavidin beads. Beads were washed with high-salt (1 M NaCl) buffer before elution of proteins on a denaturing gel and silver staining. BB70 is an antibody specific for Hsp70. This antibody also recognizes Grp78 and Grp75, the endoplasmic reticulum and the mitochondrial Hsp70 paralogues, respectively. (c) Protein complexes were isolated as indicated in (b) in cells pretreated with <b>17a</b>. CP = chemical precipitation. (d) Analysis of the Hsp70–HOP complex. SKBr3 cells were treated for 24 h with vehicle or indicated concentrations of <b>20a</b>. Upon cell lysing, Hsp70 complexes were isolated with an anti-Hsp70 antibody (IP BB70) and analyzed by WB. Specificity of binding was tested with a control IgG. Gels were quantified by densitometry, values normalized to the control (vehicle only treated cells), and data graphed against the concentration of <b>20a</b>. Error bars represent the SEM (<i>n</i> = 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">For a specific Hsp70-mediated biological effect it is expected that compounds should act with a similar potency in the above-described battery of assays (for example, the IC<sub>50</sub> measured in the client degradation assay should be near the IC<sub>50</sub> measured in Hsp70–HOP complex alteration and so on).<a onclick="showRef(event, 'ref2 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref2 ref35 ref36">(2, 35, 36)</a> Inclusion in the testing module of three different Hsp70-addicted cell lines, including one P-gp/MDR-1 expressing, increased our likelihood to eliminate early on poorly permeable compounds and those marred by potential for P-gp/MDR-1-induced resistance.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Structure–Activity Relationship in the Hsp70 Inhibitor Series</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83244" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83244" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In addition to ligand design, we used the homology model to investigate structure–activity relationships in the designed Hsp70 inhibitor series (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). To study potential ligand–protein interactions, we docked each derivative into the allosteric site. This strategy, combined with the phenotypic, target-derived biological investigation (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), as described above, was used to understand differences in tumor Hsp70 inhibitory activity among the designed derivatives.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding interactions of hHsp70 with derivative <b>17a</b>, as predicted by Glide (Schrodinger LLC, New York). Hydrogen bonds are shown as dotted red lines, and the interaction distance is shown by dotted purple lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Site C</h3><div class="NLM_p last">Attached to ring A is substituent X<sub>7</sub> pointing toward the exit of the binding site (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). At this position we could accommodate a variety of substituents such as piperazine, morpholine, piperidine, pyrrolidine, methoxy, and amino (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Methylpiperazine, however, was preferred over all others (<b>17a</b> versus <b>17b</b>, <b>17c</b>, and <b>31</b>; <b>20a</b> versus <b>20b</b> and <b>20c</b>; <b>27a</b> versus <b>27b</b>, <b>27c</b>, <b>27d</b>, and <b>30</b>; <b>36a</b> versus <b>37</b>). At physiological pH, methylpiperazine is likely to be protonated, and this H is predicted by docking to form a hydrogen bond interaction with the backbone carbonyl of His89 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Indeed, an approximately 10-fold drop in activity was observed when the <i>N</i>-Me of methylpiperazine was substituted with O (as in morpholine) or C (as in piperidine). Additionally, when this amine was oxidized to the corresponding <i>N</i>-oxide, as in derivative <b>28</b>, activity was almost abolished, potentially due to the unfavorable interaction of the <i>N</i>-oxide oxygen with the backbone carbonyl of His89. The pyrrolidine-containing derivative <b>27d</b> had a poor aqueous solubility, which likely accounted for the erratic cellular activity we observed for this compound.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Site B</h3><div class="NLM_p last">Substituents X<sub>5</sub> and X<sub>6</sub> of ring A are placed in the middle cavity of the binding site comprised of both nonpolar and polar amino acid residues, as described above (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). Substituents at these positions, such as methoxy, ethoxy, and methyl, were well tolerated (compare <b>17a</b> (methoxy), <b>20a</b> (ethoxy), and <b>42a</b> (methyl)). Modeling predicts for such substituents a potential for hydrophobic (alkyl portion of these substituents with Val59) and electrostatic (oxygen of methoxy and ethoxy with Arg261) interactions (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), and all derivatives containing these substituents had favorable biological activity. Modeling also indicated the potential for steric clash for X<sub>5</sub> and X<sub>6</sub> substituents of larger size, such as in <b>45a</b>, and indeed, we observed a substantial loss of activity for this derivative (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Site A</h3><div class="NLM_p">At the bottom of the allosteric pocket lies Cys267, which is predicted to form a covalent bond with the acrylamide positioned at X<sub>4</sub> on ring B (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The contribution of the acrylamide moiety toward covalent binding with the protein can be seen by comparing compounds in which it is attached to either a pyrimidine or phenyl ring. Since the two nitrogen atoms of the pyrimidine ring render the ring more electron deficient, acrylamide functions attached to it would be expected to be more active Michael acceptors than in the corresponding phenyl compounds. Indeed, a trend for increased activity was seen for the pyrimidine-based compounds when compared to the similar phenyl derivatives (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <b>27a</b> and <b>27b</b> versus <b>36a</b> and <b>37</b>, respectively).</div><div class="NLM_p">In addition to covalent Cys modification, the acrylamide substituent at position X<sub>4</sub> is poised to form several interactions with the adjacent protein residues (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Specifically, the alkene group is positioned to establish hydrophobic interactions with Leu237 and Val238. The carbonyl group is poised to form electrostatic interactions with the guanidine group of Arg264, ε-NH<sub>2</sub> of Lys271, and backbone −NH of Glu268 and could potentially also form hydrogen bonds with the surrounding residues.</div><div class="NLM_p">To further understand the contribution of the acrylamide to binding, we prepared several methyl-substituted acrylamide derivatives (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Each of these derivatives was found to be less active than the unsubstituted acrylamide derivatives (<b>36a</b> versus <b>36b</b>;<b> 42a</b> versus <b>42b</b> and <b>42c</b>). This decrease in reactivity can be explained by both steric and electronic effects. The methyl group could act to sterically hinder nucleophilic attack by the reactive cysteine residue (Cys267). Furthermore, the methyl group is a mild electron-donating group and would decrease the electrophilicity of the Michael acceptor.</div><div class="NLM_p last">Ring B occupies the lower part of the binding site which also contains Arg264. Thus, the aromatic rings that were designed to compose ring B, such as phenyl and pyrimidine, are predicted to be stabilized by cation−π interactions with the guanidine group of this arginine residue (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Ring B also orients substituents toward several important pocket residues. Specifically, at the lower part of the pocket are Asp234 and Glu268, which have the potential to interact with substituents on ring B, such as those located at position X<sub>3</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Accordingly, derivatives for which X<sub>3</sub> was NH<sub>2</sub> (i.e., <b>17a</b>) were more potent than similar derivatives having a hydrogen at this position (i.e., <b>27a</b>) potentially because NH<sub>2</sub> could form hydrogen bonds with the carboxylate groups of Asp234 and Glu268.</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Evaluation of Selectivity and Target-Mediated Cellular activity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11072" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11072" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">From these studies, derivatives <b>17a</b> and <b>20a</b> emerged as most active (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Next, we attached <b>17a</b> to biotin with two aims in mind, first, to demonstrate effective and selective isolation of Hsp70 from cancer cells by <b>17a</b> and, second, to further validate that the acrylamide was not the sole contributor to ligand–protein binding. Specifically, we have created two derivatives of <b>17a</b> by attaching to it linkers that allow for biotin modification of <b>17a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a). In derivative <b>44a</b>, the linker was attached from the piperazine ring and thus predicted to point outside the allosteric pocket. Indeed, <b>44a</b> retained biological activity similar to that of <b>17a</b> (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In derivative <b>45a</b>, the linker was attached on ring A through substituent X<sub>5</sub>, thus at a position that would create steric clashes between the substituent and Hsp70 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a). Indeed, <b>45a</b> was of much reduced activity when compared to <b>17a</b> (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). We next attached <b>44a</b> and <b>45a</b> to biotin and then immobilized, dose-dependently, the resulting <b>44b</b> and <b>45b</b> biotin-labeled ligands onto streptavidin-containing beads. We then used these beads to isolate Hsp70 from cancer cell extracts.</div><div class="NLM_p">As expected from a mode of binding in which enthalpy substantially contributes to binding, efficient isolation of Hsp70 from a cancer cell extract was observed for the beads containing derivative <b>44b</b> but not <b>45b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a><b>a</b>). If binding were solely driven by covalent modification through the acrylamide functionality, both <b>44b</b> and <b>45b</b> would interact equally well with Hsp70 and, thus, isolate similar amounts of Hsp70 from the cell extract. In conclusion, a proper fit into the protein pocket in addition to covalent modification was important for the ability of these ligands to bind to and inhibit Hsp70.</div><div class="NLM_p">To demonstrate the selectivity of interaction, we incubated cancer cells with <b>44b</b> and then proceeded to isolate the captured proteins on streptavidin beads. Upon washing the affinity-purified complexes and running them on a denaturing gel, the selectivity of <b>44b</b> toward Hsp70 was demonstrated by the presence of a single band upon silver staining (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b). This band as demonstrated by its size of 70 kDa, its ability to run at a position identical to that of the protein isolated by an anti-Hsp70 antibody (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b, BB70), and its recognition by an Hsp70-specific antibody (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a) and mass spectrum analysis<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> corresponds to Hsp70. Furthermore, preincubation of cells with soluble <b>17a</b> prior to affinity purification led to a dose-dependent reduction of immobilized Hsp70, demonstrating the specificity of the interaction (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c). Altogether, these findings confirm that the designed ligands act in cells by specifically binding to Hsp70.</div><div class="NLM_p">When cancer cells were incubated with select derivatives (i.e., <b>20a</b>), we observed a dose-dependent alteration in the formation of Hsp70–HOP complexes in cancer cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>d). As mentioned above, HOP is a cochaperone that bridges Hsp70 and Hsp90 to form a megachaperone complex (see test 4 in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This chaperone machinery regulates the stability of several onco-client proteins, such as HER2 and Raf-1, whose degradation, as caused by chaperone inhibition, was tested here (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Of importance, alteration in the Hsp70–HOP complex formation occurred at the same low concentrations (IC<sub>50</sub> = 1.73 μM, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>d) where we also observed degradation of HER2 and Raf-1 by this inhibitor (1 and 2.5 μM, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), further supporting the Hsp70-mediated mechanism of action of these ligands.</div><div class="NLM_p">We noted no effect on Hsp90 for the ligands reported here at concentrations as high as 500 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Specifically, unlike the direct Hsp90 inhibitor PU24FCl,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> a compound with cellular activity comparable to that of the most active Hsp70 inhibitors described here, such as <b>17a</b> and <b>20a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, HER2, Raf-1), the Hsp70 inhibitors failed to compete with a fluorescently labeled geldanamycin derivative, GM-Cy3B<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> for Hsp90 binding (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Geldanamycin is an Hsp90 inhibitor that binds to the Hsp90 regulatory pocket<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> located in the N-terminal domain of Hsp90. The fluorescence polarization based Hsp90 assay that incorporates GM-Cy3B is designed in such a way that it probes not only for direct binders to the ATP pocket but also for those compounds that may allosterically interfere with the conformation of Hsp90 to block compound access to the ATP pocket.</div><div class="NLM_p">We also tested myricetin (<b>4</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) in these assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Using NMR techniques,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> this compound was proposed to interact with the bacterial Hsp70 homologue, DnaK, at a site potentially close to that occupied by our designed Hsp70 inhibitors. <b>4</b> was also recently reported to inhibit the DnaK–DnaJ (bacterial Hsp70–Hsp40) complex formation (IC<sub>50</sub> = 14.5 μM).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> We could however not measure Hsp70-mediated biological effects for <b>4</b> in the SKBr3 cancer cells at concentrations as high as 100 μM, possibly due to the poor stability of <b>4</b> in the cells. Indeed, LC/MS–MS analyses of cellular extracts demonstrated rapid myricetin degradation with the agent virtually undetectable after 10 min of incubation (not shown). Interestingly, when tested for its potential to bind Hsp90, we found <b>4</b> to alter geldanamycin’s binding to Hsp90 (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Polyphenols such as <b>4</b> are recognized for their high propensity to bind nonspecifically to proteins. As such, caution must be taken when interpreting biological and biochemical results derived through the use of such compounds.</div><div class="NLM_p">Next, we tested select lead compounds in vitro for potential to interfere with other proteins. At the physiologically relevant concentration of 10 μM, derivative <b>17a</b> was inert when tested against the scanMAX 402 kinase panel (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). This panel contains a set of kinases covering the AGC, CAMK, CMGC, CK1, STE, TK, TKL, lipid, and atypical kinase families, plus important mutant forms. Developed by Ambit Biosciences, it employs proprietary active-site-dependent competition binding assays to determine how compounds bind to kinases. It is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site-directed ligand and can be used in detection of multiple inhibitor types (e.g., types I and II and non-ATP-competitive).<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a></div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Derivative <b>17a</b> (at 10 μM) was tested in the scanMAX screen (Ambit) against 402 kinases. The TREE<i>spot</i> interaction map for <b>17a</b> is presented. Only c-Met (red dot on the kinase tree) appears as a potential low-affinity kinase hit of <b>17a</b>. KINOME<i>scan</i>’s selectivity score (<i>S</i>) is a quantitative measure of compound selectivity. It is calculated by dividing the number of kinases that bind to the compound by the total number of distinct kinases tested, excluding mutant variants. <i>S</i>(35) = (number of nonmutant kinases with %Ctrl < 35)/(number of nonmutant kinases tested).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, we describe here SAR studies in the first rationally designed scaffolds with binding potential to a novel allosteric pocket in human Hsp70. This site is located in the N-terminal domain of the chaperone and was recently identified by our homology modeling studies.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> It is not revealed by reported crystal structures of Hsp70, as these capture the protein in a closed conformation in which the reactive Cys267 is unavailable for ligand binding and the pocket is narrow.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24-27)</a> The designed ligands are of a yet unexplored chemical space based on the 2,5′-thiodipyrimidine and 5-(phenylthio)pyrimidine scaffolds, and thus, we are also first to report here a chemical strategy that allows for the assembly of such compounds.</div><div class="NLM_p">The weight of the evidence in this paper and in our previous report<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> indicates that these compounds are acting on Hsp70 through binding to the allosteric pocket. Only if reasonably correct could the homology model enable the rational design of a ligand that, when incubated with the thousands of proteins expressed in a cancer cell, substantially affinity purifies one, Hsp70. Seconded by a biological investigation of these ligands based on specific modulation of the target, Hsp70, in the context of a cancer cell, our data clearly define the mode of action of these ligands, in the cancer cell, through inhibition of Hsp70. From these studies, we identify derivatives <b>17a</b> and <b>20a</b> as being the most active of the series. Addition of high nanomolar to low micromolar concentrations of these agents to several cancer cells led to a reduction in the steady-state levels of Hsp70–HOP–Hsp90 complex chaperoned oncoproteins, an effect associated with inhibition of cell growth and apoptosis.</div><div class="NLM_p">Because Hsp70 contains an active cysteine embedded in the allosteric pocket, the derivatives presented herein contain an acrylamide functionality that may create a covalent bond with such a residue upon Hsp70 protein binding. We have used several techniques to demonstrate the potential formation of a covalent bond between the inhibitor and the protein.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> First, when the biotinylated analogue of <b>17a</b>, <b>44b</b>, was incubated with cancer cells, we noted a time-dependent progressive increase in the amount of immobilized Hsp70. This profile is indicative of time-dependent covalent modification of the protein and is specific for compounds such as <b>17a</b>, where irreversible binding plays a role. Second, mass spectrum analysis of the trypsin digest of the <b>44b</b>–Hsp70 complex identified a major <i>m</i>/<i>z</i> peak at 1867.915.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This corresponds to <b>44b</b> bound to LRTAC<sup>267</sup>ERAK and confirms that the site of interaction of <b>17a</b> with Hsp70 is within site 1, where Cys267 is located and, furthermore, that <b>17a</b> forms an irreversible bond with the protein upon binding. Third, when we probed binding of <b>44b</b> to both the WT Hsp70 protein and the C267S mutant, we noted that high-salt, high-detergent conditions eluted preferentially the Hsp70-C267S mutant protein over the WT form from preformed Hsp70–<b>44b</b> complexes.</div><div class="NLM_p">There is precedent for the use of an acrylamide “warhead” in the development of several irreversible kinase inhibitors currently in clinical trials for cancer.<a onclick="showRef(event, 'ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref45 ref46">(42-46)</a> There is, of course, a concern that such an entity could indiscriminately react with non-target-related proteins, resulting in unwanted biological effects. However, in spite of the presence of an acrylamide, derivatives described here are not excessively reactive and, in addition, have an appropriate fit in the active site of the target, anticipating a favorable enthalpic effect. It is also important to note that, for proteins with long half-lives, such as Hsp70,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> irreversible inhibition is mechanistically advantageous as it confers complete target inhibition until resynthesis of the target protein<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and thus allows for less frequent dosing, which may also tip the balance toward a better therapeutic index for such compounds.</div><div class="NLM_p">In addition to providing both a novel pharmacophore and medicinal chemistry for its assembly, in this paper we describe a testing battery for assessing Hsp70-mediated mechanisms in cancer cells and for evaluating specific ligand action in cells through Hsp70 inhibition. Altogether, these findings provide a novel blueprint for a cancer-oriented development of Hsp70-directed ligands.</div><div class="NLM_p last">To conclude, the series of novel chemical entities reported herein interact with a yet unexplored pocket in Hsp70. These compounds of tractable SAR favorably permeate cancer cells and exhibit their biological activity through inhibition of the tumor Hsp70 species, validating the scaffold as an important starting point for the development of Hsp70 inhibitors with potential therapeutic applications. The accompanying paper in this issue describes the synthesis and structure–activity evaluation of inhibitors of this series that target the same allosteric pocket of Hsp70 described herein but act through a reversible mechanism of action.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83573" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83573" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Chemistry</h3><div class="NLM_p">All reagents were purchased from either Aldrich or Acros Organics and used without purification. All reactions were performed under argon protection. NMR spectra were recorded on a Bruker AV-III-500 MHz NMR spectrometer. Chemical shifts are reported in δ values in parts per million downfield from TMS as the internal standard. <sup>1</sup>H data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constant (Hz), integration. <sup>13</sup>C chemical shifts are reported in δ values in parts per million downfield from TMS as the internal standard. High-resolution mass spectra were recorded on a Waters LCT Premier system. Low-resolution mass spectra were obtained on a Waters Acquity Ultra Performance LC instrument with electrospray ionization and an SQ detector. Analytical HPLC was performed on a Waters Autopurification system with PDA, MicroMass ZQ, and ELSD detectors. The purity of the title compounds used in pharmacology testing was determined by HPLC–MS using the following method: 10–12 min gradient on a Waters2525 binary gradient pump of increasing concentrations of acetonitrile in water (5% → 95%) containing 0.1% formic acid with a flow rate of 1.2 mL/min and UV detection at λ = 220 and 254 nm on an XBridge C18 150 mm × 4.6 mm, 5 μm column. Title compounds used in pharmacology testing were >95% pure. Analytical thin-layer chromatography was performed on 250 μM silica gel F<sub>254</sub> plates. Preparative thin-layer chromatography was performed on 1000 μM silica gel F<sub>254</sub> plates. Flash column chromatography was performed employing 230–400 mesh silica gel. Solvents were HPLC grade. Myricetin was purchased from Indofine Chemical Co. (Hillsborough, NJ). The synthesis of compounds <b>44a</b>,<b>b</b> and <b>45a</b>,<b>b</b> is described in detail in the <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>.</div><div id="sec8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> 4,6-Dimethoxy-<i>N</i>,<i>N</i>-bis(4-methoxybenzyl)pyrimidin-2-amine (<b>9a</b>)</h4><div class="NLM_p last">To a solution of 2-amino-4,6-dimethoxypyrimidine (2.0 g, 12.9 mmol) (<b>8a</b>) in 20 mL of DMF at 0 °C was added NaH (1.24 g, 51.5 mmol), and the mixture was stirred at rt for 10 min. 4-Methoxybenzyl chloride (4.03 g, 25.7 mmol) was added, and the mixture was stirred at rt overnight. The reaction was quenched with methanol and solvent removed under reduced pressure. The residue was dissolved in EtOAc, washed with brine, and dried over MgSO<sub>4</sub>. Solvent was evaporated under reduced pressure, and the residue was purified by column chromatography (hexane/EtOAc, 4:1) to afford 4.8 g (95%) of <b>9a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.26 (d, <i>J</i> = 8.4 Hz, 4H), 6.89 (d, <i>J</i> = 8.4 Hz, 4H), 5.47 (s, 1H), 4.78 (s, 4H), 3.85 (s, 6H), 3.80 (s, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.9, 161.5, 158.7, 130.9, 129.1, 113.8, 78.7, 55.2, 53.4, 48.3. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 396.3.</div></div><div id="sec8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 5-Iodo-4,6-dimethoxy-<i>N</i>,<i>N</i>-bis(4-methoxybenzyl)pyrimidin-2-amine (<b>10a</b>)</h4><div class="NLM_p last">To a solution of <b>9a</b> (4.8 g, 12.3 mmol) in 50 mL of acetonitrile was added NIS (4.13 g, 18.4 mmol), and the resulting solution was stirred at rt for 1 h. Solvent was evaporated, and the residue was purified by column chromatography (hexane/EtOAc, 4:1) to afford 6.3 g (98%) of <b>10a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.18 (d, <i>J</i> = 8.6 Hz, 4H), 6.83 (d, <i>J</i> = 8.6 Hz, 4H), 4.71 (s, 4H), 3.89 (s, 6H), 3.79 (s, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 169.1, 160.9, 158.8, 130.5, 129.0, 113.9, 55.3, 54.7, 48.6, 43.9. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 522.4.</div></div><div id="sec8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 2-((2-(Bis(4-methoxybenzyl)amino)-4,6-dimethoxypyrimidin-5-yl)thio)pyrimidine-4,6-diamine (<b>11a</b>)</h4><div class="NLM_p last">A mixture of <b>10a</b> (6.2 g, 11.9 mmol), 4,6-diamino-2-mercaptopyrimidine (1.7 g, 11.9 mmol), neocuproine (0.538 g, 2.38 mmol), CuI (0.452 g, 2.38 mmol), and K<sub>2</sub>CO<sub>3</sub> (3.3 g, 33.8 mmol) in 100 mL of DMSO was stirred at 120 °C for 16 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 20:1) to afford 4.2 g (65%) of <b>11a</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.18 (d, <i>J</i> = 8.6 Hz, 4H), 6.80 (d, <i>J</i> = 8.6 Hz, 4H), 5.09 (s, 1H), 4.68 (s, 4H), 4.40 (s, 4H), 3.79 (s, 6H), 3.74 (s, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 536.5.</div></div><div id="sec8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> <i>N</i>,<i>N</i>′<i>-</i>(2-((2-(Bis(4-methoxybenzyl)amino)-4,6-dimethoxypyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>12a</b>)</h4><div class="NLM_p last">A solution of <b>11a</b> (3.2 g, 6.0 mmol) and DMAP (0.037 g, 0.3 mmol) in 20 mL of acetic anhydride was stirred at 110 °C for 2 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (hexane/EtOAc, 1:1) to afford 3.4 g (91%) of <b>12a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/DMSO-<i>d</i><sub>6</sub>): δ 8.25 (br s, 1H), 7.70 (br s, 2H), 7.18 (d, <i>J</i> = 10.0 Hz, 4H), 6.81 (d, <i>J</i> = 10.0 Hz, 4H), 4.70 (s, 4H), 3.78 (s, 6H), 3.74 (s, 6H), 2.10 (s, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 620.4.</div></div><div id="sec8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>N</i>,<i>N</i>′-(2-((2-Amino-4,6-dimethoxypyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>13a</b>)</h4><div class="NLM_p last">A solution of <b>12a</b> (0.950 g, 1.5 mmol) in 20 mL of TFA/CHCl<sub>3</sub> (1:1) was heated at 62 °C for 24 h. Excess TFA and solvent were removed under reduced pressure, and the residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 20:1) to afford 0.550 g (95%) of <b>13a</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.51 (br s, 2H), 8.37 (br s, 1H), 6.98 (s, 2H), 3.78 (s, 6H), 2.06 (s, 6H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.9, 170.1, 169.2, 162.5, 158.9, 92.8, 78.5, 53.9, 24.1. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 380.2.</div></div><div id="sec8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>,<i>N</i>′-(2-((2-Fluoro-4,6-dimethoxypyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>14a</b>)</h4><div class="NLM_p last"><b>13a</b> (2.0 g, 5.3 mmol) was added to a plastic tube fitted with a stir bar and cooled to 0 °C followed by addition of a solution of HF/pyridine (3.6 mL, 144 mmol). NaNO<sub>2</sub> (0.545 g, 7.9 mmol) was added in portions over a period of 20 min with stirring. The resulting solution was vigorously stirred for an additional 50 min at 0 °C and 2 h at rt. CaCO<sub>3</sub> (14.4 g, 144 mmol) was added to quench excess HF. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> and purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub>(7N), 20:1) to afford 1.1 g (54%) of <b>14a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.45 (s, 1H), 7.61 (s, 2H), 4.00 (s, 6H), 2.18 (s, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 383.2.</div></div><div id="sec8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>,<i>N</i>′-(2-((4,6-Dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>15a</b>)</h4><div class="NLM_p last">To a solution of <b>14a</b> (30 mg, 0.078 mmol) in 2 mL of DMF was added 1-methylpiperazine (31 mg, 0.31 mmol), and the resulting solution was heated at 90 °C for 1 h. Solvent and excess reagent were removed under reduced pressure, and the residue was purified by column chromatography (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to yield 32 mg (90%) of <b>15a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.36 (br s, 1H), 8.13 (br s, 2H), 3.88 (s, 6H), 3.87 (m, 4H), 2.46 (m, 4H), 2.35 (s, 3H), 1.99 (s, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 172.2, 169.4, 168.9, 160.4, 158.9, 96.1, 95.9, 54.7, 54.3, 46.1, 43.8, 24.7. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 463.2.</div></div><div id="sec8_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-((4,6-Dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidine-4,6-diamine (<b>16a</b>)</h4><div class="NLM_p last">A mixture of <b>15a</b> (50 mg, 0.108 mmol) and 1 N NaOH(aq) (2 mL) in 4 mL of methanol was stirred at 60 °C for 1 h. Solvents were removed under reduced pressure, and the residue was purified by preparatory TLC to afford 39 mg (95%) of <b>16a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 5.19 (s, 1H), 4.48 (s, 4H), 3.88 (s, 6H), 3.87 (m, 4H), 2.48 (m, 4H), 2.35 (s, 3H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 378.9.</div></div><div id="sec8_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-(6-Amino-2-((4,6-dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>17a</b>)</h4><div class="NLM_p last">To a solution of <b>16a</b> (0.370 g, 0.977 mmol) and Et<sub>3</sub>N (0.988 g, 9.77 mmol) in 10 mL of anhydrous dioxane was added acryloyl chloride (0.855 g, 9.77 mmol) dropwise under a water bath. The resulting mixture was stirred at rt for 24 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 0.211 g (50%) of <b>17a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.96 (br s, 1H), 7.04 (s, 1H), 6.41 (d, <i>J</i> = 16.8 Hz, 1H), 6.17 (dd, <i>J</i> = 16.8, 10.3 Hz, 1H), 5.78 (d, <i>J</i> = 10.3 Hz, 1H), 4.83 (br s, 2H), 3.88 (s, 6H), 3.87 (m, 4H), 2.47 (m, 4H), 2.35 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 169.3, 168.8, 162.6, 162.5, 158.3, 154.9, 128.9, 127.1, 86.7, 78.2, 53.1, 52.4, 44.5, 41.9. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>25</sub>N<sub>8</sub>O<sub>3</sub>S, 433.1770; found, 433.1750. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 6.28 min.</div></div><div id="sec8_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>,<i>N</i>′-(2-((4,6-Dimethoxy-2-morpholinopyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>15b</b>)</h4><div class="NLM_p last">To a solution of <b>14a</b> (60 mg, 0.157 mmol) in 2 mL of DMF was added morpholine (54 mg, 0.620 mmol), and the resulting solution was heated at 90 °C for 1 h. Solvent and excess reagent were removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to yield 56 mg (79%) of <b>15b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.41 (br s, 1H), 7.82 (br s, 2H), 3.83 (s, 6H), 3.77 (m, 4H), 3.68 (m, 4H), 2.16 (s, 6H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>24</sub>N<sub>7</sub>O<sub>5</sub>S, 450.1560; found, 450.1548. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 8.47 min.</div></div><div id="sec8_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-((4,6-Dimethoxy-2-morpholinopyrimidin-5-yl)thio)pyrimidine-4,6-diamine (<b>16b</b>)</h4><div class="NLM_p last">A mixture of <b>15b</b> (45 mg, 0.100 mmol) and 1 N NaOH(aq) (2 mL) in 4 mL of methanol was stirred at 60 °C for 1 h. Solvents were removed under reduced pressure, and the residue was purified by preparatory TLC to afford 35 mg (95%) of <b>16b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 5.19 (s, 1H), 4.44 (s, 4H), 3.87 (s, 6H), 3.83 (m, 4H), 3.77 (m, 4H), 2.16 (s, 6H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>20</sub>N<sub>7</sub>O<sub>3</sub>S, 366.1348; found, 366.1361. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 6.45 min.</div></div><div id="sec8_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-(6-Amino-2-((4,6-dimethoxy-2-morpholinopyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>17b</b>)</h4><div class="NLM_p last">To a solution of <b>16b</b> (50 mg, 0.111 mmol) and Et<sub>3</sub>N (56 mg, 0.555 mmol) in 2 mL of anhydrous dioxane was added acryloyl chloride (50 mg, 0.555 mmol) under a water bath. The resulting mixture was stirred at rt for 24 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 26 mg (55%) of <b>17b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.73 (br s, 1H), 7.05 (s, 1H), 6.42 (d, <i>J</i> = 16.9 Hz, 1H), 6.17 (dd, <i>J</i> = 16.7, 10.4 Hz, 1H), 5.80 (d, <i>J</i> = 10.3 Hz, 1H), 4.78 (br s, 2H), 3.89 (s, 6H), 3.81 (m, 4H), 3.75 (m, 4H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>22</sub>N<sub>7</sub>O<sub>4</sub>S, 420.1454; found, 420.1470.</div></div><div id="sec8_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>,<i>N</i>′-(2-((4,6-Dimethoxy-2-(piperidin-1-yl)pyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>15c</b>)</h4><div class="NLM_p last">To a solution of <b>14a</b> (60 mg, 0.157 mmol) in 2 mL of DMF was added piperidine (52 mg, 0.611 mmol), and the resulting solution was heated at 90 °C for 1 h. Solvent and excess reagent were removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to yield 55 mg (78%) of <b>15c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.32 (br s, 1H), 7.77 (br s, 2H), 3.88 (s, 6H), 2.16 (m, 6H), 1.54–1.70 (m, 6H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>26</sub>N<sub>7</sub>O<sub>4</sub>S, 448.1767; found, 448.1766. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 10.13 min.</div></div><div id="sec8_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-((4,6-Dimethoxy-2-(piperidin-1-yl)pyrimidin-5-yl)thio)pyrimidine-4,6-diamine (<b>16c</b>)</h4><div class="NLM_p last">A mixture of <b>15c</b> (55 mg, 0.123 mmol) and 1 N NaOH(aq) (2 mL) in 4 mL of methanol was stirred at 60 °C for 1 h. Solvents were removed under reduced pressure, and the residue was purified by preparatory TLC to afford 43 mg (96%) of <b>16c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 5.18 (s, 1H), 4.42 (s, 4H), 3.88 (s, 6H), 3.80 (m, 4H), 1.60–1.71 (m, 6H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>22</sub>N<sub>7</sub>O<sub>2</sub>S, 364.1556; found, 364.1544. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 7.43 min.</div></div><div id="sec8_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-(6-Amino-2-((4,6-dimethoxy-2-(piperidin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>17c</b>)</h4><div class="NLM_p last">To a solution of <b>16c</b> (46 mg, 0.127 mmol) and Et<sub>3</sub>N (130 mg, 1.30 mmol) in 4 mL of anhydrous dioxane was added acryloyl chloride (119 mg, 1.30 mmol) dropwise under a water bath. The resulting mixture was stirred at rt for 12 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 28 mg (52%) of <b>17c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/DMSO-<i>d</i><sub>6</sub>): δ 9.33 (s, 1H), 7.09 (s, 1H), 6.47–6.35 (m, 2H), 5.71 (d, <i>J</i> = 9.3 Hz, 1H), 5.31 (br s, 2H), 3.88 (s, 6H), 3.81 (m, 4H), 1.69 (m, 2H), 1.62 (m, 4H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>24</sub>N<sub>7</sub>O<sub>3</sub>S, 418.1661; found, 418.1660. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 8.06 min.</div></div><div id="sec8_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-Amino-4,6-diethoxypyrimidine (<b>8b</b>)</h4><div class="NLM_p last">To a solution of 2-amino-4,6-dichloropyrimidine (1.0 g, 6.09 mmol) in 20 mL of absolute ethanol was added NaH (0.585 g, 24.39 mmol) at rt. The mixture was stirred under reflux for 12 h. Solvent was removed under reduced pressure, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with brine. Solvent was evaporated, and the resulting solid was purified by column chromatography (hexane/EtOAc, 4:1) to afford 1.0 g (89%) of <b>8b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 5.42 (s, 1H), 4.78 (br s, 2H), 4.24 (q, <i>J</i> = 7.1 Hz, 4H), 1.34 (t, <i>J</i> = 7.1 Hz, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 183.9.</div></div><div id="sec8_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4,6-Diethoxy-<i>N</i>,<i>N</i>-bis(4-methoxybenzyl)pyrimidin-2-amine (<b>9b</b>)</h4><div class="NLM_p last">To a solution of <b>8b</b> (1.00 g, 5.46 mmol) in 20 mL of DMF at 0 °C was added NaH (0.524 g, 21.83 mmol), and the resulting solution was stirred at rt for 10 min. 4-Methoxybenzyl chloride (1.88 g, 12.0 mmol) was added, and the mixture was stirred at rt overnight. The reaction was quenched with ethanol, and solvent was removed under reduced pressure. The residue was dissolved in EtOAc, washed with brine, dried over MgSO<sub>4</sub>, and concentrated to give a residue that was purified by column chromatography (hexane/EtOAc, 4:1) to afford 2.25 g (97%) of <b>9b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.18 (d, <i>J</i> = 8.1, 4H), 6.84 (d, <i>J</i> = 8.1, 4H), 5.38 (s, 1H), 4.70 (s, 4H), 4.27 (q, <i>J</i> = 7.1 Hz, 4H), 3.79 (s, 6H), 1.29 (t, <i>J</i> = 7.1 Hz, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.5, 161.4, 158.6, 130.9, 129.0, 113.7, 78.6, 61.8, 55.2, 48.1, 14.6. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 424.2.</div></div><div id="sec8_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 5-Iodo-4,6-diethoxy-<i>N</i>,<i>N</i>-bis(4-methoxybenzyl)pyrimidin-2-amine (<b>10b</b>)</h4><div class="NLM_p last">To a solution of <b>9b</b> (2.2 g, 5.2 mmol) in 50 mL of acetonitrile was added NIS (1.7 g, 8 mmol), and the resulting solution was stirred at rt for 1 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (hexane/EtOAc, 4:1) to afford 2.75 g (96%) of <b>10b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.17 (m, 4H), 6.84 (m, 4H), 4.68 (s, 4H), 4.34 (q, <i>J</i> = 7.1 Hz, 4H), 3.80 (s, 6H), 1.32 (t, <i>J</i> = 7.1 Hz, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>/DMSO-<i>d</i><sub>6</sub>): δ 168.3, 160.4, 158.2, 130.1, 128.4, 113.2, 62.6, 54.8, 48.1, 44.2, 14.1. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 550.1.</div></div><div id="sec8_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-((2-(Bis(4-methoxybenzyl)amino)-4,6-diethoxypyrimidin-5-yl)thio)pyrimidine-4,6-diamine (<b>11b</b>)</h4><div class="NLM_p last">A mixture of <b>10b</b> (2.75 g, 5.0 mmol), 4,6-diamino-2-mercaptopyrimidine (0.71 g, 5.0 mmol), neocuproine (0.226 g, 1.0 mmol), CuI (0.190 g, 1.0 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.38 g, 10.0 mmol) in 60 mL of DMSO was stirred at 120 °C for 16 h. Solvent was removed under reduced pressure, and the residue was partially purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 20:1) to afford 2.2 g (80%) of impure <b>11b</b> [MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 564.2], which was used without further purification in the next step.</div></div><div id="sec8_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>,<i>N</i>′-(2-((2-(Bis(4-methoxybenzyl)amino)-4,6-diethoxypyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>12b</b>)</h4><div class="NLM_p last">A solution of <b>11b</b> (1.2 g, 2.19 mmol) and DMAP (0.013 g, 0.11 mmol) in 20 mL of acetic anhydride was stirred at 110 °C for 2 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (hexane/EtOAc, 1:1) to afford 1.2 g (89%) of <b>12b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.22 (s, 2H), 7.21 (d, <i>J</i> = 8.5 Hz, 4H), 6.86 (d, <i>J</i> = 8.5 Hz, 4H), 4.70 (s, 4H) 4.32 (q, <i>J</i> = 7.1 Hz, 4H), 3.80 (s, 6H), 2.16 (s, 6H), 1.20 (t, <i>J</i> = 7.1 Hz, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 648.1.</div></div><div id="sec8_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>,<i>N</i>′-(2-((2-Amino-4,6-diethoxypyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>13b</b>)</h4><div class="NLM_p last">A solution of <b>12b</b> (2.00 g, 3.09 mmol) in 20 mL of TFA/CHCl<sub>3</sub> (1:1) was heated at 62 °C for 24 h. Excess TFA and solvent were removed under reduced pressure, and the residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 20:1) to afford 1.15 g (92%) of <b>13b</b>. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 407.8.</div></div><div id="sec8_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>,<i>N</i>′-(2-((2-Fluoro-4,6-diethoxypyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>14b</b>)</h4><div class="NLM_p last"><b>13b</b> (1.5 g, 3.68 mmol) was added to a plastic tube fitted with a stir bar and cooled to 0 °C followed by addition of a solution of HF/pyridine (3.0 mL, 120 mmol). After several minutes NaNO<sub>2</sub> (0.380 g, 5.52 mmol) was added in portions over a period of 20 min with stirring. The resulting solution was vigorously stirred for an additional 50 min at 0 °C. CaCO<sub>3</sub> (12.0 g, 120 mmol) was added to quench excess HF. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> and purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 20:1) to afford 0.76 g (46%) of <b>14b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.47 (br s, 1H), 7.85 (br s, 2H), 4.44 (q, <i>J</i> = 7.1 Hz, 4H), 2.17 (s, 6H), 1.31 (t, <i>J</i> = 7.1 Hz, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 411.3.</div></div><div id="sec8_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>,<i>N</i>′-(2-((4,6-Diethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>18a</b>)</h4><div class="NLM_p last">To a solution of <b>14b</b> (0.165 g, 0.402 mmol) in 3 mL of DMF was added 1-methylpiperazine (400 mg, 4.4 mmol), and the resulting solution was heated to 90 °C for 1 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to yield 0.180 g (91%) of <b>18a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.35 (br s, 1H), 8.06 (br s, 2H), 4.35 (q, <i>J</i> = 7.1 Hz, 4H), 3.82 (m, 4H), 2.43 (m, 4H), 2.36 (s, 3H), 2.15 (s, 6H), 1.26 (t, <i>J</i> = 7.1 Hz, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 491.2.</div></div><div id="sec8_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-((4,6-Diethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidine-4,6-diamine (<b>19a</b>)</h4><div class="NLM_p last">A mixture of <b>18a</b> (0.130 g, 0.265 mmol) and 1 N NaOH(aq) (2 mL) in 7 mL of methanol was stirred at 60 °C for 1 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 10:1) to afford 0.100 g (93%) of <b>19a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 5.17 (br s, 1H), 4.48 (s, 4H), 4.34 (q, <i>J</i> = 7.1 Hz, 4H), 3.83 (m, 4H), 2.47 (m, 4H), 2.35 (s, 3H), 1.27 (t, <i>J</i> = 7.1 Hz, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 407.1.</div></div><div id="sec8_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(6-Amino-2-((4,6-diethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>20a</b>)</h4><div class="NLM_p last">To a solution of <b>19a</b> (20 mg, 0.049 mmol) and Et<sub>3</sub>N (49 mg, 0.49 mmol) in 1 mL of anhydrous dioxane was added acryloyl chloride (44 mg, 0.49 mmol). The resulting mixture was stirred at rt for 12 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 9 mg (40%) of <b>20a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.14 (br s, 1H), 7.04 (s, 1H), 6.40 (d, <i>J</i> = 16.9 Hz, 1H), 6.19 (dd, <i>J</i> = 16.9, 10.4 Hz, 1H), 5.77 (d, <i>J</i> = 10.4 Hz, 1H), 4.83 (br s, 2H), 4.35 (q, <i>J</i> = 7.0 Hz, 4H), 3.83 (m, 4H), 2.46 (m, 4H), 2.35 (s, 3H), 1.28 (t, <i>J</i> = 7.0 Hz, 6H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.1, 169.2, 164.8, 164.2, 159.4, 156.4, 131.3, 128.1, 87.5, 79.9, 62.0, 54.3, 46.6, 43.2, 14.4. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>29</sub>N<sub>8</sub>O<sub>3</sub>S, 461.2083; found, 461.2096. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 5.57 min.</div></div><div id="sec8_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>,<i>N</i>′-(2-((4,6-Diethoxy-2-morpholinopyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>18b</b>)</h4><div class="NLM_p last">To a solution of <b>14b</b> (165 mg, 0.402 mmol) in 3 mL of DMF was added morpholine (350 mg, 4.02 mmol), and the resulting solution was heated at 90 °C for 1 h. Solvent and excess reagent were removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to yield 192 mg (81%) of <b>18b</b>. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 478.1. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.35 (br s, 1H), 8.06 (br s, 2H), 4.34 (q, <i>J</i> = 7.0 Hz, 4H), 3.82–3.84 (m, 4H), 2.43–2.45 (m, 4H), 2.15 (s, 6H), 1.26 (t, <i>J</i> = 7.0 Hz, 6H).</div></div><div id="sec8_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-((4,6-Diethoxy-2-morpholinopyrimidin-5-yl)thio)pyrimidine-4,6-diamine (<b>19b</b>)</h4><div class="NLM_p last">A mixture of <b>18b</b> (0.200 g, 0.42 mmol) and 1 N NaOH(aq) (2 mL) in 5 mL of methanol was stirred at 60 °C for 1 h. Solvent was removed under reduced pressure, and the residue was purified by chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 0.153 g (93%) of <b>19b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 6.39 (br s, 1H), 4.31 (q, <i>J</i> = 6.2 Hz, 4H), 3.51–3.83 (m, 4H), 1.90–1.95 (m, 4H), 1.19 (t, <i>J</i> = 6.2 Hz, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 394.1.</div></div><div id="sec8_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(6-Amino-2-((4,6-diethoxy-2-morpholinopyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>20b</b>)</h4><div class="NLM_p last">To a solution of <b>19b</b> (20 mg, 0.051 mmol) and Et<sub>3</sub>N (51 mg, 0.51 mmol) in 1 mL of anhydrous dioxane was added acryloyl chloride (46 mg, 0.51 mmol). The resulting mixture was stirred at rt for 12 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 10 mg (42%) of <b>20b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.14 (br s, 1H), 7.04 (s, 1H), 6.40 (d, <i>J</i> = 16.9 Hz, 1H), 6.18 (dd, <i>J</i> = 16.9, 10.4 Hz, 1H), 5.78 (d, <i>J</i> = 10.4 Hz, 1H), 4.82 (s, 2H), 4.35 (q, <i>J</i> = 7.1 Hz, 4H), 3.79 (m, 4H), 3.76 (m, 4H), 1.27 (t, <i>J</i> = 7.2 Hz, 6H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>26</sub>N<sub>7</sub>O<sub>4</sub>S, 448.1767; found, 448.1754. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 7.97 min.</div></div><div id="sec8_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>,<i>N</i>′-(2-((4,6-Diethoxy-2-(piperidin-1-yl)pyrimidin-5-yl)thio)pyrimidine-4,6-diyl)diacetamide (<b>18c</b>)</h4><div class="NLM_p last">To a solution of <b>14b</b> (165 mg, 0.402 mmol) in 3 mL of DMF was added piperidine (342 mg, 4.02 mmol), and the resulting solution was heated at 90 °C for 1 h. Solvent and excess reagent were removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to yield 167 mg (87%) of <b>18c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.60 (br s, 2H), 8.35 (br s, 1H), 4.34 (q, <i>J</i> = 7.1 Hz, 4H), 3.75 (m, 4H), 2.17 (s, 6H), 1.67 (m, 2H), 1.58 (m, 4H), 1.27 (t, <i>J</i> = 7.1 Hz, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 476.2.</div></div><div id="sec8_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-((4,6-Diethoxy-2-(piperidin-1-yl)pyrimidin-5-yl)thio)pyrimidine-4,6-diamine (<b>19c</b>)</h4><div class="NLM_p last">A mixture of <b>18c</b> (0.200 g, 0.42 mmol) and 1 N NaOH(aq) (2 mL) in 5 mL of methanol was stirred at 60 °C for 1 h. Solvent was removed under reduced pressure, and the residue was purified by chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 0.156 g (95%) of <b>19c</b>. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 392.2.</div></div><div id="sec8_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(6-Amino-2-((4,6-diethoxy-2-(piperidin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>20c</b>)</h4><div class="NLM_p last">To a solution of <b>19c</b> (30 mg, 0.076 mmol) and Et<sub>3</sub>N (76 mg, 0.76 mmol) in 1 mL of anhydrous dioxane was added acryloyl chloride (69 mg, 0.76 mmol) dropwise. The resulting mixture was stirred at rt for 12 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 16 mg (48%) of <b>20c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.09 (br s, 1H), 7.03 (s, 1H), 6.40 (dd, <i>J</i> = 16.9, 1.1 Hz, 1H), 6.19 (dd, <i>J</i> = 16.9, 10.3 Hz, 1H), 5.77 (dd, <i>J</i> = 10.3, 1.1 Hz, 1H), 4.82 (s, 2H), 4.35 (q, <i>J</i> = 7.1 Hz, 4H), 3.76 (m, 4H), 1.65–1.69 (m, 2H), 1.57–1.61 (m, 4H), 1.26 (t, <i>J</i> = 7.1 Hz, 6H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>28</sub>N<sub>7</sub>O<sub>3</sub>S, 446.1974; found, 446.1974. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 10.67 min.</div></div><div id="sec8_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 5-((4-Aminopyrimidin-2-yl)thio)-4,6-dimethoxy-<i>N</i>,<i>N</i>-bis(4-methoxybenzyl)pyrimidin-2-amine (<b>21</b>)</h4><div class="NLM_p last">A mixture of <b>10a</b> (8.2 g, 15.8 mmol), 4-amino-2-mercaptopyrimidine (2.2 g, 17.3 mmol), neocuproine (0.711 g, 3.16 mmol), CuI (0.616 g, 3.16 mmol), and K<sub>2</sub>CO<sub>3</sub> (4.36 g, 31.6 mmol) in 100 mL of DMSO was stirred at 130 °C for 16 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:0 to 90:10) to afford 7.6 g (92%) of <b>21</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.97 (d, <i>J</i> = 5.7 Hz, 1H), 7.23 (d, <i>J</i> = 8.3 Hz, 4H), 6.86 (d, <i>J</i> = 8.3 Hz, 4H), 6.05 (d, <i>J</i> = 5.7 Hz, 1H), 4.94 (br s, 2H), 4.75 (s, 4H), 3.87 (s, 6H), 3.81 (s, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 521.1.</div></div><div id="sec8_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(2-((2-(Bis(4-methoxybenzyl)amino)-4,6-dimethoxypyrimidin-5-yl)thio)pyrimidin-4-yl)acetamide (<b>22</b>)</h4><div class="NLM_p last">A solution of <b>21</b> (7.6 g, 14.6 mmol) in 50 mL of acetic anhydride was stirred at 120 °C for 1 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:0 to 90:10) to afford 7.37 g (93%) of <b>22</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.17 (s, 1H), 8.32 (d, <i>J</i> = 5.5 Hz, 1H), 7.76 (br s, 1H), 7.22 (d, <i>J</i> = 8.3 Hz, 4H), 6.85 (d, <i>J</i> = 8.3 Hz, 4H), 4.73 (s, 4H), 3.84 (s, 6H), 3.79 (s, 6H), 2.16 (s, 3H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 563.2.</div></div><div id="sec8_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(2-((2-Amino-4,6-dimethoxypyrimidin-5-yl)thio)pyrimidin-4-yl)acetamide (<b>23</b>)</h4><div class="NLM_p last">A solution of <b>22</b> (7.0 g, 12.9 mmol) in 30 mL of TFA was heated at 60 °C for 12 h. Excess TFA and solvent were removed under reduced pressure, and the residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 20:1) to afford 4.16 g (85%) of <b>23</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 10.23 (br s, 1H), 8.21 (s, 1H), 7.75 (s, 1H), 5.98 (br s, 2H), 3.88 (s, 6H), 2.14 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 170.8, 170.2, 170.0, 161.8, 157.5, 157.4, 105.1, 80.2, 53.7, 23.8. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>15</sub>N<sub>6</sub>O<sub>3</sub>S, 323.0926; found, 323.0913. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 5.56 min.</div></div><div id="sec8_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(2-((2-Fluoro-4,6-dimethoxypyrimidin-5-yl)thio)pyrimidin-4-yl)acetamide (<b>24</b>)</h4><div class="NLM_p last"><b>23</b> (1.72 g, 5.32 mmol) was added to a plastic tube fitted with a stir bar and cooled to 0 °C followed by addition of a solution of HF/pyridine (3.6 mL, 144 mmol). NaNO<sub>2</sub> (0.545 g, 7.9 mmol) was added in portions over a period of 20 min with stirring. The resulting solution was vigorously stirred for an additional 50 min at 0 °C and 2 h at rt. CaCO<sub>3</sub> (14.4 g, 144 mmol) was added to destroy excess HF. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> and purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 20:1) to afford 0.99 g (57%) of <b>24</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.34 (d, <i>J</i> = 5.6 Hz, 1H), 7.82 (d, <i>J</i> = 5.6 Hz, 1H), 4.00 (s, 6H), 2.21 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 173.2, 169.2, 162.8, 161.1, 159.0, 157.1, 105.9, 90.7, 55.8, 24.8. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>13</sub>FN<sub>5</sub>O<sub>3</sub>S, 326.0723; found, 326.0732. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 7.75 min.</div></div><div id="sec8_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(2-((4,6-Dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acetamide (<b>25a</b>)</h4><div class="NLM_p last">To a solution of <b>24</b> (213 mg, 0.655 mmol) in DMF (10 mL) was added 1-methylpiperazine (0.291 mL, 262 mg, 2.62 mmol), and the resulting solution was heated at 90 °C for 1 h. Solvent was removed under reduced pressure, and the residue was purified by chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 50:1 to 30:1) to afford 0.253 g (95%) of <b>25a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.34 (d, <i>J</i> = 5.6 Hz, 1H), 8.09 (br s, 1H), 7.75 (br s, 1H), 3.90 (s, 6H), 3.88 (m, 4H), 2.48 (m, 4H), 2.38 (s, 3H), 2.18 (s, 3H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>24</sub>N<sub>7</sub>O<sub>3</sub>S, 406.1661; found, 406.1661. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 5.75 min.</div></div><div id="sec8_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-((4,6-Dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-amine (<b>26a</b>)</h4><div class="NLM_p last"><b>25a</b> (253 mg, 0.624 mmol) in MeOH (2 mL) and 1 N NaOH(aq) (10 mL) was stirred at 60 °C for 80 min. Solvent was removed under reduced pressure, and the residue was purified by chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 50:1 to 25:1) to afford 221 mg (97%) of <b>26a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.95 (d, <i>J</i> = 5.8 Hz, 1H), 6.04 (d, <i>J</i> = 5.8 Hz, 1H), 5.01 (s, 2H), 3.89 (br s, 10H), 2.48 (m, 4H), 2.36 (s, 3H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>22</sub>N<sub>7</sub>O<sub>2</sub>S, 364.1556; found, 364.1542. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 4.90 min.</div></div><div id="sec8_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(2-((4,6-Dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>27a</b>)</h4><div class="NLM_p last">To a solution of <b>26a</b> (50 mg, 0.138 mmol) and Et<sub>3</sub>N (69 mg, 0.688 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added acryloyl chloride (62 mg, 0.688 mmol) under a water bath. The resulting mixture was stirred at rt for 24 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 42 mg (72%) of <b>27a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.37 (d, <i>J</i> = 5.6 Hz, 1H), 8.07 (s, 1H), 7.85 (d, <i>J</i> = 5.6 Hz, 1H), 6.47 (d, <i>J</i> = 16.9 Hz, 1H), 6.23 (dd, <i>J</i> = 16.9, 10.3 Hz, 1H), 5.86 (d, <i>J</i> = 10.3 Hz, 1H), 3.89 (m, 10H), 2.49 (m, 4H), 2.37 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.5, 171.1, 164.0, 160.2, 159.0, 157.1, 130.3, 129.9, 105.8, 79.5, 54.9, 54.3, 46.2, 43.6. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>24</sub>N<sub>7</sub>O<sub>3</sub>S, 418.1661; found, 418.1666.</div></div><div id="sec8_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(2-((4,6-Dimethoxy-2-morpholinopyrimidin-5-yl)thio)pyrimidin-4-yl)acetamide (<b>25b</b>)</h4><div class="NLM_p last">To a solution of <b>24</b> (100 mg, 0.307 mmol) in DMF (4 mL) was added morpholine (107 mg, 1.23 mmol), and the resulting solution was heated at 90 °C for 1 h. Solvent and excess reagent were removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to yield 102 mg (85%) of <b>25b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.35 (d, <i>J</i> = 5.6 Hz, 1H), 8.10 (s, 1H), 7.75 (br s, 1H), 3.89 (s, 6H), 3.84 (m, 4H), 3.77 (m, 4H), 2.18 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 168.6, 161.0, 159.2, 158.7, 130.6, 129.3, 113.8, 82.3, 71.5, 55.2, 47.9, 29.5. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>21</sub>N<sub>6</sub>O<sub>4</sub>S, 393.1345; found, 393.1332. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 7.57 min.</div></div><div id="sec8_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-((4,6-Dimethoxy-2-morpholinopyrimidin-5-yl)thio)pyrimidin-4-amine (<b>26b</b>)</h4><div class="NLM_p last">A mixture of <b>25b</b> (100 mg, 0.255 mmol) and 1 N NaOH(aq) (4 mL) in 8 mL of methanol was stirred at 60 °C for 1 h. Solvents were removed under reduced pressure, and the residue was purified by preparatory TLC to afford 84 mg (94%) of <b>26b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.95 (d, <i>J</i> = 5.7 Hz, 1H), 6.05 (d, <i>J</i> = 5.7 Hz, 1H), 4.96 (s, 2H), 3.90 (s, 6H), 3.82 (m, 4H), 3.76 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.3, 171.1, 162.5, 160.2, 156.2, 101.1, 80.5, 66.8, 54.2, 44.2. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>19</sub>N<sub>6</sub>O<sub>3</sub>S, 351.1239; found, 351.1248. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 6.30 min.</div></div><div id="sec8_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(2-((4,6-Dimethoxy-2-morpholinopyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>27b</b>)</h4><div class="NLM_p last">To a solution of <b>26b</b> (50 mg, 0.143 mmol) and Et<sub>3</sub>N (72 mg, 0.713 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added acryloyl chloride (65 mg, 0.713 mmol) under a water bath. The resulting mixture was stirred at rt for 24 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 43 mg (74%) of <b>27b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.37 (d, <i>J</i> = 5.6 Hz, 1H), 8.03 (s, 1H), 7.85 (d, <i>J</i> = 5.6 Hz, 1H), 6.47 (d, <i>J</i> = 16.9 Hz, 1H), 6.22 (dd, <i>J</i> = 16.9, 10.3 Hz, 1H), 5.86 (d, <i>J</i> = 10.3 Hz, 1H), 3.89 (s, 6H), 3.85 (m, 4H), 3.77 (m, 4H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>21</sub>N<sub>6</sub>O<sub>4</sub>S, 405.1345; found, 405.1338. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 8.07 min.</div></div><div id="sec8_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(2-((4,6-Dimethoxy-2-(piperidin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acetamide (<b>25c</b>)</h4><div class="NLM_p last">To a solution of <b>24</b> (100 mg, 0.307 mmol) in DMF (4 mL) was added piperidine (105 mg, 1.23 mmol), and the resulting solution was heated at 90 °C for 1 h. Solvent and excess reagent were removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to yield 104 mg (87%) of <b>25c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.35 (d, <i>J</i> = 5.6 Hz, 1H), 8.00 (br s, 1H), 7.73 (br s, 1H), 3.88 (s, 6H), 3.80 (m, 4H), 2.18 (s, 3H), 1.66 (m, 2H), 1.59 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.6, 171.0, 160.1, 158.9, 156.9, 105.3, 82.5, 54.1, 44.8, 29.7, 25.8, 24.8. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>23</sub>N<sub>6</sub>O<sub>3</sub>S, 391.1552; found, 391.1549. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 9.18 min.</div></div><div id="sec8_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-((4,6-Dimethoxy-2-(piperidin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-amine (<b>26c</b>)</h4><div class="NLM_p last">A mixture of <b>25c</b> (100 mg, 0.256 mmol) and 1 N NaOH(aq) (4 mL) in 8 mL of methanol was stirred at 60 °C for 1 h. Solvents were removed under reduced pressure, and the residue was purified by preparatory TLC to afford 83 mg (93%) of <b>26c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.95 (d, <i>J</i> = 5.6 Hz, 1H), 6.03 (d, <i>J</i> = 5.6 Hz, 1H), 4.95 (s, 2H), 3.88 (s, 6H), 3.79 (m, 4H), 1.66 (m, 2H), 1.60 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.5, 171.0, 162.5, 160.0, 156.2, 101.0, 54.1, 44.8, 25.7, 24.8. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>21</sub>N<sub>6</sub>O<sub>2</sub>S, 349.1447; found, 349.1434. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 7.60 min.</div></div><div id="sec8_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(2-((4,6-Dimethoxy-2-(piperidin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>27c</b>)</h4><div class="NLM_p last">To a solution of <b>26c</b> (50 mg, 0.144 mmol) and Et<sub>3</sub>N (72 mg, 0.718 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added acryloyl chloride (65 mg, 0.718 mmol) under a water bath. The resulting mixture was stirred at rt for 24 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 45 mg (78%) of <b>27c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.37 (d, <i>J</i> = 5.6 Hz, 1H), 7.95 (s, 1H), 7.83 (d, <i>J</i> = 5.6 Hz, 1H), 6.48 (dd, <i>J</i> = 16.9, 0.8 Hz, 1H), 6.23 (dd, <i>J</i> = 16.9, 10.4 Hz, 1H), 5.85 (dd, <i>J</i> = 10.3, 0.8 Hz, 1H), 3.88 (s, 6H), 3.81 (m, 4H), 1.69 (m, 2H), 1.62 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.7, 171.0, 164.0, 160.1, 158.9, 157.0, 130.3, 105.6, 54.1, 44.8, 25.8, 24.8. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>23</sub>N<sub>6</sub>O<sub>3</sub>S, 403.1552; found, 403.1541. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 9.23 min.</div></div><div id="sec8_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(2-((4,6-Dimethoxy-2-(pyrrolidin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acetamide (<b>25d</b>)</h4><div class="NLM_p last">To a solution of <b>24</b> (100 mg, 0.307 mmol) in DMF (4 mL) was added pyrrolidine (87 mg, 1.23 mmol), and the resulting solution was heated at 90 °C for 1 h. Solvent and excess reagent were removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to yield 95 mg (82%) of <b>25d</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.34 (d, <i>J</i> = 5.6 Hz, 1H), 8.10 (s, 1H), 7.72 (br s, 1H), 3.89 (s, 6H), 3.59 (m, 4H), 2.17 (s, 3H), 1.96 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.7, 170.8, 159.0, 158.9, 156.9, 105.3, 78.3, 54.0, 46.6, 25.4, 24.7. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>21</sub>N<sub>6</sub>O<sub>3</sub>S, 377.1396; found, 377.1383. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 8.85 min.</div></div><div id="sec8_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-((4,6-Dimethoxy-2-(pyrrolidin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-amine (<b>26d</b>)</h4><div class="NLM_p last">A mixture of <b>25d</b> (90 mg, 0.239 mmol) and 1 N NaOH(aq) (4 mL) in 8 mL of methanol was stirred at 60 °C for 1 h. Solvents were removed under reduced pressure, and the residue was purified by preparatory TLC to afford 77 mg (96%) of <b>26d</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.96 (d, <i>J</i> = 5.7 Hz, 1H), 6.03 (d, <i>J</i> = 5.7 Hz, 1H), 4.88 (s, 2H), 3.90 (s, 6H), 3.58 (t, <i>J</i> = 6.0 Hz, 4H), 1.96 (t, <i>J</i> = 6.0 Hz, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.7, 170.9, 162.4, 159.0, 156.3, 100.9, 79.0, 54.0, 46.5, 25.4. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>19</sub>N<sub>6</sub>O<sub>2</sub>S, 335.1290; found, 335.1291. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 7.32 min.</div></div><div id="sec8_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(2-((4,6-Dimethoxy-2-(pyrrolidin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>27d</b>)</h4><div class="NLM_p last">To a solution of <b>26d</b> (50 mg, 0.150 mmol) and Et<sub>3</sub>N (76 mg, 0.748 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added acryloyl chloride (68 mg, 0.748 mmol) under a water bath. The resulting mixture was stirred at rt for 24 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 43 mg (73%) of <b>27d</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.37 (d, <i>J</i> = 5.6 Hz, 1H), 7.94 (s, 1H), 7.83 (d, <i>J</i> = 5.6 Hz, 1H), 6.47 (dd, <i>J</i> = 16.9, 0.8 Hz, 1H), 6.22 (dd, <i>J</i> = 16.9, 10.4 Hz, 1H), 5.85 (dd, <i>J</i> = 10.4, 0.8 Hz, 1H), 3.91 (s, 6H), 3.61 (m, 4H), 1.98 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.6, 171.0, 164.7, 159.2, 158.8, 130.4, 129.7, 105.9, 54.2, 46.7, 25.5. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>21</sub>N<sub>6</sub>O<sub>3</sub>S, 389.1396; found, 389.1398. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 10 min), <i>t</i><sub>R</sub> = 9.15 min.</div></div><div id="sec8_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(5-((4-Acrylamidopyrimidin-2-yl)thio)-4,6-dimethoxypyrimidin-2-yl)-1-methylpiperazine 1-Oxide (<b>28</b>)</h4><div class="NLM_p last">To a mixture of <b>27a</b> (20 mg, 0.0479 mmol) and NaHCO<sub>3</sub> (40 mg, 0.479 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) cooled to −78 °C was added <i>m</i>-CPBA (9.1 mg, 0.0527 mmol). The reaction mixture was stirred for 4 h at −78 °C. Then Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> was added in one portion. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 20:1) to afford 17 mg (83%) of <b>28</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.47 (br s, 1H), 8.33 (d, <i>J</i> = 5.7 Hz, 1H), 7.89 (d, <i>J</i> = 5.7 Hz, 1H), 6.43–6.49 (m, 2H), 5.81 (dd, <i>J</i> = 7.7, 3.8 Hz, 1H), 4.67–4.75 (m, 2H), 3.85–3.95 (m, 8H), 3.41–3.51 (m, 7H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.2, 170.8, 164.8, 159.6, 158.8, 157.7, 130.6, 129.7, 106.2, 81.1, 65.3, 60.2, 54.5, 38.6. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>24</sub>N<sub>7</sub>O<sub>4</sub>S, 434.1610; found, 434.1592. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (40–95% ACN in 10 min), <i>t</i><sub>R</sub> = 6.35 min.</div></div><div id="sec8_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-((2,4,6-Trimethoxypyrimidin-5-yl)thio)pyrimidin-4-amine (<b>29</b>)</h4><div class="NLM_p last">To a solution of <b>24</b> (100 mg, 0.307 mmol) in MeOH (5 mL) was added NaOCH<sub>3</sub> (36 mg, 0.675 mmol), and the resulting solution was heated at 90 °C for 1 h. Then 1 N NaOH(aq) (2 mL) was added and heating continued at 60 °C for 1 h. Solvent and excess reagent were removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to yield 68 mg (75%) of <b>29</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.77 (d, <i>J</i> = 5.8 Hz, 1H), 6.86 (br s, 2H), 6.11 (d, <i>J</i> = 5.8 Hz, 1H), 3.95 (s, 3H), 3.87 (s, 6H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 295.9.</div></div><div id="sec8_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-(2-((2,4,6-Trimethoxypyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>30</b>)</h4><div class="NLM_p last">To a solution of <b>29</b> (50 mg, 0.169 mmol) and Et<sub>3</sub>N (26 mg, 0.254 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added acryloyl chloride (23 mg, 0.254 mmol) under a water bath. The resulting mixture was stirred at rt for 2 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 20:1) to afford 40 mg (68%) of <b>30</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.29 (d, <i>J</i> = 5.6 Hz, 1H), 7.81 (d, <i>J</i> = 5.6 Hz, 1H), 7.78 (s, 1H), 6.40 (d, <i>J</i> = 16.9 Hz, 1H), 6.15 (dd, <i>J</i> = 16.9, 10.3 Hz, 1H), 5.80 (d, <i>J</i> = 10.3 Hz, 1H), 3.97 (s, 3H), 3.95 (s, 6H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>16</sub>N<sub>5</sub>O<sub>4</sub>S, 350.0923; found, 350.0936.</div></div><div id="sec8_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-(6-Amino-2-((2-amino-4,6-dimethoxypyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>31</b>)</h4><div class="NLM_p last">To a solution of <b>11a</b> (50 mg, 0.093 mmol) and Et<sub>3</sub>N (14 mg, 0.140 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added acryloyl chloride (12.7 mg, 0.140 mmol) under a water bath. The resulting mixture was stirred at rt for 2 h. Solvent was removed under reduced pressure, the residue was dissolved in 1 mL of TFA/CHCl<sub>3</sub> (1:1), and the resulting solution was heated at 62 °C for 12 h. TFA and solvent were removed under reduced pressure, and the residue was purified by preparatory TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 18 mg (55%) of <b>31</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 7.04 (s, 1H), 6.32–6.41 (m, 2H), 5.80 (dd, <i>J</i> = 10.3, 0.8 Hz, 1H), 3.88 (s, 6H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>16</sub>N<sub>7</sub>O<sub>3</sub>S, 350.1035; found, 350.1025. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (5–95% ACN in 12 min), <i>t</i><sub>R</sub> = 5.92 min.</div></div><div id="sec8_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4,6-Dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidine (<b>33a</b>)</h4><div class="NLM_p last">A 5 g (0.0286 mol) portion of 2-chloro-4,6-dimethoxypyrimidine (<b>32</b>) and 7.93 mL (7.16 g, 0.0715 mol) of <i>N</i>-methylpiperazine in 22 mL of DMF were heated at 90 °C for 2.5 h. The reaction mixture was concentrated under reduced pressure, and the residue was taken up into 200 mL of CH<sub>2</sub>Cl<sub>2</sub>. This was washed with brine (3 × 50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to give 6.51 g (95%) of <b>33a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 5.37 (s, 1H), 3.85 (s, 6H), 3.82 (m, 4H), 2.44 (m, 4H), 2.33 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 172.0, 160.8, 77.8, 55.0, 53.4, 46.3, 43.7. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 239.2.</div></div><div id="sec8_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 5-Iodo-4,6-dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidine (<b>34a</b>)</h4><div class="NLM_p last">To 1.59 g (6.67 mmol) of <b>33a</b> in 40 mL of acetonitrile were added 1.80 g (8.01 mmol) of NIS and 0.771 mL (1.14 g, 10.0 mmol) of TFA, and the resulting solution was stirred at rt for 1.5 h. The reaction mixture was concentrated to dryness, and the residue was taken up into 100 mL of CH<sub>2</sub>Cl<sub>2</sub>, washed with 10% sodium thiosulfate (50 mL) and 5% NaHCO<sub>3</sub> (3 × 50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to give a residue which was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 1:0 to 20:1) to yield 2.06 g (86%) of <b>34a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 3.93 (s, 6H), 3.82 (m, 4H), 2.47 (m, 4H), 2.36 (s, 3H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 365.1.</div></div><div id="sec8_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 3-((4,6-Dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)aniline (<b>35a</b>)</h4><div class="NLM_p last">A mixture of <b>34a</b> (0.200 g, 0.549 mmol), 3-aminothiophenol (70 μL, 0.082 g, 0.659 mmol), neocuproine (0.023 g, 0.11 mmol), CuI (0.038 g, 0.011 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.152 g, 1.10 mmol) in DMF (7 mL) was stirred at 130 °C for 16 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 200:1 to 40:1) to afford 0.133 g (67%) of <b>35a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 6.97 (t, <i>J</i> = 8.0 Hz, 1H), 6.46–6.51 (m, 1H), 6.36–6.40 (m, 2H), 3.88–4.03 (m, 10H), 3.58 (br s, 2H), 2.52 (m, 4H), 2.38 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.8, 160.1, 146.9, 139.5, 129.6, 116.2, 112.2, 112.1, 81.1, 55.0, 54.6, 46.3, 43.8. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>24</sub>N<sub>5</sub>O<sub>2</sub>S, 362.1651; found, 362.1649.</div></div><div id="sec8_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-(3-((4,6-Dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)phenyl)acrylamide (<b>36a</b>)</h4><div class="NLM_p last">To a solution of <b>35a</b> (50 mg, 0.138 mmol) and Et<sub>3</sub>N (21 mg, 0.207 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added acryloyl chloride (19 mg, 0.207 mmol) under a water bath. The resulting mixture was stirred at rt for 2 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 20:1) to afford 44 mg (77%) of <b>36a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.49 (m, 1H), 7.36 (m, 1H), 7.14 (m, 2H), 6.84 (d, <i>J</i> = 7.5 Hz, 1H), 6.36 (m, 1H), 6.22 (m, 1H), 5.73 (m, 1H), 4.02 (m, 4H), 3.90 (s, 6H), 2.70 (m, 4H), 2.50 (s, 3H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub>S, 416.1756; found, 416.1742.</div></div><div id="sec8_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>N</i>-(3-((4,6-Dimethoxy-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)phenyl)methacrylamide (<b>36b</b>)</h4><div class="NLM_p last">To a solution of <b>35a</b> (50 mg, 0.138 mmol) and Et<sub>3</sub>N (140 mg, 1.38 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added methacryloyl chloride (144 mg, 1.38 mmol) dropwise under a water bath. The resulting mixture was stirred at rt for 16 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 20:1) to afford 38 mg (65%) of <b>36b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.40–7.47 (m, 2H), 7.12–7.18 (m, 2H), 6.79–6.83 (m, 1H), 5.74 (d, <i>J</i> = 1.2 Hz, 1H), 5.43 (d, <i>J</i> = 1.2 Hz, 1H), 3.99 (m, 4H), 3.91 (s, 6H), 2.65 (m, 4H), 2.47 (s, 3H), 2.03 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.8, 166.7, 160.1, 141.2, 139.5, 138.4, 129.4, 121.9, 119.9, 117.1, 116.9, 81.3, 54.72, 54.67, 45.9, 43.3, 19.0. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub>S, 430.1913; found, 430.1902. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (40–95% ACN in 10 min), <i>t</i><sub>R</sub> = 3.02 min.</div></div><div id="sec8_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4-(4,6-Dimethoxypyrimidin-2-yl)morpholine (<b>33b</b>)</h4><div class="NLM_p last">A 5 g (0.0286 mol) portion of <b>32</b> and 6.25 mL (6.23 g, 0.0715 mol) of morpholine in 22 mL of DMF were heated at 90 °C for 2.5 h. The reaction mixture was concentrated under reduced pressure, and the residue was taken up into 200 mL of CH<sub>2</sub>Cl<sub>2</sub>. This was washed with brine (3 × 50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to give 6.00 g (93%) of <b>33b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 5.40 (s, 1H), 3.86 (s, 6H), 3.77 (m, 4H), 3.75 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 172.0, 160.9, 78.2, 66.8, 53.5, 44.2. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 226.2.</div></div><div id="sec8_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 4-(5-Iodo-4,6-dimethoxypyrimidin-2-yl)morpholine (<b>34b</b>)</h4><div class="NLM_p last">To 1.5 g (6.66 mmol) of <b>33b</b> in 40 mL of acetonitrile was added 1.80 g (8.00 mmol) of NIS, and the resulting solution was stirred at rt for 2 h. The reaction mixture was concentrated to dryness, and the residue was taken up into 100 mL of CH<sub>2</sub>Cl<sub>2</sub>, washed with 10% sodium thiosulfate (50 mL) and 5% NaHCO<sub>3</sub> (3 × 50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to give a residue which was purified by column chromatography (hexane/EtOAc, 80:20) to yield 1.99 g (85%) of <b>34b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 3.92 (s, 6H), 3.71–3.79 (m, 8H). MS (<i>m</i>/<i>z</i>): 352.1 [M + H]<sup>+</sup>.</div></div><div id="sec8_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 3-((4,6-Dimethoxy-2-morpholinopyrimidin-5-yl)thio)aniline (<b>35b</b>)</h4><div class="NLM_p last">A mixture of <b>34b</b> (1.33 g, 3.8 mmol), 3-aminothiophenol (0.48 mL, 0.571 g, 4.56 mmol), neocuproine (0.172 g, 0.76 mmol), CuI (0.144 g, 0.76 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.57 g, 11.3 mmol) in 30 mL of DMF was stirred at 120 °C for 16 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (hexane/EtOAc, 1:1) to afford 0.92 g (70%) of <b>35b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 6.97 (m, 1H), 6.49 (d, <i>J</i> = 8.0 Hz, 1H), 6.37–6.40 (m, 2H), 3.90 (s, 6H), 3.83–3.86 (m, 4H), 3.77–3.80 (m, 4H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>S, 349.1334; found, 349.1341. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (40–95% ACN in 10 min), <i>t</i><sub>R</sub> = 3.16 min.</div></div><div id="sec8_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> <i>N</i>-(3-((4,6-Dimethoxy-2-morpholinopyrimidin-5-yl)thio)phenyl)acrylamide (<b>37</b>)</h4><div class="NLM_p last">To a solution of <b>35b</b> (50 mg, 0.144 mmol) and Et<sub>3</sub>N (22 mg, 0.215 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added acryloyl chloride (19 mg, 0.215 mmol) under a water bath. The resulting mixture was stirred at rt for 2 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CHCl<sub>3</sub>/MeOH–NH<sub>3</sub> (7 N), 20:1) to afford 36 mg (63%) of <b>37</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.46–7.50 (m, 2H), 7.12–7.16 (m, 2H), 6.81 (d, <i>J</i> = 7.4 Hz, 1H), 6.38 (d, <i>J</i> = 16.9 Hz, 1H), 6.20 (dd, <i>J</i> = 16.9, 10.3 Hz, 1H), 5.71 (d, <i>J</i> = 10.3 Hz, 1H), 3.90 (s, 6H), 3.82–3.86 (m, 4H), 3.75–3.79 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 171.5, 163.5, 160.1, 139.3, 138.2, 135.3, 131.2, 129.2, 127.7, 121.7, 116.7, 80.9, 66.7, 54.4, 44.2. HRMS (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>SNa, 425.1259; found, 425.1260. HPLC: (a) H<sub>2</sub>O + 0.1% TFA, (b) ACN + 0.1% TFA (40–95% ACN in 10 min), <i>t</i><sub>R</sub> = 7.15 min.</div></div><div id="sec8_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 4,6-Dimethyl-2-(4-methylpiperazin-1-yl)pyrimidine (<b>39a</b>)</h4><div class="NLM_p last">A 1.43 g (10 mmol) portion of 2-chloro-4,6-dimethylpyrimidine (<b>38</b>) and 2.50 g (25 mmol) of <i>N</i>-methylpiperazine in 20 mL of DMF were heated at 90 °C for 2.5 h. The reaction mixture was concentrated under reduced pressure, and the residue was taken up into 100 mL of CH<sub>2</sub>Cl<sub>2</sub>. This was washed with brine (3 × 25 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to give 1.92 g (93%) of <b>39a</b>. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 207.0.</div></div><div id="sec8_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 5-Iodo-4,6-dimethyl-2-(4-methylpiperazin-1-yl)pyrimidine (<b>40a</b>)</h4><div class="NLM_p last">To 1.61 g (7.8 mmol) of <b>39a</b> in 40 mL of acetonitrile were added 3.7 g (16.4 mmol) of NIS and 2.4 mL (3.56 g, 31.2 mmol) of TFA, and the resulting solution was stirred at rt for 17 h. The reaction mixture was concentrated to dryness, and the residue was taken up into 150 mL of CH<sub>2</sub>Cl<sub>2</sub>, washed with 10% sodium thiosulfate (50 mL) and 5% NaHCO<sub>3</sub> (3 × 50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to give a residue which was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 1:0 to 10:1) to yield 2.32 g (90%) of <b>40a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 3.82 (m, 4H), 2.52 (s, 6H), 2.43 (m, 4H), 2.33 (s, 3H). MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 332.9.</div></div><div id="sec8_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-((4,6-Dimethyl-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-amine (<b>41a</b>)</h4><div class="NLM_p last">A mixture of <b>40a</b> (350 mg, 1.05 mmol), 4-amino-2-mercaptopyrimidine (147 mg, 1.15 mmol), neocuproine (47 mg, 0.21 mmol), CuI (40 mg, 0.21 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.46 g, 10.5 mmol) in 20 mL of DMF was stirred at 110 °C for 16 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:0 to 90:10) to afford 261 mg (75%) of <b>41a</b>. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 332.4.</div></div><div id="sec8_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> <i>N</i>-(2-((4,6-Dimethyl-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>42a</b>)</h4><div class="NLM_p last">To a solution of <b>41a</b> (50 mg, 0.151 mmol) and Et<sub>3</sub>N (76 mg, 0.755 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added acryloyl chloride (68 mg, 0.755 mmol) dropwise under a water bath. The resulting mixture was stirred at rt for 16 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 44 mg (75%) of <b>42a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.40 (d, <i>J</i> = 5.6 Hz, 1H), 7.90 (d, <i>J</i> = 5.6 Hz, 1H), 7.79 (br s, 1H), 6.49 (d, <i>J</i> = 16.9 Hz, 1H), 6.22 (dd, <i>J</i> = 16.9, 10.4 Hz, 1H), 5.89 (d, <i>J</i> = 10.4 Hz, 1H), 3.92 (m, 4H), 2.48 (m, 4H), 2.45 (s, 6H), 2.36 (s, 3H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>24</sub>N<sub>7</sub>OS, 386.1763; found, 386.1762.</div></div><div id="sec8_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (<i>E</i>)-<i>N</i>-(2-((4,6-Dimethyl-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)but-2-enamide (<b>42b</b>)</h4><div class="NLM_p last">To a solution of <b>41a</b> (50 mg, 0.151 mmol) and Et<sub>3</sub>N (152 mg, 1.51 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added crotonyl chloride (158 mg, 1.51 mmol) dropwise under a water bath. The resulting mixture was stirred at rt for 16 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 20:1) to afford 41 mg (67%) of <b>42b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.37 (d, <i>J</i> = 5.7 Hz, 1H), 7.88 (d, <i>J</i> = 5.7 Hz, 1H), 7.67 (s, 1H), 7.01–7.10 (m, 1H), 5.92 (dd, <i>J</i> = 15.2, 1.7 Hz, 1H), 3.96 (m, 4H), 2.52 (m, 4H), 2.45 (s, 6H), 2.43 (s, 3H), 1.94 (dd, <i>J</i> = 7.0, 1.7 Hz, 3H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>26</sub>N<sub>7</sub>OS, 400.1920; found, 400.1920.</div></div><div id="sec8_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>N</i>-(2-((4,6-Dimethyl-2-(4-methylpiperazin-1-yl)pyrimidin-5-yl)thio)pyrimidin-4-yl)methacrylamide (<b>42c</b>)</h4><div class="NLM_p last">To a solution of <b>41a</b> (50 mg, 0.151 mmol) and Et<sub>3</sub>N (152 mg, 1.51 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added methacryloyl chloride (158 mg, 1.51 mmol) dropwise under a water bath. The resulting mixture was stirred at rt for 16 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 20:1) to afford 60 mg (75%) of <b>42c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.37 (d, <i>J</i> = 5.7 Hz, 1H), 8.08 (br s, 1H), 7.87 (d, <i>J</i> = 5.7 Hz, 1H), 5.85 (s, 1H), 5.60 (s, 1H), 3.95 (m, 4H), 2.52 (m, 4H), 2.45 (s, 6H), 2.38 (s, 3H), 2.04 (s, 3H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>26</sub>N<sub>7</sub>OS, 400.1920; found, 400.1909.</div></div><div id="sec8_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 4-(4,6-Dimethylpyrimidin-2-yl)morpholine (<b>39b</b>)</h4><div class="NLM_p last">A 1.43 g (10 mmol) portion of <b>38</b> and 2.18 g (25 mmol) of morpholine in 20 mL of DMF were heated at 90 °C for 2.5 h. The reaction mixture was concentrated under reduced pressure, and the residue was taken up into 100 mL of CH<sub>2</sub>Cl<sub>2</sub>. This was washed with brine (3 × 25 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to give 1.84 g (95%) of <b>39b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 6.30 (s, 1H), 3.79 (m, 4H), 3.75 (m, 4H), 2.29 (s, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 167.1, 161.9, 109.4, 67.0, 44.3, 24.0. MS (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> 216.1.</div></div><div id="sec8_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-(5-Iodo-4,6-dimethylpyrimidin-2-yl)morpholine (<b>40b</b>)</h4><div class="NLM_p last">To 1.50 g (7.8 mmol) of <b>39b</b> in 40 mL of acetonitrile were added 2.1 g (9.4 mmol) of NIS and 0.898 mL (1.33 g, 11.7 mmol) of TFA, and the resulting solution was stirred at rt for 2 h. The reaction mixture was concentrated to dryness, and the residue was taken up into 100 mL of CH<sub>2</sub>Cl<sub>2</sub>, washed with 10% sodium thiosulfate (50 mL) and 5% NaHCO<sub>3</sub> (3 × 50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to give a residue which was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 1:0 to 20:1) to yield 2.09 g (84%) of <b>40b</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 3.77 (m, 4H), 3.73 (m, 4H), 2.53 (s, 6H). MS (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> 341.9.</div></div><div id="sec8_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 2-((4,6-Dimethyl-2-morpholinopyrimidin-5-yl)thio)pyrimidin-4-amine (<b>41b</b>)</h4><div class="NLM_p last">A mixture of <b>40b</b> (1.0 g, 3.13 mmol), 4-amino-2-mercaptopyrimidine (0.477 g, 3.76 mmol), neocuproine (0.140 g, 0.626 mmol), CuI (0.122 g, 0.626 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.864 g, 6.26 mmol) in 60 mL of DMF was stirred at 110 °C for 16 h. Solvent was removed under reduced pressure, and the residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:0 to 90:10) to afford 0.690 g (69%) of <b>41b</b>. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 319.1.</div></div><div id="sec8_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>N</i>-(2-((4,6-Dimethyl-2-morpholinopyrimidin-5-yl)thio)pyrimidin-4-yl)acrylamide (<b>43</b>)</h4><div class="NLM_p last">To a solution of <b>41b</b> (50 mg, 0.157 mmol) and Et<sub>3</sub>N (79 mg, 0.786 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added acryloyl chloride (71 mg, 0.786 mmol) dropwise under a water bath. The resulting mixture was stirred at rt for 16 h. Solvent was removed under reduced pressure, and the residue was purified by preparatory TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH–NH<sub>3</sub> (7 N), 10:1) to afford 58 mg (68%) of <b>43</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.39 (d, <i>J</i> = 5.7 Hz, 1H), 6.49 (d, <i>J</i> = 16.9 Hz, 1H), 6.27 (dd, <i>J</i> = 16.9, 10.3 Hz, 1H), 5.86 (d, <i>J</i> = 10.3 Hz, 1H), 3.89 (m, 4H), 3.78 (m, 4H), 2.46 (s, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 172.2, 170.4, 164.6, 160.4, 159.0, 157.8, 130.1, 130.0, 109.2, 106.2, 66.8, 44.1, 23.7. MS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 373.0.</div></div></div><div id="sec9" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Biological Testing</h3><div id="sec9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Cell Lines</h4><div class="NLM_p last">SKBr3 cells were a gift from Dr. Neal Rosen (Memorial Sloan-Kettering Cancer Center, MSKCC) and Kasumi-1 and MOLM-13 from Dr. S. Nimer (MSKCC). Cells were cultured routinely in DME/F12 (SKBr3) or in RPMI (Kasumi-1, MOML-13) supplemented with 10% fetal bovine serum, 1% <span class="smallcaps smallerCapital">l</span>-glutamine, 1% penicillin, and streptomycin.</div></div><div id="sec9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Western Blotting</h4><div class="NLM_p last">Cells were grown to 60–70% confluence and treated with inhibitor or DMSO vehicle for the indicated times. Protein lysates were prepared in 50 mM Tris, pH 7.4, 150 mM NaCl, and 1% NP-40 lysis buffer. Protein concentrations were measured using the BCA kit (Pierce) according to the manufacturer’s instructions. Protein lysates (10–50 μg) were resolved by SDS–PAGE, transferred onto a nitrocellulose membrane, and incubated with the indicated primary antibodies: anti-HER2 from rabbit (1:250, 28-0004, Zymed), anti-Hsp70 from mouse (1:500, SPA-810, Stressgen), anti-Raf-1 from rabbit (1:500, sc-133, Santa Cruz), anti-PARP (p85 fragment) from rabbit (1:500, G7341, Promega), anti-HOP from mouse (1:500, SRA-1500, Enzo) and anti-β-actin from mouse (1:2500, A1978, Sigma-Aldrich). Membranes were then incubated with a corresponding peroxidase-conjugated secondary antibody (1:3000 dilution).</div></div><div id="sec9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Hsp90 Binding Assay</h4><div class="NLM_p last">For the competition studies, fluorescence polarization (FP) assays were performed as previously reported.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Briefly, FP measurements were performed on an Analyst GT instrument (Molecular Devices, Sunnyvale, CA). Measurements were taken in black 96-well microtiter plates (Corning no. 3650) where both the excitation and the emission occurred from the top of the wells. A stock of 10 μM GM-cy3B was prepared in DMSO and diluted with Felts buffer (20 mM HEPES (K), pH 7.3, 50 mM KCl, 2 mM DTT, 5 mM MgCl<sub>2</sub>, 20 mM Na<sub>2</sub>MoO<sub>4</sub>, and 0.01% NP40 with 0.1 mg/mL BGG). To each 96-well plate were added 6 nM fluorescent GM (GM-cy3B), 3 μg of SKBr3 lysate (total protein), and tested inhibitor (initial stock in DMSO) in a final volume of 100 μL of HFB buffer. Drugs were added in triplicate wells. For each assay, background wells (buffer only), tracer controls (free, fluorescent GM only), and bound GM controls (fluorescent GM in the presence of SKBr3 lysate) were included on each assay plate. GM was used as a positive control. The assay plate was incubated on a shaker at 4 °C for 24 h, and the FP values (mP) were measured. The fraction of tracer bound to Hsp90 was correlated to the FP value and plotted against the values of competitor concentrations. The inhibitor concentration at which 50% of bound GM was displaced was obtained by fitting the data. All experimental data were analyzed using SOFTmax Pro 4.3.1 and plotted using Prism 4.0 (Graphpad Software Inc., San Diego, CA).</div></div><div id="sec9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Chemical Precipitation in Cell Extracts</h4><div class="NLM_p last">Protein lysates were prepared using 20 mM Tris, pH 7.4, 25 mM NaCl, 0.1% NP-40 lysis buffer. Streptavidin agarose beads (50 μL) (Thermo Scientific) were washed three times with lysis buffer, <b>44b</b> and <b>45b</b> were added at the indicated concentrations, and the complexes were incubated at 4 °C for 1 h. Upon a three-time wash with buffer, the beads were added to the indicated total cellular protein in the binding buffer. Samples were incubated at 4 °C overnight, washed five times with the lysis buffer, and applied to SDS–PAGE (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a).</div></div><div id="sec9_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Chemical Precipitation in a Live Cell</h4><div class="NLM_p last">Cancer cells were treated with <b>44b</b> (25 μM) or <span class="smallcaps smallerCapital">d</span>-biotin for 6 h and then lysed in a buffer containing 20 mM Tris, pH 7.4, 25 mM NaCl, and 0.1% NP-40. Aliquots (500 μg total protein) were incubated with streptavidin beads for 1 h at 4 °C. Purified protein complexes were washed with 20 mM Tris, pH 7.4, 1 M NaCl, 0.1% NP-40 (high salt) buffer and applied to SDS–PAGE. The gel was stained with the SilverQuest staining kit (Invitrogen) (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b).</div></div><div id="sec9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Immunoprecipitation</h4><div class="NLM_p last">Cancer cells were collected and lysed in a buffer containing 20 mM Tris, pH 7.4, 25 mM NaCl, and 0.1% NP-40. The anti-Hsp70 antibody (BB70; 5 μL) was added to 500 μg of extract together with protein G agarose beads (30 μL) (Upstate), and the mixture was incubated at 4 °C overnight. Samples were washed with lysis buffer and applied to SDS–PAGE. The gel was stained with the SilverQuest staining kit (Invitrogen) (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b).</div></div><div id="sec9_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Competition Assay</h4><div class="NLM_p last">Cancer cells were pretreated for 2 h with increasing concentrations of <b>17a</b> and then lysed in a buffer containing 20 mM Tris, pH 7.4, 25 mM NaCl, and 0.1% NP-40. Meanwhile, to prepare the <b>44b</b>–streptavidin bead conjugates, <b>44b</b> (50 μM) was added to high-capacity streptavidin agarose beads (Thermo Scientific) (30 μL per experimental sample), incubated for 1 h at 4 °C, and then washed with lysis buffer. Protein extracts (500 μg of total protein) were then incubated overnight with the <b>44b</b>–streptavidin bead conjugate. The complexes were washed in high-salt buffer, applied to SDS–PAGE, and stained with the SilverQuest staining kit (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c).</div></div><div id="sec9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Hsp70–HOP Complex Analysis</h4><div class="NLM_p last">SKBr3 <b>c</b>ells were treated with the indicated concentrations of the inhibitor for 24 h. Samples were collected and lysed in 20 mM Tris, pH 7.4, 25 mM NaCl, 0.1% NP-40 buffer with protease inhibitors added. Aliquots of 500 μg of total protein adjusted to 100 μL with the lysis buffer were prepared. Samples were incubated with 5 μL of BB70 antibody (Stressmarq) or normal IgG (as a negative control) and 20 μL of protein G agarose beads (Upstate) at 4 °C overnight. Samples were washed five times with the lysis buffer and applied to SDS–PAGE followed by a standard Western blotting procedure to detect levels of HOP protein in the Hsp70 complexes upon treatment.</div></div><div id="sec9_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Growth Inhibition Assay</h4><div class="NLM_p last">We evaluated the antiproliferative effects of inhibitors using the dye Alamar Blue. This reagent offers a rapid objective measure of cell viability in cell culture, and it uses the indicator dye resazurin to measure the metabolic capacity of cells, an indicator of cell viability. Briefly, cells were plated on Costar 96-well plates. For attached cells (such as SKBr3), 8000 cells/well were used. For suspension cells (such as Kasumi-1), 20000 cells/well were plated. Cells were allowed to incubate for 24 h at 37 °C before drug treatment. Drugs were added in triplicate at the indicated concentrations, and the plate was incubated for 72 h. Alamar Blue (50 μM) was added and the plate read 6 h later using the Analyst GT (fluorescence intensity mode, excitation 530 nm, emission 580 nm, with a 560 nm dichroic mirror). Results were analyzed using the Softmax Pro software. The percentage cell growth inhibition was calculated by comparing fluorescence readings obtained from treated versus control cells, accounting for the initial cell population (time zero). IC<sub>50</sub> was calculated as the drug concentration that inhibits cell growth by 50%.</div></div><div id="sec9_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Caspase-3,7 Activation.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></h4><div class="NLM_p last">MOLM-13 cells (30000 cells/well) were plated in black 96-well plates (Corning no. 3603) in 40 μL of RPMI medium and left in an incubator (37 °C, 5% CO<sub>2</sub>) for up to 24 h. Cells were treated for 16 h with compounds or DMSO (control) at the desired concentrations in 50 μL of medium. Drugs were added in triplicate wells. Following exposure of cells to Hsp70 inhibitors, 50 μL of buffer containing 10 mM HEPES (pH 7.5), 2 mM EDTA, 0.1% CHAPS, and the caspase substrate Z-DEVD-R110 at 25 μM was added to each well. Plates were incubated until the signal stabilized, and then the fluorescence signal of each well was measured in an Analyst GT microplate reader. The percentage increase in apoptotic cells was calculated by comparison of the fluorescence reading obtained from treated versus control cells.</div></div><div id="sec9_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Kinase Screen</h4><div class="NLM_p last">For most assays, kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an <i>Escherichia coli</i> host derived from the BL21 strain. <i>E. coli</i> were grown to log phase and infected with T7 phage from a frozen stock (multiplicity of infection 0.4) and incubated with shaking at 32 °C until lysis (90–150 min). The lysates were centrifuged (6000<i>g</i>) and filtered (0.2 μm) to remove cell debris. The remaining kinases were produced in HEK-293 cells and subsequently tagged with DNA for qPCR detection. Streptavidin-coated magnetic beads were treated with biotinylated small-molecule ligands for 30 min at room temperature to generate affinity resins for kinase assays. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand and to reduce nonspecific phage binding. Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17× PBS, 0.05% Tween 20, 6 mM DTT). Test compounds were prepared as 40× stocks in 100% DMSO and directly diluted into the assay. All reactions were performed in polypropylene 384-well plates in a final volume of 0.04 mL. The assay plates were incubated at room temperature with shaking for 1 h, and the affinity beads were washed with wash buffer (1× PBS, 0.05% Tween 20). The beads were then resuspended in elution buffer (1× PBS, 0.05% Tween 20, 0.5 μM nonbiotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentration in the eluates was measured by qPCR. KINOME<i>scan</i>’s selectivity score (<i>S</i>) is a quantitative measure of compound selectivity. It is calculated by dividing the number of kinases that bind to the compound by the total number of distinct kinases tested, excluding mutant variants. TREE<i>spot</i> is a proprietary data visualization software tool developed by KINOME<i>scan</i>. Kinases found to bind are marked with red circles, where larger circles indicate higher affinity binding. The kinase dendrogram was adapted and is reproduced with permission from Science and Cell Signaling Technology, Inc.</div></div></div><div id="sec10" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Computational Studies</h3><div class="NLM_p last">All computations were carried out on an HP workstation xw8200 with the Ubuntu 8.10 operating system using Maestro v8.5 (Schrodinger LLC, New York). Grids were prepared using the Receptor Grid Generation tool in Glidev4.0. Docking calculations were run in the standard precision (SP) mode of Glide v4.0. The <i>maxkeep</i> variable, which sets the maximum number of poses generated during the initial phase of the docking calculation, was set to 5000, and the <i>keep best</i> variable, which sets the number of poses per ligand that enter the energy minimization, was set to 1000. The energy minimization protocol includes a dielectric constant of 4.0 and 1000 steps of conjugate gradient. Upon completion of each docking calculation, at most 100 poses per ligand were allowed to generate. The best docked conformation was chosen considering the orientation and Glidescore (G-score).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96"><a href="/doi/suppl/10.1021/jm401551n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Description of the synthesis of compounds <b>44a</b>,<b>b</b> and <b>45a</b>,<b>b</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401551n/suppl_file/jm401551n_si_001.pdf">jm401551n_si_001.pdf (272.82 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID codes of crystal structures used as a starting point for building the homology model are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1S3X">1S3X</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KHO">2KHO</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P32">2P32</a>.</p><div class="testing" data-doi="10.1021/jm401551n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tony Taldone</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#35415459515a5b50417558465e56561b5a4752"><span class="__cf_email__" data-cfemail="493d28252d26272c3d09243a222a2a67263b2e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriela Chiosis</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b1d2d9d8dec2d8c2d6f1dcc2dad2d29fdec3d6"><span class="__cf_email__" data-cfemail="8cefe4e5e3ffe5ffebcce1ffe7efefa2e3feeb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanlong Kang</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hardik J. Patel</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pallav D. Patel</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Rodina</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Gozman</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronnie Maharaj</span> - <span class="hlFld-Affiliation affiliation">Pharmacology
Program, Weill Graduate School of Medical Sciences, Cornell University, New York, New York 10021, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina C. Clement</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maulik R. Patel</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey L. Brodsky</span> - <span class="hlFld-Affiliation affiliation">Department
of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason C. Young</span> - <span class="hlFld-Affiliation affiliation">Groupe
de Recherche Axé sur la Structure des Protéines, Department
of Biochemistry, McGill University, Montreal, Quebec, Canada H3G 0B1</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d940e6929-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82124" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82124" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are supported in part by MSKCC’s Technology Transfer Fund (G.C., A.R., Y.K.), Department of Defense Grant W81XWH-10-1-0490 (T.T.), Susan G. Komen for the Cure (T.T., G.C.), the SPORE Pilot Award and Research & Therapeutics Program in Prostate Cancer (G.C.), NIH Grant R01 CA119001 (G.C.), Clinical and Translational Science Center (CTSC) Grant UL1 RR024996 (A.G.), the Breast Cancer Research Fund (G.C.), the Leukemia and Lymphoma Society (G.C.), the Hirshberg Foundation for Pancreatic Cancer Research (G.C.), and NIH Grants 1U01 AG032969-01A1 (G.C.), 1R01 CA172546-01A1 (G.C.), and 1R01 CA155226-01 (G.C.). We thank Dr. George Sukenick and Dr. Hui Liu of the NMR Analytical Core Facility at MSKCC for expert mass spectral analysis.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i102" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i102"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i103" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i103"> Abbreviations Used</h2><tr><td class="NLM_term">Hsp70</td><td class="NLM_def"><p class="first last">heat shock protein 70</p></td></tr><tr><td class="NLM_term">Hsp90</td><td class="NLM_def"><p class="first last">heat shock protein 90</p></td></tr><tr><td class="NLM_term">HOP</td><td class="NLM_def"><p class="first last">heat shock organizing protein</p></td></tr><tr><td class="NLM_term">Hsc70</td><td class="NLM_def"><p class="first last">heat shock cognate 70</p></td></tr><tr><td class="NLM_term">Hsp40</td><td class="NLM_def"><p class="first last">heat shock protein 40</p></td></tr><tr><td class="NLM_term">BAG</td><td class="NLM_def"><p class="first last">Bcl-2-associated anthogene</p></td></tr><tr><td class="NLM_term">Hsp110</td><td class="NLM_def"><p class="first last">heat shock protein 110</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">Immunoprecipitation</p></td></tr><tr><td class="NLM_term">NBD</td><td class="NLM_def"><p class="first last">nucleotide-binding domain</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">HER2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">P-gp/MDR-1</td><td class="NLM_def"><p class="first last">P-glycoprotein/multidrug resistance protein 1</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i104">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Daugaard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jäättelä, M.</span><span> </span><span class="NLM_article-title">The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">3702</span><span class="NLM_x">–</span> <span class="NLM_lpage">3710</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=3702-3710&author=M.+Daugaardauthor=M.+Rohdeauthor=M.+J%C3%A4%C3%A4ttel%C3%A4&title=The+heat+shock+protein+70+family%3A+highly+homologous+proteins+with+overlapping+and+distinct+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaugaard%26aufirst%3DM.%26aulast%3DRohde%26aufirst%3DM.%26aulast%3DJ%25C3%25A4%25C3%25A4ttel%25C3%25A4%26aufirst%3DM.%26atitle%3DThe%2520heat%2520shock%2520protein%252070%2520family%253A%2520highly%2520homologous%2520proteins%2520with%2520overlapping%2520and%2520distinct%2520functions%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D3702%26epage%3D3710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Brodsky, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Hsp70 molecular chaperones: emerging roles in human disease and identification of small molecule modulators</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.2174%2F156802606777811997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=16842158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1215-1225&author=J.+F.+Brodskyauthor=G.+Chiosis&title=Hsp70+molecular+chaperones%3A+emerging+roles+in+human+disease+and+identification+of+small+molecule+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp70 molecular chaperones: emerging roles in human disease and identification of small molecule modulators</span></div><div class="casAuthors">Brodsky, Jeffrey L.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1215-1225</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mol. chaperones are best known for their ability to aid in the solubilization of mis-folded proteins, and as a result play essential roles in protein folding, degrdn., and transport.  However, many mol. chaperones also play essential roles in signal transduction cascades.  For example, Hsp70 mol. chaperones are a highly conserved, abundant class of chaperones that are found in every species and in nearly every cellular compartment in eukaryotes.  In addn. to their well-established roles in facilitating protein folding and in the targeting of proteins to organelles and to proteolytic machines, Hsp70s are anti-apoptotic and inhibition of Hsp70 function in some cases is sufficient to induce tumor cell death.  Hsp70 function is also vital for the replication of viruses.  Based on these data, small mol. Hsp70 modulators might, in principle, be used for the treatment of specific cancers, infections, and protein conformational diseases.  In this review, we summarize the structural and functional characteristics of Hsp70 chaperones, and then discuss their roles in cellular physiol.  Finally, we will review the recent discovery of small mols. that alter Hsp70 expression and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKvQuXC1mQE7Vg90H21EOLACvtfcHk0ljejN8MU7x74Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLs%253D&md5=8d71a06d57fd9ac349e31cddad49d452</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F156802606777811997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777811997%26sid%3Dliteratum%253Aachs%26aulast%3DBrodsky%26aufirst%3DJ.%2BF.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHsp70%2520molecular%2520chaperones%253A%2520emerging%2520roles%2520in%2520human%2520disease%2520and%2520identification%2520of%2520small%2520molecule%2520modulators%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1215%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lanneau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solary, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontenay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, C.</span><span> </span><span class="NLM_article-title">Heat shock proteins: essential proteins for apoptosis regulation</span> <span class="citation_source-journal">J. Cell Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1111%2Fj.1582-4934.2008.00273.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=18266962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlCrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=743-761&author=D.+Lanneauauthor=M.+Brunetauthor=E.+Frisanauthor=E.+Solaryauthor=M.+Fontenayauthor=C.+Garrido&title=Heat+shock+proteins%3A+essential+proteins+for+apoptosis+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock proteins: essential proteins for apoptosis regulation</span></div><div class="casAuthors">Lanneau, D.; Brunet, M.; Frisan, E.; Solary, E.; Fontenay, M.; Garrido, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">743-761</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Many different external and intrinsic apoptotic stimuli induce the accumulation in cells of a set of proteins known as stress or heat-shock proteins (HSPs).  HSPs are conserved proteins present in both prokaryotes and eukaryotes.  These proteins play an essential role as mol. chaperones by assisting the correct folding of nascent and stress-accumulated misfolded proteins, and by preventing their aggregation.  HSPs have a protective function, i.e., they allow cells to survive to otherwise lethal conditions.  Various mechanisms have been proposed to account for the cytoprotective functions of HSPs.  Several of these proteins have been demonstrated to directly interact with components of the cell signaling pathways, e.g., those of the tightly regulated caspase-dependent programmed cell death machinery, upstream, downstream, and at the mitochondrial level.  HSPs can also affect the caspase-independent apoptosis-like process by interacting with apoptogenic factors such as apoptosis-inducing factor (AIF) or by acting at the lysosome level.  Here, the authors describe the different key apoptotic proteins interacting with HSPs and the consequences of these interactions in cell survival, proliferation, and apoptotic processes.  The authors' purpose is illustrated by emerging strategies in targeting these protective proteins to treat hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF4Fhw_RO4p7Vg90H21EOLACvtfcHk0ljejN8MU7x74Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlCrt70%253D&md5=d8b5c1c6411c5499268ba1a3eedf97c0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00273.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00273.x%26sid%3Dliteratum%253Aachs%26aulast%3DLanneau%26aufirst%3DD.%26aulast%3DBrunet%26aufirst%3DM.%26aulast%3DFrisan%26aufirst%3DE.%26aulast%3DSolary%26aufirst%3DE.%26aulast%3DFontenay%26aufirst%3DM.%26aulast%3DGarrido%26aufirst%3DC.%26atitle%3DHeat%2520shock%2520proteins%253A%2520essential%2520proteins%2520for%2520apoptosis%2520regulation%26jtitle%3DJ.%2520Cell%2520Mol.%2520Med.%26date%3D2008%26volume%3D12%26spage%3D743%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Powers, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=250-262&author=M.+V.+Powersauthor=P.+A.+Clarkeauthor=P.+Workman&title=Dual+targeting+of+HSC70+and+HSP72+inhibits+HSP90+function+and+induces+tumor-specific+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DDual%2520targeting%2520of%2520HSC70%2520and%2520HSP72%2520inhibits%2520HSP90%2520function%2520and%2520induces%2520tumor-specific%2520apoptosis%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D14%26spage%3D250%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mayer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukau, B.</span><span> </span><span class="NLM_article-title">Hsp70 chaperones: cellular functions and molecular mechanism</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1007%2Fs00018-004-4464-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=15770419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlymt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2005&pages=670-684&author=M.+P.+Mayerauthor=B.+Bukau&title=Hsp70+chaperones%3A+cellular+functions+and+molecular+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp70 chaperones: Cellular functions and molecular mechanism</span></div><div class="casAuthors">Mayer, M. P.; Bukau, B.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">670-684</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Hsp70 proteins are central components of the cellular network of mol. chaperones and folding catalysts.  They assist a large variety of protein folding processes in the cell by transient assocn. of their substrate binding domain with short hydrophobic peptide segments within their substrate proteins.  The substrate binding and release cycle is driven by the switching of Hsp70 between the low-affinity ATP bound state and the high-affinity ADP bound state.  Thus, ATP binding and hydrolysis are essential in vitro and in vivo for the chaperone activity of Hsp70 proteins.  This ATPase cycle is controlled by co-chaperones of the family of J-domain proteins, which target Hsp70s to their substrates, and by nucleotide exchange factors, which det. the lifetime of the Hsp70-substrate complex.  Addnl. co-chaperones fine-tune this chaperone cycle.  For specific tasks, the Hsp70 cycle is coupled to the action of other chaperones, such as Hsp90 and Hsp100.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsdr6juDha1rVg90H21EOLACvtfcHk0lh0F3PnamghsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlymt78%253D&md5=c12378f4e13b2241521b3abe09d8f88b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs00018-004-4464-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-004-4464-6%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%2BP.%26aulast%3DBukau%26aufirst%3DB.%26atitle%3DHsp70%2520chaperones%253A%2520cellular%2520functions%2520and%2520molecular%2520mechanism%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2005%26volume%3D62%26spage%3D670%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Young, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agashe, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">Pathways of chaperone-mediated protein folding in the cytosol</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnrm1492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=15459659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVSlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=781-791&author=J.+C.+Youngauthor=V.+R.+Agasheauthor=K.+Siegersauthor=F.+U.+Hartl&title=Pathways+of+chaperone-mediated+protein+folding+in+the+cytosol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways of chaperone-mediated protein folding in the cytosol</span></div><div class="casAuthors">Young, Jason C.; Agashe, Vishwas R.; Siegers, Katja; Hartl, F. Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">781-791</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cells are faced with the task of folding thousands of different polypeptides into a wide range of conformations.  For many proteins, the folding process requires the action of mol. chaperones.  In the cytosol of prokaryotic and eukaryotic cells, mol. chaperones of different structural classes form a network of pathways that can handle substrate polypeptides from the point of initial synthesis on ribosomes to the final stages of folding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozOmZCjGhXsbVg90H21EOLACvtfcHk0lh0F3PnamghsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVSlsrg%253D&md5=e5b25a79128866bd17f7915dd6f42c6d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm1492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1492%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DJ.%2BC.%26aulast%3DAgashe%26aufirst%3DV.%2BR.%26aulast%3DSiegers%26aufirst%3DK.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DPathways%2520of%2520chaperone-mediated%2520protein%2520folding%2520in%2520the%2520cytosol%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D781%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Evans, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Heat shock protein 70 (hsp70) as an emerging drug target</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4585</span><span class="NLM_x">–</span> <span class="NLM_lpage">4602</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100054f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4585-4602&author=C.+G.+Evansauthor=L.+Changauthor=J.+E.+Gestwicki&title=Heat+shock+protein+70+%28hsp70%29+as+an+emerging+drug+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target</span></div><div class="casAuthors">Evans, Christopher G.; Chang, Lyra; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4585-4602</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5hrQMA77XsrVg90H21EOLACvtfcHk0lh0F3PnamghsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejsLc%253D&md5=b87bdc9b76e66d62c130a162037387b5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm100054f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100054f%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DC.%2BG.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DHeat%2520shock%2520protein%252070%2520%2528hsp70%2529%2520as%2520an%2520emerging%2520drug%2520target%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4585%26epage%3D4602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Patury, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Pharmacological targeting of the Hsp70 chaperone</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.2174%2F156802609789895674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=19860737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFakur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1337-1351&author=S.+Paturyauthor=Y.+Miyataauthor=J.+E.+Gestwicki&title=Pharmacological+targeting+of+the+Hsp70+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological targeting of the Hsp70 chaperone</span></div><div class="casAuthors">Patury, Srikanth; Miyata, Yoshinari; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1337-1351</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat shock protein 70 (Hsp70), acts at multiple steps in a protein's life cycle, including during the processes of folding, trafficking, remodeling and degrdn.  To accomplish these various tasks, the activity of Hsp70 is shaped by a host of co-chaperones, which bind to the core chaperone and influence its functions.  Genetic studies have strongly linked Hsp70 and its co-chaperones to numerous diseases, including cancer, neurodegeneration and microbial pathogenesis, yet the potential of this chaperone as a therapeutic target remains largely underexplored.  Here, we review the current state of Hsp70 as a drug target, with a special emphasis on the important challenges and opportunities imposed by its co-chaperones, protein-protein interactions and allostery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPBOUYJuccBbVg90H21EOLACvtfcHk0lhkSCvTBhrkzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFakur8%253D&md5=7fb9ff641b0fc4b82c8a94ffee822c64</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F156802609789895674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789895674%26sid%3Dliteratum%253Aachs%26aulast%3DPatury%26aufirst%3DS.%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DPharmacological%2520targeting%2520of%2520the%2520Hsp70%2520chaperone%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1337%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Leu, J. I.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimkina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D. L.</span><span> </span><span class="NLM_article-title">A small molecule inhibitor of inducible heat shock protein 70</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=15-27&author=J.+I.-J.+Leuauthor=J.+Pimkinaauthor=A.+Frankauthor=M.+E.+Murphyauthor=D.+L.+George&title=A+small+molecule+inhibitor+of+inducible+heat+shock+protein+70"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeu%26aufirst%3DJ.%2BI.-J.%26aulast%3DPimkina%26aufirst%3DJ.%26aulast%3DFrank%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DM.%2BE.%26aulast%3DGeorge%26aufirst%3DD.%2BL.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520inducible%2520heat%2520shock%2520protein%252070%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D36%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Leu, J. I.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimkina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D. L.</span><span> </span><span class="NLM_article-title">HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1158%2F1541-7786.MCR-11-0019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=21636681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVOktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=936-947&author=J.+I.-J.+Leuauthor=J.+Pimkinaauthor=P.+Pandeyauthor=M.+E.+Murphyauthor=D.+L.+George&title=HSP70+inhibition+by+the+small-molecule+2-phenylethynesulfonamide+impairs+protein+clearance+pathways+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">HSP70 Inhibition by the Small-Molecule 2-Phenylethynesulfonamide Impairs Protein Clearance Pathways in Tumor Cells</span></div><div class="casAuthors">Leu, J. I.-Ju; Pimkina, Julia; Pandey, Pooja; Murphy, Maureen E.; George, Donna L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">936-947</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The evolutionarily conserved stress-inducible HSP70 mol. chaperone plays a central role in maintaining protein quality control in response to various forms of stress.  Constitutively elevated HSP70 expression is a characteristic of many tumor cells and contributes to their survival.  We recently identified the small-mol. 2-phenylethyenesulfonamide (PES) as a novel HSP70 inhibitor.  Here, we present evidence that PES-mediated inhibition of HSP70 family proteins in tumor cells results in an impairment of the two major protein degrdn. systems, namely, the autophagy-lysosome system and the proteasome pathway.  HSP70 family proteins work closely with the HSP90 mol. chaperone to maintain the stability and activities of their many client proteins, and PES causes a disruption in the HSP70/HSP90 chaperone system.  As a consequence, many cellular proteins, including known HSP70/HSP90 substrates, accumulate in detergent-insol. cell fractions, indicative of aggregation and functional inactivation.  Overall, PES simultaneously disrupts several cancer crit. survival pathways, supporting the idea of targeting HSP70 as a potential approach for cancer therapeutics.  Mol Cancer Res; 9(7); 936-47.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXnDyVjlbD1LVg90H21EOLACvtfcHk0lhkSCvTBhrkzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVOktbw%253D&md5=36e6fd9093b96ff6c04914a86f277e4f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-11-0019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-11-0019%26sid%3Dliteratum%253Aachs%26aulast%3DLeu%26aufirst%3DJ.%2BI.-J.%26aulast%3DPimkina%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DP.%26aulast%3DMurphy%26aufirst%3DM.%2BE.%26aulast%3DGeorge%26aufirst%3DD.%2BL.%26atitle%3DHSP70%2520inhibition%2520by%2520the%2520small-molecule%25202-phenylethynesulfonamide%2520impairs%2520protein%2520clearance%2520pathways%2520in%2520tumor%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2011%26volume%3D9%26spage%3D936%26epage%3D947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Braunstein, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coplan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrico, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodsky, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batuman, O.</span><span> </span><span class="NLM_article-title">Antimyeloma effects of the heat shock protein 70 molecular chaperone inhibitor MAL3-101</span> <span class="citation_source-journal">J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">ID 232037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=ID+232037&author=M.+J.+Braunsteinauthor=S.+S.+Scottauthor=C.+M.+Scottauthor=S.+Behrmanauthor=P.+Walterauthor=P.+Wipfauthor=J.+D.+Coplanauthor=W.+Chricoauthor=D.+Josephauthor=J.+L.+Brodskyauthor=O.+Batuman&title=Antimyeloma+effects+of+the+heat+shock+protein+70+molecular+chaperone+inhibitor+MAL3-101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBraunstein%26aufirst%3DM.%2BJ.%26aulast%3DScott%26aufirst%3DS.%2BS.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DBehrman%26aufirst%3DS.%26aulast%3DWalter%26aufirst%3DP.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DCoplan%26aufirst%3DJ.%2BD.%26aulast%3DChrico%26aufirst%3DW.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DBrodsky%26aufirst%3DJ.%2BL.%26aulast%3DBatuman%26aufirst%3DO.%26atitle%3DAntimyeloma%2520effects%2520of%2520the%2520heat%2520shock%2520protein%252070%2520molecular%2520chaperone%2520inhibitor%2520MAL3-101%26jtitle%3DJ.%2520Oncol.%26date%3D2011%26volume%3D2011%26spage%3DID%2520232037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertelsen, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuade, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderweg, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Chemical screens against a reconstituted multiprotein complex: myricetin blocks DnaJ regulation of DnaK through an allosteric mechanism</span> <span class="citation_source-journal">Chem Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1016%2Fj.chembiol.2010.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=21338918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Kjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=210-221&author=L.+Changauthor=Y.+Miyataauthor=P.+M.+Ungauthor=E.+B.+Bertelsenauthor=T.+J.+McQuadeauthor=H.+A.+Carlsonauthor=E.+R.+Zuiderwegauthor=J.+E.+Gestwicki&title=Chemical+screens+against+a+reconstituted+multiprotein+complex%3A+myricetin+blocks+DnaJ+regulation+of+DnaK+through+an+allosteric+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Screens against a Reconstituted Multiprotein Complex: Myricetin Blocks DnaJ Regulation of DnaK through an Allosteric Mechanism</span></div><div class="casAuthors">Chang, Lyra; Miyata, Yoshinari; Ung, Peter M. U.; Bertelsen, Eric B.; McQuade, Thomas J.; Carlson, Heather A.; Zuiderweg, Erik R. P.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-221</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">DnaK is a mol. chaperone responsible for multiple aspects of bacterial proteostasis.  The intrinsically slow ATPase activity of DnaK is stimulated by its co-chaperone, DnaJ, and these proteins often work in concert.  To identify inhibitors the authors screened plant-derived exts. against a reconstituted mixt. of DnaK and DnaJ.  This approach resulted in the identification of flavonoids, including myricetin, which inhibited activity by up to 75%.  Interestingly, myricetin prevented DnaJ-mediated stimulation of ATPase activity, with minimal impact on either DnaK's intrinsic turnover rate or its stimulation by another co-chaperone, GrpE.  Using NMR, the authors found that myricetin binds DnaK at an unanticipated site between the IB and IIB subdomains and that it allosterically blocked binding of DnaK to DnaJ.  Together, these results highlight a "gray box" screening approach, which might facilitate the identification of inhibitors of other protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99yN2zfPqm7Vg90H21EOLACvtfcHk0ligm7tP4Bmdng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Kjtrc%253D&md5=597bc82a96fc30c3fafc6948db320eae</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DUng%26aufirst%3DP.%2BM.%26aulast%3DBertelsen%26aufirst%3DE.%2BB.%26aulast%3DMcQuade%26aufirst%3DT.%2BJ.%26aulast%3DCarlson%26aufirst%3DH.%2BA.%26aulast%3DZuiderweg%26aufirst%3DE.%2BR.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DChemical%2520screens%2520against%2520a%2520reconstituted%2520multiprotein%2520complex%253A%2520myricetin%2520blocks%2520DnaJ%2520regulation%2520of%2520DnaK%2520through%2520an%2520allosteric%2520mechanism%26jtitle%3DChem%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D210%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rousaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jinwal, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderweg, E. R.</span><span> </span><span class="NLM_article-title">Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2011&pages=614-632&author=A.+Rousakiauthor=Y.+Miyataauthor=U.+K.+Jinwalauthor=C.+A.+Dickeyauthor=J.+E.+Gestwickiauthor=E.+R.+Zuiderweg&title=Allosteric+drugs%3A+the+interaction+of+antitumor+compound+MKT-077+with+human+Hsp70+chaperones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRousaki%26aufirst%3DA.%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DJinwal%26aufirst%3DU.%2BK.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26aulast%3DZuiderweg%26aufirst%3DE.%2BR.%26atitle%3DAllosteric%2520drugs%253A%2520the%2520interaction%2520of%2520antitumor%2520compound%2520MKT-077%2520with%2520human%2520Hsp70%2520chaperones%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D411%26spage%3D614%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Cho, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baek, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, I.</span><span> </span><span class="NLM_article-title">A small molecule that binds to an ATPase domain of Hsc70 promotes membrane trafficking of mutant cystic fibrosis transmembrane conductance regulator</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">20267</span><span class="NLM_x">–</span> <span class="NLM_lpage">20276</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja206762p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=20267-20276&author=H.+J.+Choauthor=H.+Y.+Geeauthor=K.+H.+Baekauthor=S.+K.+Koauthor=J.+M.+Parkauthor=H.+Leeauthor=N.+D.+Kimauthor=M.+G.+Leeauthor=I.+Shin&title=A+small+molecule+that+binds+to+an+ATPase+domain+of+Hsc70+promotes+membrane+trafficking+of+mutant+cystic+fibrosis+transmembrane+conductance+regulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja206762p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja206762p%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DGee%26aufirst%3DH.%2BY.%26aulast%3DBaek%26aufirst%3DK.%2BH.%26aulast%3DKo%26aufirst%3DS.%2BK.%26aulast%3DPark%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DShin%26aufirst%3DI.%26atitle%3DA%2520small%2520molecule%2520that%2520binds%2520to%2520an%2520ATPase%2520domain%2520of%2520Hsc70%2520promotes%2520membrane%2520trafficking%2520of%2520mutant%2520cystic%2520fibrosis%2520transmembrane%2520conductance%2520regulator%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D20267%26epage%3D20276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Williams, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, I.</span><span> </span><span class="NLM_article-title">An apoptosis-inducing small molecule that binds to heat shock protein 70</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">7466</span><span class="NLM_x">–</span> <span class="NLM_lpage">7469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=7466-7469&author=D.+R.+Williamsauthor=S.+K.+Koauthor=S.+Parkauthor=M.+R.+Leeauthor=I.+Shin&title=An+apoptosis-inducing+small+molecule+that+binds+to+heat+shock+protein+70"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BR.%26aulast%3DKo%26aufirst%3DS.%2BK.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DShin%26aufirst%3DI.%26atitle%3DAn%2520apoptosis-inducing%2520small%2520molecule%2520that%2520binds%2520to%2520heat%2520shock%2520protein%252070%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D7466%26epage%3D7469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kawakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shishido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. B.</span><span> </span><span class="NLM_article-title">Structure–activity of novel rhodacyanine dyes as antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970590k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=130-142&author=M.+Kawakamiauthor=K.+Koyaauthor=T.+Ukaiauthor=N.+Tatsutaauthor=A.+Ikegawaauthor=K.+Ogawaauthor=T.+Shishidoauthor=L.+B.+Chen&title=Structure%E2%80%93activity+of+novel+rhodacyanine+dyes+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm970590k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970590k%26sid%3Dliteratum%253Aachs%26aulast%3DKawakami%26aufirst%3DM.%26aulast%3DKoya%26aufirst%3DK.%26aulast%3DUkai%26aufirst%3DT.%26aulast%3DTatsuta%26aufirst%3DN.%26aulast%3DIkegawa%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DShishido%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%2BB.%26atitle%3DStructure%25E2%2580%2593activity%2520of%2520novel%2520rhodacyanine%2520dyes%2520as%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D130%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kawakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shishido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. B.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel rhodacyanine dyes that exhibit antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3151</span><span class="NLM_x">–</span> <span class="NLM_lpage">3160</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9702692" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3151-3160&author=M.+Kawakamiauthor=K.+Koyaauthor=T.+Ukaiauthor=N.+Tatsutaauthor=A.+Ikegawaauthor=K.+Ogawaauthor=T.+Shishidoauthor=L.+B.+Chen&title=Synthesis+and+evaluation+of+novel+rhodacyanine+dyes+that+exhibit+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm9702692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9702692%26sid%3Dliteratum%253Aachs%26aulast%3DKawakami%26aufirst%3DM.%26aulast%3DKoya%26aufirst%3DK.%26aulast%3DUkai%26aufirst%3DT.%26aulast%3DTatsuta%26aufirst%3DN.%26aulast%3DIkegawa%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DShishido%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%2BB.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520rhodacyanine%2520dyes%2520that%2520exhibit%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3151%26epage%3D3160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokurno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macias, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A. J.</span><span> </span><span class="NLM_article-title">Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1510</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801627a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1arsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1510-1513&author=D.+S.+Williamsonauthor=J.+Borgognoniauthor=A.+Clayauthor=Z.+Danielsauthor=P.+Dokurnoauthor=M.+J.+Drysdaleauthor=N.+Foloppeauthor=G.+L.+Francisauthor=C.+J.+Grahamauthor=R.+Howesauthor=A.+T.+Maciasauthor=J.+B.+Murrayauthor=R.+Parsonsauthor=T.+Shawauthor=A.+E.+Surgenorauthor=L.+Terryauthor=Y.+Wangauthor=M.+Woodauthor=A.+J.+Massey&title=Novel+adenosine-derived+inhibitors+of+70+kDa+heat+shock+protein%2C+discovered+through+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design</span></div><div class="casAuthors">Williamson, Douglas S.; Borgognoni, Jenifer; Clay, Alexandra; Daniels, Zoe; Dokurno, Pawel; Drysdale, Martin J.; Foloppe, Nicolas; Francis, Geraint L.; Graham, Christopher J.; Howes, Rob; Macias, Alba T.; Murray, James B.; Parsons, Rachel; Shaw, Terry; Surgenor, Allan E.; Terry, Lindsey; Wang, Yikang; Wood, Mike; Massey, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1510-1513</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and synthesis of novel adenosine-derived inhibitors of HSP70, guided by modeling and X-ray crystallog. structures of these compds. in complex with HSC70/BAG-1, is described.  Examples exhibited submicromolar affinity for HSP70, were highly selective over HSP90, and some displayed potency against HCT116 cells.  Exposure of I to HCT116 cells caused significant redn. in cellular levels of Raf-1 and Her2 at concns. similar to that which caused cell growth arrest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7sPdbJciUk7Vg90H21EOLACvtfcHk0lgEJnOOEYQtrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1arsbg%253D&md5=714b981545d1aa8db6627a252b3da8cc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm801627a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801627a%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DClay%26aufirst%3DA.%26aulast%3DDaniels%26aufirst%3DZ.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFrancis%26aufirst%3DG.%2BL.%26aulast%3DGraham%26aufirst%3DC.%2BJ.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DMacias%26aufirst%3DA.%2BT.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26aulast%3DTerry%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DMassey%26aufirst%3DA.%2BJ.%26atitle%3DNovel%2520adenosine-derived%2520inhibitors%2520of%252070%2520kDa%2520heat%2520shock%2520protein%252C%2520discovered%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1510%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Jhaveri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1823</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=742-755&author=K.+Jhaveriauthor=T.+Taldoneauthor=S.+Modiauthor=G.+Chiosis&title=Advances+in+the+clinical+development+of+heat+shock+protein+90+%28Hsp90%29+inhibitors+in+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAdvances%2520in%2520the%2520clinical%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1823%26spage%3D742%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Massey, A. J.</span><span> </span><span class="NLM_article-title">ATPases as drug targets: insights from heat shock proteins 70 and 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7280</span><span class="NLM_x">–</span> <span class="NLM_lpage">7286</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100342z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7280-7286&author=A.+J.+Massey&title=ATPases+as+drug+targets%3A+insights+from+heat+shock+proteins+70+and+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">ATPases as Drug Targets: Insights from Heat Shock Proteins 70 and 90</span></div><div class="casAuthors">Massey, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7280-7286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouskN9BSeSLLVg90H21EOLACvtfcHk0liD_hwVgUTuJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVGgsrY%253D&md5=1fb082e98a0e666b2276cb7dc1e38c2a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm100342z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100342z%26sid%3Dliteratum%253Aachs%26aulast%3DMassey%26aufirst%3DA.%2BJ.%26atitle%3DATPases%2520as%2520drug%2520targets%253A%2520insights%2520from%2520heat%2520shock%2520proteins%252070%2520and%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7280%26epage%3D7286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Massey, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokurno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macias, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffroy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dopson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span> </span><span class="NLM_article-title">A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1007%2Fs00280-009-1194-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=20012863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXns1SisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=535-545&author=A.+J.+Masseyauthor=D.+S.+Williamsonauthor=H.+Browneauthor=J.+B.+Murrayauthor=P.+Dokurnoauthor=T.+Shawauthor=A.+T.+Maciasauthor=Z.+Danielsauthor=S.+Geoffroyauthor=M.+Dopsonauthor=P.+Lavanauthor=N.+Matassovaauthor=G.+L.+Francisauthor=C.+J.+Grahamauthor=R.+Parsonsauthor=Y.+Wangauthor=A.+Padfieldauthor=M.+Comerauthor=M.+J.+Drysdaleauthor=M.+Wood&title=A+novel%2C+small+molecule+inhibitor+of+Hsc70%2FHsp70+potentiates+Hsp90+inhibitor+induced+apoptosis+in+HCT116+colon+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells</span></div><div class="casAuthors">Massey, Andrew J.; Williamson, Douglas S.; Browne, Helen; Murray, James B.; Dokurno, Pawel; Shaw, Terry; Macias, Alba T.; Daniels, Zoe; Geoffroy, Stephanie; Dopson, Melanie; Lavan, Paul; Matassova, Natalia; Francis, Geraint L.; Graham, Christopher J.; Parsons, Rachel; Wang, Yikang; Padfield, Antony; Comer, Mike; Drysdale, Martin J.; Wood, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">535-545</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: The anti-apoptotic function of the 70 kDa family of heat shock proteins and their role in cancer is well documented.  Dual targeting of Hsc70 and Hsp70 with siRNA induces proteasome-dependent degrdn. of Hsp90 client proteins and extensive tumor specific apoptosis as well as the potentiation of tumor cell apoptosis following pharmacol. Hsp90 inhibition.  Methods: We have previously described the discovery and synthesis of novel adenosine-derived inhibitors of the 70 kDa family of heat shock proteins; the first inhibitors described to target the ATPase binding domain.  The in vitro activity of VER-155008 was evaluated in HCT116, HT29, BT474 and MDA-MB-468 carcinoma cell lines.  Cell proliferation, cell apoptosis and caspase 3/7 activity was detd. for VER-155008 in the absence or presence of small mol. Hsp90 inhibitors.  Results: VER-155008 inhibited the proliferation of human breast and colon cancer cell lines with GI50s in the range 5.3-14.4 μM, and induced Hsp90 client protein degrdn. in both HCT116 and BT474 cells.  As a single agent, VER-155008 induced caspase-3/7 dependent apoptosis in BT474 cells and non-caspase dependent cell death in HCT116 cells.  VER-155008 potentiated the apoptotic potential of a small mol. Hsp90 inhibitor in HCT116 but not HT29 or MDA-MB-468 cells.  In vivo, VER-155008 demonstrated rapid metab. and clearance, along with tumor levels below the predicted pharmacol. active level.  Conclusion: These data suggest that small mol. inhibitors of Hsc70/Hsp70 phenotypically mimic the cellular mode of action of a small mol. Hsp90 inhibitor and can potentiate the apoptotic potential of a small mol. Hsp90 inhibitor in certain cell lines.  The factors detg. whether or not cells apoptose in response to Hsp90 inhibition or the combination of Hsp90 plus Hsc70/Hsp70 inhibition remain to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodJSKJxiDK87Vg90H21EOLACvtfcHk0liD_hwVgUTuJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXns1SisbY%253D&md5=754638ba62eb7779978f15326042451c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00280-009-1194-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-009-1194-3%26sid%3Dliteratum%253Aachs%26aulast%3DMassey%26aufirst%3DA.%2BJ.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DBrowne%26aufirst%3DH.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DMacias%26aufirst%3DA.%2BT.%26aulast%3DDaniels%26aufirst%3DZ.%26aulast%3DGeoffroy%26aufirst%3DS.%26aulast%3DDopson%26aufirst%3DM.%26aulast%3DLavan%26aufirst%3DP.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DFrancis%26aufirst%3DG.%2BL.%26aulast%3DGraham%26aufirst%3DC.%2BJ.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPadfield%26aufirst%3DA.%26aulast%3DComer%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DWood%26aufirst%3DM.%26atitle%3DA%2520novel%252C%2520small%2520molecule%2520inhibitor%2520of%2520Hsc70%252FHsp70%2520potentiates%2520Hsp90%2520inhibitor%2520induced%2520apoptosis%2520in%2520HCT116%2520colon%2520carcinoma%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2010%26volume%3D66%26spage%3D535%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baaklini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharaj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirico, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talele, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Identification of an allosteric pocket on human Hsp70 reveals a mode of inhibition of this therapeutically important protein</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1469</span><span class="NLM_x">–</span> <span class="NLM_lpage">1480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1016%2Fj.chembiol.2013.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=24239008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsl2js7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1469-1480&author=A.+Rodinaauthor=P.+D.+Patelauthor=Y.+Kangauthor=Y.+Patelauthor=I.+Baakliniauthor=M.+J.+H.+Wongauthor=T.+Taldoneauthor=P.+Yanauthor=C.+Yangauthor=R.+Maharajauthor=A.+Gozmanauthor=M.+R.+Patelauthor=H.+J.+Patelauthor=W.+Chiricoauthor=H.+Erdjument-Bromageauthor=T.+T.+Taleleauthor=J.+C.+Youngauthor=G.+Chiosis&title=Identification+of+an+allosteric+pocket+on+human+Hsp70+reveals+a+mode+of+inhibition+of+this+therapeutically+important+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Allosteric Pocket on Human Hsp70 Reveals a Mode of Inhibition of This Therapeutically Important Protein</span></div><div class="casAuthors">Rodina, Anna; Patel, Pallav D.; Kang, Yanlong; Patel, Yogita; Baaklini, Imad; Wong, Michael J. H.; Taldone, Tony; Yan, Pengrong; Yang, Chenghua; Maharaj, Ronnie; Gozman, Alexander; Patel, Maulik R.; Patel, Hardik J.; Chirico, William; Erdjument-Bromage, Hediye; Talele, Tanaji T.; Young, Jason C.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1469-1480</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Hsp70s are important cancer chaperones that act upstream of Hsp90 and exhibit independent anti-apoptotic activities.  To develop chem. tools for the study of human Hsp70, we developed a homol. model that unveils a previously unknown allosteric site located in the nucleotide binding domain of Hsp70.  Combining structure-based design and phenotypic testing, we discovered a previously unknown inhibitor of this site, YK5.  In cancer cells, this compd. is a potent and selective binder of the cytosolic but not the organellar human Hsp70s and has biol. activity partly by interfering with the formation of active oncogenic Hsp70/Hsp90/client protein complexes.  YK5 is a small mol. inhibitor rationally designed to interact with an allosteric pocket of Hsp70 and represents a previously unknown chem. tool to investigate cellular mechanisms assocd. with Hsp70.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIWNzS6oXrObVg90H21EOLACvtfcHk0liD_hwVgUTuJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsl2js7jN&md5=3d87791cfc4be81fb78159124a83b926</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DY.%26aulast%3DBaaklini%26aufirst%3DI.%26aulast%3DWong%26aufirst%3DM.%2BJ.%2BH.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DMaharaj%26aufirst%3DR.%26aulast%3DGozman%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DChirico%26aufirst%3DW.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTalele%26aufirst%3DT.%2BT.%26aulast%3DYoung%26aufirst%3DJ.%2BC.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520an%2520allosteric%2520pocket%2520on%2520human%2520Hsp70%2520reveals%2520a%2520mode%2520of%2520inhibition%2520of%2520this%2520therapeutically%2520important%2520protein%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1469%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Taldone, T.; Kang, Y.; Patel, H. J.; Patel, M. R.; Patel, P. D.; Rodina, A.; Patel, Y.; Gozman, A.; Maharaj, R.; Clement, C. C.; Lu, A.; Young, J. C.; Chiosis, G.</span><span> </span><span class="NLM_article-title">Heat shock protein 70 inhibitors. 2. 2,5′-thiodipyrimidines, 5-(phenylthio)pyrimidines, 2-(pyridin-3-ylthio)pyrimidines, and 3-(phenylthio)pyridines as reversible binders to an allosteric site on heat shock protein 70</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/jm401552y</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm401552y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+Taldone&author=Y.+Kang&author=H.+J.+Patel&author=M.+R.+Patel&author=P.+D.+Patel&author=A.+Rodina&author=Y.+Patel&author=A.+Gozman&author=R.+Maharaj&author=C.+C.+Clement&author=A.+Lu&author=J.+C.+Young&author=G.+Chiosis&title=Heat+shock+protein+70+inhibitors.+2.+2%2C5%E2%80%B2-thiodipyrimidines%2C+5-%28phenylthio%29pyrimidines%2C+2-%28pyridin-3-ylthio%29pyrimidines%2C+and+3-%28phenylthio%29pyridines+as+reversible+binders+to+an+allosteric+site+on+heat+shock+protein+70&doi=10.1021%2Fjm401552y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm401552y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401552y%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26atitle%3DHeat%2520shock%2520protein%252070%2520inhibitors.%25202.%25202%252C5%25E2%2580%25B2-thiodipyrimidines%252C%25205-%2528phenylthio%2529pyrimidines%252C%25202-%2528pyridin-3-ylthio%2529pyrimidines%252C%2520and%25203-%2528phenylthio%2529pyridines%2520as%2520reversible%2520binders%2520to%2520an%2520allosteric%2520site%2520on%2520heat%2520shock%2520protein%252070%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26doi%3D10.1021%2Fjm401552y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Sriram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osipiuk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span> </span><span class="NLM_article-title">Human Hsp70 molecular chaperone binds two calcium ions within the ATPase domain</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=403-414&author=M.+Sriramauthor=J.+Osipiukauthor=B.+Freemanauthor=R.+Morimotoauthor=A.+Joachimiak&title=Human+Hsp70+molecular+chaperone+binds+two+calcium+ions+within+the+ATPase+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DOsipiuk%26aufirst%3DJ.%26aulast%3DFreeman%26aufirst%3DB.%26aulast%3DMorimoto%26aufirst%3DR.%26aulast%3DJoachimiak%26aufirst%3DA.%26atitle%3DHuman%2520Hsp70%2520molecular%2520chaperone%2520binds%2520two%2520calcium%2520ions%2520within%2520the%2520ATPase%2520domain%26jtitle%3DStructure%26date%3D1997%26volume%3D5%26spage%3D403%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Stevens, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellecchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderweg, E. R.</span><span> </span><span class="NLM_article-title">The solution structure of the bacterial HSP70 chaperone protein domain DnaK (393–507) in complex with the peptide NRLLLTG</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1110%2Fps.03269103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=14573869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXoslelu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=2588-2596&author=S.+Y.+Stevensauthor=S.+Caiauthor=M.+Pellecchiaauthor=E.+R.+Zuiderweg&title=The+solution+structure+of+the+bacterial+HSP70+chaperone+protein+domain+DnaK+%28393%E2%80%93507%29+in+complex+with+the+peptide+NRLLLTG"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The solution structure of the bacterial HSP70 chaperone protein domain DnaK(393-507) in complex with the peptide NRLLLTG</span></div><div class="casAuthors">Stevens, Shawn Y.; Cai, Sheng; Pellecchia, Maurizio; Zuiderweg, Erik R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2588-2596</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The Hsp70 family of mol. chaperones participates in a no. of cellular processes, including binding to nascent polypeptide chains and assistance in protein (re)folding and degrdn.  We present the soln. structure of the substrate binding domain (residues 393-507) of the Escherichia coli Hsp70, DnaK, that is bound to the peptide NRLLLTG and compare it to the crystal structure of DnaK(389-607) bound to the same peptide.  The construct discussed here does not contain the α-helical domain that characterizes earlier published peptide-bound structures of the Hsp70.  It is established that removing the α-helical domain in its entirety does not affect the primary interactions or structure of the DnaK(393-507) in complex with the peptide NRLLLTG.  In particular, the arch that protects the substrate-binding cleft is also formed in the absence of the helical lid.  15N-relaxation measurements show that the peptide-bound form of DnaK(393-507) is relatively rigid.  As compared to the peptide-free state, the peptide-bound state of the domain shows distinct, widespread, and contiguous differences in structure extending toward areas previously defined as important to the allosteric regulation of the Hsp70 chaperones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0OXfHhOWlMLVg90H21EOLACvtfcHk0lhFcbHcaL_I6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXoslelu74%253D&md5=d57cd363bddd9082a1c7c26ab99b1dba</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1110%2Fps.03269103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.03269103%26sid%3Dliteratum%253Aachs%26aulast%3DStevens%26aufirst%3DS.%2BY.%26aulast%3DCai%26aufirst%3DS.%26aulast%3DPellecchia%26aufirst%3DM.%26aulast%3DZuiderweg%26aufirst%3DE.%2BR.%26atitle%3DThe%2520solution%2520structure%2520of%2520the%2520bacterial%2520HSP70%2520chaperone%2520protein%2520domain%2520DnaK%2520%2528393%25E2%2580%2593507%2529%2520in%2520complex%2520with%2520the%2520peptide%2520NRLLLTG%26jtitle%3DProtein%2520Sci.%26date%3D2003%26volume%3D12%26spage%3D2588%26epage%3D2596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Worrall, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span> </span><span class="NLM_article-title">Crystal structure of the C-terminal three-helix bundle subdomain of C. elegans Hsp70</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=105-110&author=L.+J.+Worrallauthor=M.+D.+Walkinshaw&title=Crystal+structure+of+the+C-terminal+three-helix+bundle+subdomain+of+C.+elegans+Hsp70"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWorrall%26aufirst%3DL.%2BJ.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26atitle%3DCrystal%2520structure%2520of%2520the%2520C-terminal%2520three-helix%2520bundle%2520subdomain%2520of%2520C.%2520elegans%2520Hsp70%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D357%26spage%3D105%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Wisniewska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotenyova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, H.</span><span> </span><span class="NLM_article-title">Crystal structures of the ATPase domains of four human Hsp70 isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B′, and HSPA5/BiP/GRP78</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e8625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e8625&author=M.+Wisniewskaauthor=T.+Karlbergauthor=L.+Lehtioauthor=I.+Johanssonauthor=T.+Kotenyovaauthor=M.+Mocheauthor=H.+Schuler&title=Crystal+structures+of+the+ATPase+domains+of+four+human+Hsp70+isoforms%3A+HSPA1L%2FHsp70-hom%2C+HSPA2%2FHsp70-2%2C+HSPA6%2FHsp70B%E2%80%B2%2C+and+HSPA5%2FBiP%2FGRP78"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWisniewska%26aufirst%3DM.%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DJohansson%26aufirst%3DI.%26aulast%3DKotenyova%26aufirst%3DT.%26aulast%3DMoche%26aufirst%3DM.%26aulast%3DSchuler%26aufirst%3DH.%26atitle%3DCrystal%2520structures%2520of%2520the%2520ATPase%2520domains%2520of%2520four%2520human%2520Hsp70%2520isoforms%253A%2520HSPA1L%252FHsp70-hom%252C%2520HSPA2%252FHsp70-2%252C%2520HSPA6%252FHsp70B%25E2%2580%25B2%252C%2520and%2520HSPA5%252FBiP%252FGRP78%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De8625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurochkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertelsen, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderweg, E. R.</span><span> </span><span class="NLM_article-title">Allostery in Hsp70 chaperones is transduced by subdomain rotations</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1016%2Fj.jmb.2009.01.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=19361428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVCrsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=475-490&author=A.+Bhattacharyaauthor=A.+V.+Kurochkinauthor=G.+N.+Yipauthor=Y.+Zhangauthor=E.+B.+Bertelsenauthor=E.+R.+Zuiderweg&title=Allostery+in+Hsp70+chaperones+is+transduced+by+subdomain+rotations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Allostery in Hsp70 Chaperones Is Transduced by Subdomain Rotations</span></div><div class="casAuthors">Bhattacharya, Akash; Kurochkin, Alexander V.; Yip, Grover N. B.; Zhang, Yongbo; Bertelsen, Eric B.; Zuiderweg, Erik R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-490</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Hsp70s (heat shock protein 70 kDa) are central to protein folding, refolding, and trafficking in organisms ranging from archaea to Homo sapiens under both normal and stressed cellular conditions.  Hsp70s are comprised of a nucleotide-binding domain (NBD) and a substrate-binding domain (SBD).  The nucleotide binding site in the NBD and the substrate binding site in the SBD are allosterically linked: ADP binding promotes substrate binding, while ATP binding promotes substrate release.  Hsp70s have been linked to inhibition of apoptosis (i.e., cancer) and diseases assocd. with protein misfolding such as Alzheimer's, Parkinson's, and Huntington's.  It has long been a goal to characterize the nature of allosteric coupling in these proteins.  However, earlier studies of the isolated NBD could not show any difference in overall conformation between the ATP state and the ADP state.  Hence the question: How is the state of the nucleotide communicated between NBD and SBD Here we report a soln. NMR study of the 44-kDa NBD of Hsp70 from Thermus thermophilus in the ADP and AMPPNP states.  Using the soln. NMR methods of residual dipolar coupling anal., we det. that significant rotations occur for different subdomains of the NBD upon exchange of nucleotide.  These rotations modulate access to the nucleotide binding cleft in the absence of a nucleotide exchange factor.  Moreover, the rotations cause a change in the accessibility of a hydrophobic surface cleft remote from the nucleotide binding site, which previously has been identified as essential to allosteric communication between NBD and SBD.  We propose that it is this change in the NBD surface cleft that constitutes the allosteric signal that can be recognized by the SBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDgfOozqB_ALVg90H21EOLACvtfcHk0lipIFjFZf6org"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVCrsL4%253D&md5=dc693ae61ac52cf59cf0df5dbb370375</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.01.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.01.062%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DKurochkin%26aufirst%3DA.%2BV.%26aulast%3DYip%26aufirst%3DG.%2BN.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBertelsen%26aufirst%3DE.%2BB.%26aulast%3DZuiderweg%26aufirst%3DE.%2BR.%26atitle%3DAllostery%2520in%2520Hsp70%2520chaperones%2520is%2520transduced%2520by%2520subdomain%2520rotations%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26spage%3D475%26epage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Woo, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafer, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, R.</span><span> </span><span class="NLM_article-title">ATP-induced conformational changes in Hsp70: molecular dynamics and experimental validation of an in silico predicted conformation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">11470</span><span class="NLM_x">–</span> <span class="NLM_lpage">11477</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi901256y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=11470-11477&author=H.+J.+Wooauthor=J.+Jiangauthor=E.+M.+Laferauthor=R.+Sousa&title=ATP-induced+conformational+changes+in+Hsp70%3A+molecular+dynamics+and+experimental+validation+of+an+in+silico+predicted+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi901256y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi901256y%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DH.%2BJ.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DLafer%26aufirst%3DE.%2BM.%26aulast%3DSousa%26aufirst%3DR.%26atitle%3DATP-induced%2520conformational%2520changes%2520in%2520Hsp70%253A%2520molecular%2520dynamics%2520and%2520experimental%2520validation%2520of%2520an%2520in%2520silico%2520predicted%2520conformation%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D11470%26epage%3D11477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirico, W. J.</span><span> </span><span class="NLM_article-title">N-Ethylmaleimide inactivates a nucleotide-free Hsp70 molecular chaperone</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">29937</span><span class="NLM_x">–</span> <span class="NLM_lpage">29944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=29937-29944&author=Q.+Liuauthor=E.+J.+Levyauthor=W.+J.+Chirico&title=N-Ethylmaleimide+inactivates+a+nucleotide-free+Hsp70+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLevy%26aufirst%3DE.%2BJ.%26aulast%3DChirico%26aufirst%3DW.%2BJ.%26atitle%3DN-Ethylmaleimide%2520inactivates%2520a%2520nucleotide-free%2520Hsp70%2520molecular%2520chaperone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D29937%26epage%3D29944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+Hsp90+confers+tumour+selectivity+on+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0lipIFjFZf6org"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520Hsp90%2520confers%2520tumour%2520selectivity%2520on%2520Hsp90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchietti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes-DaGama, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas-Lopes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alpaugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillarsetty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnchembio.670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=21946277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1anurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=818-826&author=K.+Moulickauthor=J.+H.+Ahnauthor=H.+Zongauthor=A.+Rodinaauthor=L.+Cerchiettiauthor=E.+M.+Gomes-DaGamaauthor=E.+Caldas-Lopesauthor=K.+Beebeauthor=F.+Pernaauthor=K.+Hatziauthor=L.+P.+Vuauthor=X.+Zhaoauthor=D.+Zatorskaauthor=T.+Taldoneauthor=P.+Smith-Jonesauthor=M.+Alpaughauthor=S.+S.+Grossauthor=N.+Pillarsettyauthor=T.+Kuauthor=J.+S.+Lewisauthor=S.+M.+Larsonauthor=R.+Levineauthor=H.+Erdjument-Bromageauthor=M.+L.+Guzmanauthor=S.+D.+Nimerauthor=A.+Melnickauthor=L.+Neckersauthor=G.+Chiosis&title=Affinity-based+proteomics+reveal+cancer-specific+networks+coordinated+by+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90</span></div><div class="casAuthors">Moulick, Kamalika; Ahn, James H.; Zong, Hongliang; Rodina, Anna; Cerchietti, Leandro; Gomes DaGama, Erica M.; Caldas-Lopes, Eloisi; Beebe, Kristin; Perna, Fabiana; Hatzi, Katerina; Vu, Ly P.; Zhao, Xinyang; Zatorska, Danuta; Taldone, Tony; Smith-Jones, Peter; Alpaugh, Mary; Gross, Steven S.; Pillarsetty, Nagavarakishore; Ku, Thomas; Lewis, Jason S.; Larson, Steven M.; Levine, Ross; Erdjument-Bromage, Hediye; Guzman, Monica L.; Nimer, Stephen D.; Melnick, Ari; Neckers, Len; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-826</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Most cancers were characterized by multiple mol. alterations, but identification of the key proteins involved in these signaling pathways is currently beyond reach.  The inhibitor PU-H71 preferentially targets tumor-enriched Hsp90 complexes and affinity captures Hsp90-dependent oncogenic client proteins.  The authors used PU-H71 affinity capture to design a proteomic approach that, when combined with bioinformatic pathway anal., identifies dysregulated signaling networks and key oncoproteins in chronic myeloid leukemia.  The identified interactome overlaps with the well-characterized altered proteome in this cancer, indicating that this method can provide global insights into the biol. of individual tumors, including primary patient specimens.  In addn., this approach can be used to identify previously uncharacterized oncoproteins and mechanisms, potentially leading to new targeted therapies.  Further the abundance of the PU-H71-enriched Hsp90 species, which is not dictated by Hsp90 expression alone, is predictive of the cell's sensitivity to Hsp90 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXTlQWF_MFU7Vg90H21EOLACvtfcHk0lhslto6mqVC3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1anurbN&md5=d62e663a2e054f3715a3a6e2d5e2c10e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.670%26sid%3Dliteratum%253Aachs%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DZong%26aufirst%3DH.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DGomes-DaGama%26aufirst%3DE.%2BM.%26aulast%3DCaldas-Lopes%26aufirst%3DE.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DPerna%26aufirst%3DF.%26aulast%3DHatzi%26aufirst%3DK.%26aulast%3DVu%26aufirst%3DL.%2BP.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DSmith-Jones%26aufirst%3DP.%26aulast%3DAlpaugh%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DS.%2BS.%26aulast%3DPillarsetty%26aufirst%3DN.%26aulast%3DKu%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DLevine%26aufirst%3DR.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAffinity-based%2520proteomics%2520reveal%2520cancer-specific%2520networks%2520coordinated%2520by%2520Hsp90%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D818%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Beebe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollapour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scroggins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zierer, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.18632%2Foncotarget.1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=23867252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1065-1074&author=K.+Beebeauthor=M.+Mollapourauthor=B.+Scrogginsauthor=C.+Prodromouauthor=W.+Xuauthor=M.+Tokitaauthor=T.+Taldoneauthor=L.+Pullenauthor=B.+K.+Ziererauthor=M.+J.+Leeauthor=J.+Trepelauthor=J.+Buchnerauthor=D.+Bolonauthor=G.+Chiosisauthor=L.+Neckers&title=Posttranslational+modification+and+conformational+state+of+heat+shock+protein+90+differentially+affect+binding+of+chemically+diverse+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span></div><div class="casAuthors">Beebe Kristin; Mollapour Mehdi; Scroggins Bradley; Prodromou Chrisostomos; Xu Wanping; Tokita Mari; Taldone Tony; Pullen Lester; Zierer Bettina K; Lee Min-Jung; Trepel Jane; Buchner Johannes; Bolon Daniel; Chiosis Gabriela; Neckers Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1065-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an essential molecular chaperone in eukaryotes that facilitates the conformational maturation and function of a diverse protein clientele, including aberrant and/or over-expressed proteins that are involved in cancer growth and survival.  A role for Hsp90 in supporting the protein homeostasis of cancer cells has buoyed interest in the utility of Hsp90 inhibitors as anti-cancer drugs.  Despite the fact that all clinically evaluated Hsp90 inhibitors target an identical nucleotide-binding pocket in the N domain of the chaperone, the precise determinants that affect drug binding in the cellular environment remain unclear, and it is possible that chemically distinct inhibitors may not share similar binding preferences.  Here we demonstrate that two chemically unrelated Hsp90 inhibitors, the benzoquinone ansamycin geldanamycin and the purine analog PU-H71, select for overlapping but not identical subpopulations of total cellular Hsp90, even though both inhibitors bind to an amino terminal nucleotide pocket and prevent N domain dimerization.  Our data also suggest that PU-H71 is able to access a broader range of N domain undimerized Hsp90 conformations than is geldanamycin and is less affected by Hsp90 phosphorylation, consistent with its broader and more potent anti-tumor activity.  A more complete understanding of the impact of the cellular milieu on small molecule inhibitor binding to Hsp90 should facilitate their more effective use in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLZ-jT50Ygfa91pGlMMoT5fW6udTcc2eY8yWkYg5YHhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D&md5=1db8c9dca9517cd39a1b911107869582</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1099%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DScroggins%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DTokita%26aufirst%3DM.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPullen%26aufirst%3DL.%26aulast%3DZierer%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26aulast%3DBolon%26aufirst%3DD.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DPosttranslational%2520modification%2520and%2520conformational%2520state%2520of%2520heat%2520shock%2520protein%252090%2520differentially%2520affect%2520binding%2520of%2520chemically%2520diverse%2520small%2520molecule%2520inhibitors%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26spage%3D1065%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1113</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1196%2Fannals.1391.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=17513464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2007&pages=202-216&author=P.+Workmanauthor=F.+Burrowsauthor=L.+Neckersauthor=N.+Rosen&title=Drugging+the+cancer+chaperone+HSP90%3A+combinatorial+therapeutic+exploitation+of+oncogene+addiction+and+tumor+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging the cancer chaperone HSP90: combinatorial therapeutic expolitation on oncogene addiction and tumor stress</span></div><div class="casAuthors">Workman, Paul; Burrows, Francis; Neckers, Len; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Stress Responses in Biology and Medicine</span>),
    <span class="NLM_cas:pages">202-216</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone HSP90 has emerged as an exciting target for cancer treatment.  We review the potential advantages of HSP90 inhibitors, particularly the simultaneous combinatorial depletion of multiple oncogenic "client" proteins, leading to blockade of many cancer-causing pathways and the antagonism of all of the hallmark pathol. traits of malignancy.  Cancer selectivity is achieved by exploiting cancer "dependencies," including oncogene addiction and the stressed state of malignant cells.  The multiple downstream effects of HSP90 inhibitors should make the development of resistance more difficult than with agents having more restricted effects.  We review the various classes of HSP90 inhibitor that have been developed, including the natural products geldanamycin and radicicol and also the purine scaffold and pyrazole/isoxazole class of synthetic small mol. inhibitors.  A first-in-class HSP90 drug, the geldanamycin analog 17-AAG, has provided proof of concept for HSP90 inhibition in patients at well tolerated doses and therapeutic activity has been seen.  Other inhibitors show promise in preclin. and clin. development.  Opportunities and challenges for HSP90 inhibitors are discussed, including use in combination with other agents.  Most of the current HSP90 inhibitors act by blocking the essential nucleotide binding and ATPase activity required for chaperone function.  Potential new approaches are discussed, for example, interference with cochaperone binding and function in the superchaperone complex.  Biomarkers for use with HSP90 inhibitors are described.  We stress how basic and translational research has been mutually beneficial and indicate future directions to enhance our understanding of mol. chaperones and their exploitation in cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_I-DGevqj7Vg90H21EOLACvtfcHk0lhl0CEeGaOCKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF&md5=a537c5d947847c6b3cdf613968214623</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1196%2Fannals.1391.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1391.012%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DDrugging%2520the%2520cancer%2520chaperone%2520HSP90%253A%2520combinatorial%2520therapeutic%2520exploitation%2520of%2520oncogene%2520addiction%2520and%2520tumor%2520stress%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2007%26volume%3D1113%26spage%3D202%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Caldas-Lopes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchietti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanchina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mab, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varticovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">8368</span><span class="NLM_x">–</span> <span class="NLM_lpage">8373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=8368-8373&author=E.+Caldas-Lopesauthor=L.+Cerchiettiauthor=J.+H.+Ahnauthor=C.+C.+Clementauthor=A.+I.+Roblesauthor=A.+Rodinaauthor=K.+Moulickauthor=T.+Taldoneauthor=A.+Gozmanauthor=Y.+Guoauthor=N.+Wuauthor=E.+Stanchinaauthor=J.+Whiteauthor=S.+S.+Grossauthor=Y.+Mabauthor=L.+Varticovskiauthor=A.+Melnickauthor=G.+Chiosis&title=Hsp90+inhibitor+PU-H71%2C+a+multimodal+inhibitor+of+malignancy%2C+induces+complete+responses+in+triple-negative+breast+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaldas-Lopes%26aufirst%3DE.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DRobles%26aufirst%3DA.%2BI.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DGozman%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DStanchina%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DS.%2BS.%26aulast%3DMab%26aufirst%3DY.%26aulast%3DVarticovski%26aufirst%3DL.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHsp90%2520inhibitor%2520PU-H71%252C%2520a%2520multimodal%2520inhibitor%2520of%2520malignancy%252C%2520induces%2520complete%2520responses%2520in%2520triple-negative%2520breast%2520cancer%2520models%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D106%26spage%3D8368%26epage%3D8373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0508078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=381-390&author=H.+Heauthor=D.+Zatorskaauthor=J.+Kimauthor=J.+Aguirreauthor=L.+Llaugerauthor=Y.+Sheauthor=N.+Wuauthor=R.+M.+Immorminoauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Identification+of+potent+water+soluble+purine-scaffold+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90</span></div><div class="casAuthors">He, Huazhong; Zatorska, Danuta; Kim, Joungnam; Aguirre, Julia; Llauger, Laura; She, Yuhong; Wu, Nian; Immormino, Robert M.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways.  Its inactivation may result in targeting multiple mol. alterations and, thus, in reverting the transformed phenotype.  The PU-class, a purine-scaffold Hsp90 inhibitor series, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer.  Here, a series of this class was synthesized and evaluated as inhibitors of the chaperone.  The structure-activity relationship and selectivity for tumor Hsp90 of compds. within the series is presented.  The study identifies water sol. derivs. (>5 mM in PBS pH 7.4) of nanomolar potency (IC50 ∼ 50 nM) in cellular and animal models of cancer.  Binding affinities of these compds. for Hsp90 correlate well with their biol. activities.  When administered in vivo to mice bearing MDA-MB-468 human breast cancer xenografted tumors, these agents result in pharmacol. relevant concns. and, accordingly, in modulation of Hsp90-client proteins in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwHp1Wo_iW7Vg90H21EOLACvtfcHk0lh9en1XdIgnkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF&md5=3bd02ca5bc0a147e9cffa58968433917</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0508078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508078%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potent%2520water%2520soluble%2520purine-scaffold%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D381%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Inhibition of heat shock protein Hsp90-pp60<sup>v-src</sup> heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">8324</span><span class="NLM_x">–</span> <span class="NLM_lpage">8328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1073%2Fpnas.91.18.8324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=8078881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8324-8328&author=L.+Whitesellauthor=E.+G.+Mimnaughauthor=B.+De+Costaauthor=C.+E.+Myersauthor=L.+M.+Neckers&title=Inhibition+of+heat+shock+protein+Hsp90-pp60v-src+heteroprotein+complex+formation+by+benzoquinone+ansamycins%3A+essential+role+for+stress+proteins+in+oncogenic+transformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span></div><div class="casAuthors">Whitesell, Luke; Mimnaugh, Edward G.; De Costa, Brian; Myers, Charles E.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8324-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The mol. mechanisms by which oncogenic tyrosine kinases induce cellular transformation are unclear.  Herbimycin A, geldanamycin, and certain other benzoquinone ansamycins display an unusual capacity to revert tyrosine kinase-induced oncogenic transformation.  As an approach to the study of v-src-mediated transformation, the authors examd. ansamycin action in transformed cells and found that drug-induced reversion could be achieved without direct inhibition of src phosphorylating activity.  To identify mechanisms other than kinase inhibition for drug-mediated reversion, the authors prepd. a solid phase-immobilized geldanamycin deriv. and affinity pptd. the mol. targets with which the drug interacted.  In a range of cell lines, immobilized geldanamycin bound elements of a major class of heat shock protein (HSP90) in a stable and pharmacol. specific manner.  Consistent with these binding data, the authors found that sol. geldanamycin and herbimycin A inhibited specifically the formation of a previously described src-HSP90 heteroprotein complex.  A related benzoquinone ansamycin that failed to revert transformed cells did not inhibit the formation of this complex.  These results demonstrate that HSP participation in multimol. complex formation is required for src-mediated transformation and can provide a target for drug modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTW8DJOglQLVg90H21EOLACvtfcHk0lh9en1XdIgnkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D&md5=18f1cad01698df44adaa05ef3da9f850</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8324%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DMimnaugh%26aufirst%3DE.%2BG.%26aulast%3DDe%2BCosta%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DC.%2BE.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%2520Hsp90-pp60v-src%2520heteroprotein%2520complex%2520formation%2520by%2520benzoquinone%2520ansamycins%253A%2520essential%2520role%2520for%2520stress%2520proteins%2520in%2520oncogenic%2520transformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D8324%26epage%3D8328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huezo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spampinato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modrich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1016%2Fj.chembiol.2004.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=15217612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=787-797&author=M.+Vilenchikauthor=D.+Solitauthor=A.+Bassoauthor=H.+Huezoauthor=B.+Lucasauthor=H.+Heauthor=N.+Rosenauthor=C.+Spampinatoauthor=P.+Modrichauthor=G.+Chiosis&title=Targeting+wide-range+oncogenic+transformation+via+PU24FCl%2C+a+specific+inhibitor+of+tumor+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Wide-Range Oncogenic Transformation via PU24FCl, a Specific Inhibitor of Tumor Hsp90</span></div><div class="casAuthors">Vilenchik, Maria; Solit, David; Basso, Andrea; Huezo, Henri; Lucas, Brian; He, Huazhong; Rosen, Neal; Spampinato, Claudia; Modrich, Paul; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">787-797</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Agents that inhibit Hsp90 function hold significant promise in cancer therapy.  Here we present PU24FCl, a representative of the first class of designed Hsp90 inhibitors.  By specifically and potently inhibiting tumor Hsp90, PU24FCl exhibits wide-ranging anti-cancer activities that occur at similar doses in all tested tumor types.  Normal cells are 10- to 50-fold more resistant to these effects.  Its Hsp90 inhibition results in multiple antitumor-specific effects, such as degrdn. of Hsp90-client proteins involved in cell growth, survival, and specific transformation, inhibition of cancer cell growth, delay of cell cycle progression, induction of morphol. and functional changes, and apoptosis.  In concordance with its higher affinity for tumor Hsp90, in vivo PU24FCl accumulates in tumors while being rapidly cleared from normal tissue.  Concns. achieved in vivo in tumors lead to single-agent antitumor activity at non-toxic doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHKaguPFd5FLVg90H21EOLACvtfcHk0lh9en1XdIgnkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrg%253D&md5=1bf99fe18a0a212c770fa731c197e60c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DSolit%26aufirst%3DD.%26aulast%3DBasso%26aufirst%3DA.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DSpampinato%26aufirst%3DC.%26aulast%3DModrich%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DTargeting%2520wide-range%2520oncogenic%2520transformation%2520via%2520PU24FCl%252C%2520a%2520specific%2520inhibitor%2520of%2520tumor%2520Hsp90%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D787%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Synthesis of a red-shifted fluorescence polarization probe for Hsp90</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4515</span><span class="NLM_x">–</span> <span class="NLM_lpage">4518</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4515-4518&author=K.+Moulickauthor=C.+C.+Clementauthor=J.+Aguirreauthor=J.+Kimauthor=Y.+Kangauthor=S.+Feltsauthor=G.+Chiosis&title=Synthesis+of+a+red-shifted+fluorescence+polarization+probe+for+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520a%2520red-shifted%2520fluorescence%2520polarization%2520probe%2520for%2520Hsp90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4515%26epage%3D4518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lélias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lhEOeg3Er7dcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lhEOeg3Er7dcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Hurwitz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scullin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L.</span><span> </span><span class="NLM_article-title">Afatinib treatment in advanced non-small cell lung cancer</span> <span class="citation_source-journal">Lung Cancer: Targets Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=47-57&author=J.+L.+Hurwitzauthor=P.+Scullinauthor=L.+Campbell&title=Afatinib+treatment+in+advanced+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Afatinib treatment in advanced non-small cell lung cancer</span></div><div class="casAuthors">Hurwitz, Jane L.; Scullin, Paula; Campbell, Lynn</div><div class="citationInfo"><span class="NLM_cas:title">Lung Cancer: Targets and Therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-57</span>CODEN:
                <span class="NLM_cas:coden">LCTTBI</span>;
        ISSN:<span class="NLM_cas:issn">1179-2728</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite some recent advances in the management of advanced non-small cell lung cancer (NSCLC), prognosis for these patients remains poor.  Small mol. epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have however provided a new therapeutic option in this disease setting and EGFR mutation testing is now routine practice for newly diagnosed NSCLC patients.  A proportion of patients will not respond to first-generation EGFR-TKIs however and those who do will ultimately develop resistance and disease relapse.  Next-generation EGFR-TKIs which inhibit multiple members of the EGFR family are being developed in order to increase sensitivity and overcome resistance to existing agents.  Afatinib (BIBW 2992) is an oral, irreversible inhibitor of EGFR and HER2 tyrosine kinases and is the most advanced of these agents in clin. development.  Pre-clin. and early-phase clin. trials have demonstrated a favorable safety profile as a single agent and in combination with other anti-cancer agents, and provide evidence of clin. activity in advanced NSCLC.  The LUX-Lung trials suggest that for selected patients, afatinib offers symptomatic improvement and prolonged progression-free survival, although this has not yet translated into improved overall survival.  This article aims to review the use of EGFR-TKIs in the management of advanced NSCLC and the mechanisms underlying resistance to these agents.  We will discuss the current pre-clin. and clin. data regarding afatinib, its potential to overcome resistance to firstgeneration TKIs and its emerging role in advanced NSCLC treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR6NVwLl4z9bVg90H21EOLACvtfcHk0lhxCBiNJXfIWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCm&md5=e0890492e1de41c1fee5e541e08cbb21</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DJ.%2BL.%26aulast%3DScullin%26aufirst%3DP.%26aulast%3DCampbell%26aufirst%3DL.%26atitle%3DAfatinib%2520treatment%2520in%2520advanced%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DLung%2520Cancer%253A%2520Targets%2520Ther.%26date%3D2011%26volume%3D2%26spage%3D47%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Burstein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirix, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paridaens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badwe, R.</span><span> </span><span class="NLM_article-title">Neratinib, an irreversible ErbB Receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1200%2FJCO.2009.25.8707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=20142587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFSqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=1301-1307&author=H.+J.+Bursteinauthor=Y.+Sunauthor=L.+Y.+Dirixauthor=Z.+Jiangauthor=R.+Paridaensauthor=A.+R.+Tanauthor=A.+Awadaauthor=A.+Ranadeauthor=S.+Jiaoauthor=G.+Schwartzauthor=R.+Abbasauthor=C.+Powellauthor=K.+Turnbullauthor=J.+Vermetteauthor=C.+Zacharchukauthor=R.+Badwe&title=Neratinib%2C+an+irreversible+ErbB+Receptor+tyrosine+kinase+inhibitor%2C+in+patients+with+advanced+ErbB2-positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer</span></div><div class="casAuthors">Burstein, Harold J.; Sun, Yan; Dirix, Luc Y.; Jiang, Zefei; Paridaens, Robert; Tan, Antoinette R.; Awada, Ahmad; Ranade, Anantbhushan; Jiao, Shunchang; Schwartz, Gary; Abbas, Richat; Powell, Christine; Turnbull, Kathleen; Vermette, Jennifer; Zacharchuk, Charles; Badwe, Rajendra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1301-1307</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Neratinib is an oral, irreversible pan-ErbB receptor tyrosine kinase inhibitor.  The efficacy and safety of neratinib were evaluated in two cohorts of patients with advanced ErbB2-pos. breast cancer-those with and those without prior trastuzumab treatment-in an open-label, multicenter, phase II trial.  Patients in the two cohorts (prior trastuzumab, n = 66; no prior trastuzumab, n = 70) received oral neratinib 240 mg once daily.  The primary end point was the 16-wk progression-free survival (PFS) rate for the evaluable population (prior trastuzumab, n = 63; no prior trastuzumab, n = 64), as assessed by independent review.  The 16-wk PFS rates were 59% for patients with prior trastuzumab treatment and 78% for patients with no prior trastuzumab treatment.  Median PFS was 22.3 and 39.6 wk, resp.  Objective response rates were 24% among patients with prior trastuzumab treatment and 56% in the trastuzumab-naive cohort.  The most common adverse events were diarrhea, nausea, vomiting, and fatigue.  Diarrhea was the most frequent grades 3 to 4 adverse event, occurring in 30% of patients with prior trastuzumab treatment and in 13% of patients with no prior trastuzumab treatment, which prompted dose redns. in 29% and 4% of patients, resp., but treatment discontinuation in only one patient.  No neratinib-related, grades 3 or 4 cardiotoxicity was reported.  Oral neratinib showed substantial clin. activity and was reasonably well tolerated among both heavily pretreated and trastuzumab-naive patients who had advanced, ErbB2-pos. breast cancer.  Diarrhea was the most common adverse effect but was manageable with antidiarrheal agents and dose modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqbEv1WYAZUbVg90H21EOLACvtfcHk0lhxCBiNJXfIWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFSqtbs%253D&md5=11b07ce171753c7499b50d52786859e8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.25.8707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.25.8707%26sid%3Dliteratum%253Aachs%26aulast%3DBurstein%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DParidaens%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DA.%2BR.%26aulast%3DAwada%26aufirst%3DA.%26aulast%3DRanade%26aufirst%3DA.%26aulast%3DJiao%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DG.%26aulast%3DAbbas%26aufirst%3DR.%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DTurnbull%26aufirst%3DK.%26aulast%3DVermette%26aufirst%3DJ.%26aulast%3DZacharchuk%26aufirst%3DC.%26aulast%3DBadwe%26aufirst%3DR.%26atitle%3DNeratinib%252C%2520an%2520irreversible%2520ErbB%2520Receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520patients%2520with%2520advanced%2520ErbB2-positive%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D1301%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Sequist, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besse, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitlitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freyman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananthakrishnan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J.-C.</span><span> </span><span class="NLM_article-title">Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3076</span><span class="NLM_x">–</span> <span class="NLM_lpage">3083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1200%2FJCO.2009.27.9414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=20479403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlaju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=3076-3083&author=L.+V.+Sequistauthor=B.+Besseauthor=T.+J.+Lynchauthor=V.+A.+Millerauthor=K.+K.+Wongauthor=B.+Gitlitzauthor=K.+Eatonauthor=C.+Zacharchukauthor=A.+Freymanauthor=C.+Powellauthor=R.+Ananthakrishnanauthor=S.+Quinnauthor=J.-C.+Soria&title=Neratinib%2C+an+irreversible+pan-ErbB+receptor+tyrosine+kinase+inhibitor%3A+results+of+a+phase+II+trial+in+patients+with+advanced+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Neratinib, an irreversible Pan-ErbB, receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer</span></div><div class="casAuthors">Sequist, Lecia V.; Besse, Benjamin; Lynch, Thomas J.; Miller, Vincent A.; Wong, Kwok K.; Gitlitz, Barbara; Eaton, Keith; Zacharchuk, Charles; Freyman, Amy; Powell, Christine; Ananthakrishnan, Revathi; Quinn, Susan; Soria, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3076-3083</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have had a significant impact on non-small-cell lung cancer (NSCLC) outcomes, particularly for patients with EGFR mutations.  Resistance emerges after 9 to 12 mo, primarily mediated by the T790M resistance mutation.  We studied neratinib, an irreversible pan-ErbB TKI that may overcome T790M.  Patients with advanced NSCLC underwent EGFR sequencing of available tumor tissue at enrollment.  Those with ≥ 12 wk of prior TKI therapy were placed in arm A if they were EGFR mutation pos. or arm B if they were wild-type.  Arm C included TKI-naive patients with adenocarcinoma and light smoking histories (≤ 20 pack-years).  All patients received daily oral neratinib, initially at 320 mg but subsequently reduced to 240 mg because of excessive diarrhea.  The primary end point was objective response rate (RR).  167 Patients were treated: 91 in arm A, 48 in arm B, and 28 in arm C.  Diarrhea was the most common toxicity; grade 3 incidence was 50% at 320 mg but improved to 25% after dose redn.  The RR was 3% in arm A and zero in arms B and C.  No patients with known T790M responded.  Notably, three of four patients with an exon 18 G719X EGFR mutation had a partial response and the fourth had stable disease lasting 40 wk.  Neratinib had low activity in patients with prior benefit from TKIs and in TKI-naive patients, potentially because of insufficient bioavailability from diarrhea-imposed dose limitation.  Responses were seen in patients with the rare G719X EGFR mutation, highlighting the importance of obtaining comprehensive genetic information on trials of targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Z3gsvbWbOrVg90H21EOLACvtfcHk0liNRcVq7LOIzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlaju7c%253D&md5=460e088e58919bbfcf8c153772f157b0</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.27.9414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.27.9414%26sid%3Dliteratum%253Aachs%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DBesse%26aufirst%3DB.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DMiller%26aufirst%3DV.%2BA.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DGitlitz%26aufirst%3DB.%26aulast%3DEaton%26aufirst%3DK.%26aulast%3DZacharchuk%26aufirst%3DC.%26aulast%3DFreyman%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DAnanthakrishnan%26aufirst%3DR.%26aulast%3DQuinn%26aufirst%3DS.%26aulast%3DSoria%26aufirst%3DJ.-C.%26atitle%3DNeratinib%252C%2520an%2520irreversible%2520pan-ErbB%2520receptor%2520tyrosine%2520kinase%2520inhibitor%253A%2520results%2520of%2520a%2520phase%2520II%2520trial%2520in%2520patients%2520with%2520advanced%2520non-small-cell%2520lung%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D3076%26epage%3D3083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ou, S.-H. I.</span><span> </span><span class="NLM_article-title">Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1016%2Fj.critrevonc.2011.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=22257651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A280%3ADC%252BC38vgs1GrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=407-421&author=S.-H.+I.+Ou&title=Second-generation+irreversible+epidermal+growth+factor+receptor+%28EGFR%29+tyrosine+kinase+inhibitors+%28TKIs%29%3A+a+better+mousetrap%3F+A+review+of+the+clinical+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence</span></div><div class="casAuthors">Ou Sai-Hong Ignatius</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The discovery of activating epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) in 2004 heralded the era of molecular targeted therapy in NSCLC.  First-generation small molecule, reversible tyrosine kinase inhibitors (TKIs) of EGFR, gefitinib and erlotinib, had been approved for second- or third-line treatment of NSCLC prior to the knowledge of these mutations.  However, resistance to gefitinib and erlotinib invariably develops after prolonged clinical use.  Two second-generation irreversible EGFR TKIs, afatinib (BIBW 2992) and dacomitinib (PF-00299804), that can potentially overcome the majority of these resistances are in late stage clinical development.  Here I will review the clinical data of EGFR TKIs and discuss the appropriate future role of afatinib and dacomitinib in NSCLC: whether as replacement of erlotinib or gefitinib or only after erlotinib or gefitinib failure and whether different subgroups would benefit from different approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQB3Zud0oX1WCM8MEzWGjS9fW6udTcc2eapfKi2cw--27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vgs1GrsA%253D%253D&md5=df9e3f1fe1c2bb8f328f925725024d40</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2011.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2011.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DS.-H.%2BI.%26atitle%3DSecond-generation%2520irreversible%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520tyrosine%2520kinase%2520inhibitors%2520%2528TKIs%2529%253A%2520a%2520better%2520mousetrap%253F%2520A%2520review%2520of%2520the%2520clinical%2520evidence%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2012%26volume%3D83%26spage%3D407%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kwak, E.</span><span> </span><span class="NLM_article-title">The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancer</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1498</span><span class="NLM_x">–</span> <span class="NLM_lpage">1507</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=1498-1507&author=E.+Kwak&title=The+role+of+irreversible+HER+family+inhibition+in+the+treatment+of+patients+with+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DE.%26atitle%3DThe%2520role%2520of%2520irreversible%2520HER%2520family%2520inhibition%2520in%2520the%2520treatment%2520of%2520patients%2520with%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DOncologist%26date%3D2011%26volume%3D16%26spage%3D1498%26epage%3D1507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vejda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotzmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte-Hermann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikulits, W.</span><span> </span><span class="NLM_article-title">Concomitant determination of absolute values of cellular protein amounts, synthesis rates, and turnover rates by quantitative proteome profiling</span> <span class="citation_source-journal">Mol. Cell Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1074%2Fmcp.M200026-MCP200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=12239281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFKls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=528-537&author=C.+Gernerauthor=S.+Vejdaauthor=D.+Gelbmannauthor=E.+Bayerauthor=J.+Gotzmannauthor=R.+Schulte-Hermannauthor=W.+Mikulits&title=Concomitant+determination+of+absolute+values+of+cellular+protein+amounts%2C+synthesis+rates%2C+and+turnover+rates+by+quantitative+proteome+profiling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Concomitant determination of absolute values of cellular protein amounts, synthesis rates, and turnover rates by quantitative proteome profiling</span></div><div class="casAuthors">Gerner, Christopher; Vejda, Susanne; Gelbmann, Dieter; Bayer, Editha; Gotzmann, Josef; Schulte-Hermann, Rolf; Mikulits, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Proteomics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">528-537</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9476</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Two-dimensional gel electrophoresis of protein fractions isolated from 35S-radiolabeled cells provides qual. information on intracellular amts. 35S incorporation rates, protein modifications, and subcellular localizations of up to thousands of individual proteins.  In this study we extended proteome profiling to provide quant. data on synthesis rates of individual proteins.  We combined fluorescence detection of radiolabeled proteins with SYPRO ruby staining and subsequent autoradiog. of the same gels, thereby quantifying protein amts. and 35S incorporation.  To calibrate calcn. of abs. synthesis rates, we detd. the amt. and autoradiograph intensity of radiolabeled haptoglobin secreted by interleukin-6 pretreated HepG2 cells.  This allowed us to obtain a std. calibration value for 35S incorporation per autoradiograph intensity unit.  This value was used to measure protein synthesis rates during time course expts. of heat-shocked U937 cells.  We measured the increasing amts. of hsp70 and calcd. it by integration of the detd. hsp70 synthesis rates over time.  Similar results were obtained by both methods, validating our standardization procedure.  Based on the assumption that the synthesis rate of proteins in a steady state of cell metab. would essentially compensate protein degrdn., we calcd. biol. half-lives of proteins from protein amts. and synthesis rates detd. from two-dimensional gels.  Calcd. protein half-lives were found close to those detd. by pulse-chase expts., thus validating this new method.  In conclusion, we devised a method to assess quant. proteome profiles covering detn. of individual amts., synthesis, and turnover rates of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNRfQd0ATwzLVg90H21EOLACvtfcHk0lj1SQoi3Z0ptg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFKls7s%253D&md5=afb267deb43e63fbad45fdcc09deda42</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M200026-MCP200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M200026-MCP200%26sid%3Dliteratum%253Aachs%26aulast%3DGerner%26aufirst%3DC.%26aulast%3DVejda%26aufirst%3DS.%26aulast%3DGelbmann%26aufirst%3DD.%26aulast%3DBayer%26aufirst%3DE.%26aulast%3DGotzmann%26aufirst%3DJ.%26aulast%3DSchulte-Hermann%26aufirst%3DR.%26aulast%3DMikulits%26aufirst%3DW.%26atitle%3DConcomitant%2520determination%2520of%2520absolute%2520values%2520of%2520cellular%2520protein%2520amounts%252C%2520synthesis%2520rates%252C%2520and%2520turnover%2520rates%2520by%2520quantitative%2520proteome%2520profiling%26jtitle%3DMol.%2520Cell%2520Proteomics%26date%3D2002%26volume%3D1%26spage%3D528%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0lj1SQoi3Z0ptg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">High-throughput screening fluorescence polarization assay for tumor-specific Hsp90</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1177%2F1087057107306067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=17942784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12rs7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=915-924&author=Y.+Duauthor=K.+Moulickauthor=A.+Rodinaauthor=J.+Aguirreauthor=S.+Feltsauthor=R.+Dingledineauthor=H.+Fuauthor=G.+Chiosis&title=High-throughput+screening+fluorescence+polarization+assay+for+tumor-specific+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening fluorescence polarization assay for tumor-specific Hsp90</span></div><div class="casAuthors">Du, Yuhong; Moulick, Kamalika; Rodina, Anna; Aguirre, Julia; Felts, Sara; Dingledine, Raymond; Fu, Haian; Chiosis, Gabriella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">915-924</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that has emerged as an important target in cancer and several other diseases, such as neurodegenerative diseases, nerve injuries, inflammation, and infection.  Discovery of novel agents that inhibit Hsp90 and have druglike properties is therefore a major focus in several academic and industrial labs.  In this study, the authors describe the development and optimization in a 384-well format of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization, which measures competitive binding of red-shifted fluorescently labeled geldanamycin (GM-cy3B) to Hsp90 found in the NCI-N417 small-cell lung carcinoma cells.  The authors demonstrate that GM-cy3B binds with high affinity and specificity to cellular Hsp90.  The assay results in excellent signal-to-noise ratios (>10) and Z' values (>0.75) at tracer concns. greater than 4 nM and 1 μg/well of total NCI-N417 protein, indicating a robust assay.  It also equilibrates after 5 h of incubation at room temp. and remains stable for up to 24 h.  Furthermore, it is a simple mix-and-read format that is cost-effective and uses only low amts. of fluorophore and cell lysates.  A study using more than 15,000 compds. from the National Institutes of Health Mol. Libraries Screening Center Network was performed to validate its performance in a high-throughput screening format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8tjbDItT49rVg90H21EOLACvtfcHk0lj1SQoi3Z0ptg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12rs7rO&md5=e47f199e1c11d828056f6007d3f38eab</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1177%2F1087057107306067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057107306067%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DDingledine%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHigh-throughput%2520screening%2520fluorescence%2520polarization%2520assay%2520for%2520tumor-specific%2520Hsp90%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2007%26volume%3D12%26spage%3D915%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massague, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodsky, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystal, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnchembio.2007.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=17603540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFaru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=498-507&author=A.+Rodinaauthor=M.+Vilenchikauthor=K.+Moulickauthor=J.+Aguirreauthor=J.+Kimauthor=A.+Chiangauthor=J.+Litzauthor=C.+C.+Clementauthor=Y.+Kangauthor=Y.+Sheauthor=N.+Wuauthor=S.+Feltsauthor=P.+Wipfauthor=J.+Massagueauthor=X.+Jiangauthor=J.+L.+Brodskyauthor=G.+W.+Krystalauthor=G.+Chiosis&title=Selective+compounds+define+Hsp90+as+a+major+inhibitor+of+apoptosis+in+small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer</span></div><div class="casAuthors">Rodina, Anna; Vilenchik, Maria; Moulick, Kamalika; Aguirre, Julia; Kim, Joungnam; Chiang, Anne; Litz, Julie; Clement, Cristina C.; Kang, Yanlong; She, Yuhong; Wu, Nian; Felts, Sara; Wipf, Peter; Massague, Joan; Jiang, Xuejun; Brodsky, Jeffrey L.; Krystal, Geoffrey W.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">498-507</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The heat shock protein 90 (Hsp90) has a crit. role in malignant transformation.  Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood.  By using selective compds., the authors the authors have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90.  Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled.  These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZlX5SIced7Vg90H21EOLACvtfcHk0lgbC7mQD0jI9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFaru78%253D&md5=79f2a09bca626726b09895f80c40f001</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2007.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2007.10%26sid%3Dliteratum%253Aachs%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DA.%26aulast%3DLitz%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DMassague%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DBrodsky%26aufirst%3DJ.%2BL.%26aulast%3DKrystal%26aufirst%3DG.%2BW.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DSelective%2520compounds%2520define%2520Hsp90%2520as%2520a%2520major%2520inhibitor%2520of%2520apoptosis%2520in%2520small-cell%2520lung%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D498%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mariarosaria Ferraro, Ilda D’Annessa, Elisabetta Moroni, Giulia Morra, Antonella Paladino, Silvia Rinaldi, Federica Compostella, <span class="NLM_string-name hlFld-ContribAuthor">Giorgio Colombo</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 60-87. <a href="https://doi.org/10.1021/acs.jmedchem.8b00825" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00825%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BModulators%252Bof%252BHSP90%252Band%252BHSP70%25253A%252BDynamics%252BMeets%252BFunction%252Bthrough%252BStructure-Based%252BDrug%252BDesign%26aulast%3DFerraro%26aufirst%3DMariarosaria%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D24052018%26date%3D09082018%26date%3D26072018%26volume%3D62%26issue%3D1%26spage%3D60%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hao Shao, Xiaokai Li, Michael A. Moses, Luke A. Gilbert, Chakrapani Kalyanaraman, Zapporah T. Young, Margarita Chernova, Sara N. Journey, Jonathan S. Weissman, Byron Hann, Matthew P. Jacobson, Len Neckers, <span class="NLM_string-name hlFld-ContribAuthor">Jason E. Gestwicki</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein–Protein Interactions with Heat Shock Protein 70 (Hsp70). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 6163-6177. <a href="https://doi.org/10.1021/acs.jmedchem.8b00583" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00583%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252BBenzothiazole%252BRhodacyanines%252Bas%252BAllosteric%252BInhibitors%252Bof%252BProtein%2525E2%252580%252593Protein%252BInteractions%252Bwith%252BHeat%252BShock%252BProtein%252B70%252B%252528Hsp70%252529%26aulast%3DShao%26aufirst%3DHao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12042018%26date%3D13072018%26date%3D28062018%26volume%3D61%26issue%3D14%26spage%3D6163%26epage%3D6177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabrielle  Stetz</span> and <span class="hlFld-ContribAuthor ">Gennady M.  Verkhivker</span>  . </span><span class="cited-content_cbyCitation_article-title">Probing Allosteric Inhibition Mechanisms of the Hsp70 Chaperone Proteins Using Molecular Dynamics Simulations and Analysis of the Residue Interaction Networks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (8)
                                     , 1490-1517. <a href="https://doi.org/10.1021/acs.jcim.5b00755" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00755%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DProbing%252BAllosteric%252BInhibition%252BMechanisms%252Bof%252Bthe%252BHsp70%252BChaperone%252BProteins%252BUsing%252BMolecular%252BDynamics%252BSimulations%252Band%252BAnalysis%252Bof%252Bthe%252BResidue%252BInteraction%252BNetworks%26aulast%3DStetz%26aufirst%3DGabrielle%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D28122015%26date%3D01082016%26date%3D22082016%26date%3D22072016%26volume%3D56%26issue%3D8%26spage%3D1490%26epage%3D1517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mackenzie D.  Martin</span>, <span class="hlFld-ContribAuthor ">Jeremy D.  Baker</span>, <span class="hlFld-ContribAuthor ">Amirthaa  Suntharalingam</span>, <span class="hlFld-ContribAuthor ">Bryce A.  Nordhues</span>, <span class="hlFld-ContribAuthor ">Lindsey B.  Shelton</span>, <span class="hlFld-ContribAuthor ">Dali  Zheng</span>, <span class="hlFld-ContribAuthor ">Jonathan J.  Sabbagh</span>, <span class="hlFld-ContribAuthor ">Timothy A.J.  Haystead</span>, <span class="hlFld-ContribAuthor ">Jason E.  Gestwicki</span>, and <span class="hlFld-ContribAuthor ">Chad A.  Dickey</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibition of Both Hsp70 Activity and Tau Aggregation in Vitro Best Predicts Tau Lowering Activity of Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (7)
                                     , 2041-2048. <a href="https://doi.org/10.1021/acschembio.6b00223" title="DOI URL">https://doi.org/10.1021/acschembio.6b00223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.6b00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.6b00223%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DInhibition%252Bof%252BBoth%252BHsp70%252BActivity%252Band%252BTau%252BAggregation%252Bin%252BVitro%252BBest%252BPredicts%252BTau%252BLowering%252BActivity%252Bof%252BSmall%252BMolecules%26aulast%3DMartin%26aufirst%3DMackenzie%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D09032016%26date%3D13052016%26date%3D26052016%26date%3D15072016%26date%3D13052016%26volume%3D11%26issue%3D7%26spage%3D2041%26epage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julia I-Ju  Leu</span>, <span class="hlFld-ContribAuthor ">Pingfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Maureen E.  Murphy</span>, <span class="hlFld-ContribAuthor ">Ronen  Marmorstein</span>, and <span class="hlFld-ContribAuthor ">Donna L.  George</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Basis for the Inhibition of HSP70 and DnaK Chaperones by Small-Molecule Targeting of a C-Terminal Allosteric Pocket. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (11)
                                     , 2508-2516. <a href="https://doi.org/10.1021/cb500236y" title="DOI URL">https://doi.org/10.1021/cb500236y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb500236y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb500236y%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DStructural%252BBasis%252Bfor%252Bthe%252BInhibition%252Bof%252BHSP70%252Band%252BDnaK%252BChaperones%252Bby%252BSmall-Molecule%252BTargeting%252Bof%252Ba%252BC-Terminal%252BAllosteric%252BPocket%26aulast%3DLeu%26aufirst%3DJulia%2BI-Ju%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D31032014%26date%3D22082014%26date%3D28082014%26date%3D21112014%26date%3D22082014%26volume%3D9%26issue%3D11%26spage%3D2508%26epage%3D2516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Yanlong  Kang</span>, <span class="hlFld-ContribAuthor ">Pallav D.  Patel</span>, <span class="hlFld-ContribAuthor ">John  Koren, III</span>, <span class="hlFld-ContribAuthor ">Pengrong  Yan</span>, <span class="hlFld-ContribAuthor ">Erica M.  DaGama Gomes</span>, <span class="hlFld-ContribAuthor ">Chenghua  Yang</span>, <span class="hlFld-ContribAuthor ">Maulik R.  Patel</span>, <span class="hlFld-ContribAuthor ">Liza  Shrestha</span>, <span class="hlFld-ContribAuthor ">Stefan O.  Ochiana</span>, <span class="hlFld-ContribAuthor ">Cristina  Santarossa</span>, <span class="hlFld-ContribAuthor ">Ronnie  Maharaj</span>, <span class="hlFld-ContribAuthor ">Alexander  Gozman</span>, <span class="hlFld-ContribAuthor ">Marc B.  Cox</span>, <span class="hlFld-ContribAuthor ">Hediye  Erdjument-Bromage</span>, <span class="hlFld-ContribAuthor ">Ronald C.  Hendrickson</span>, <span class="hlFld-ContribAuthor ">Leandro  Cerchietti</span>, <span class="hlFld-ContribAuthor ">Ari  Melnick</span>, <span class="hlFld-ContribAuthor ">Monica L.  Guzman</span>, and <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>  . </span><span class="cited-content_cbyCitation_article-title">Affinity Purification Probes of Potential Use To Investigate the Endogenous Hsp70 Interactome in Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (8)
                                     , 1698-1705. <a href="https://doi.org/10.1021/cb500256u" title="DOI URL">https://doi.org/10.1021/cb500256u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb500256u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb500256u%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DAffinity%252BPurification%252BProbes%252Bof%252BPotential%252BUse%252BTo%252BInvestigate%252Bthe%252BEndogenous%252BHsp70%252BInteractome%252Bin%252BCancer%26aulast%3DRodina%26aufirst%3DAnna%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D10042014%26date%3D11062014%26date%3D17062014%26date%3D15082014%26date%3D11062014%26volume%3D9%26issue%3D8%26spage%3D1698%26epage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Yanlong  Kang</span>, <span class="hlFld-ContribAuthor ">Hardik J.  Patel</span>, <span class="hlFld-ContribAuthor ">Maulik R.  Patel</span>, <span class="hlFld-ContribAuthor ">Pallav D.  Patel</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Yogita  Patel</span>, <span class="hlFld-ContribAuthor ">Alexander  Gozman</span>, <span class="hlFld-ContribAuthor ">Ronnie  Maharaj</span>, <span class="hlFld-ContribAuthor ">Cristina C.  Clement</span>, <span class="hlFld-ContribAuthor ">Alvin  Lu</span>, <span class="hlFld-ContribAuthor ">Jason C.  Young</span>, and <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>  . </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 70 Inhibitors. 2. 2,5′-Thiodipyrimidines, 5-(Phenylthio)pyrimidines, 2-(Pyridin-3-ylthio)pyrimidines, and 3-(Phenylthio)pyridines as Reversible Binders to an Allosteric Site on Heat Shock Protein 70. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1208-1224. <a href="https://doi.org/10.1021/jm401552y" title="DOI URL">https://doi.org/10.1021/jm401552y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401552y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401552y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeat%252BShock%252BProtein%252B70%252BInhibitors.%252B2.%252B2%25252C5%2525E2%252580%2525B2-Thiodipyrimidines%25252C%252B5-%252528Phenylthio%252529pyrimidines%25252C%252B2-%252528Pyridin-3-ylthio%252529pyrimidines%25252C%252Band%252B3-%252528Phenylthio%252529pyridines%252Bas%252BReversible%252BBinders%252Bto%252Ban%252BAllosteric%252BSite%252Bon%252BHeat%252BShock%252BProtein%252B70%26aulast%3DTaldone%26aufirst%3DTony%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D04102013%26date%3D18022014%26date%3D27022014%26volume%3D57%26issue%3D4%26spage%3D1208%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios  Chatzigoulas</span>, <span class="hlFld-ContribAuthor ">Zoe  Cournia</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of allosteric modulators: Challenges and successes. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2021,</strong> <em>17 </em><a href="https://doi.org/10.1002/wcms.1529" title="DOI URL">https://doi.org/10.1002/wcms.1529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1529%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DRational%252Bdesign%252Bof%252Ballosteric%252Bmodulators%25253A%252BChallenges%252Band%252Bsuccesses%26aulast%3DChatzigoulas%26aufirst%3DAlexios%26date%3D2021%26date%3D2021%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">VN  Aldobaev</span>, <span class="hlFld-ContribAuthor ">LV  Mikhina</span>, <span class="hlFld-ContribAuthor ">MA  Present</span>. </span><span class="cited-content_cbyCitation_article-title">Еvaluation of antitumor activity of some 4-aminopiperidine derivatives — low molecular weight Hsp70 inhibitors — on transplantable mouse tumors. </span><span class="cited-content_cbyCitation_journal-name">Medicine of Extreme Situations</span><span> <strong>2021,</strong> <em> </em>
                                    ((1)2021)
                                     <a href="https://doi.org/10.47183/mes.2021.009" title="DOI URL">https://doi.org/10.47183/mes.2021.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.47183/mes.2021.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.47183%2Fmes.2021.009%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicine%2520of%2520Extreme%2520Situations%26atitle%3D%2525D0%252595valuation%252Bof%252Bantitumor%252Bactivity%252Bof%252Bsome%252B4-aminopiperidine%252Bderivatives%252B%2525E2%252580%252594%252Blow%252Bmolecular%252Bweight%252BHsp70%252Binhibitors%252B%2525E2%252580%252594%252Bon%252Btransplantable%252Bmouse%252Btumors%26aulast%3DAldobaev%26aufirst%3DVN%26date%3D2021%26date%3D2021%26issue%3D%25281%25292021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Shao</span>, <span class="hlFld-ContribAuthor ">Jason E.  Gestwicki</span>. </span><span class="cited-content_cbyCitation_article-title">Neutral analogs of the heat shock protein 70 (Hsp70) inhibitor, JG-98. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (5)
                                     , 126954. <a href="https://doi.org/10.1016/j.bmcl.2020.126954" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126954%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNeutral%252Banalogs%252Bof%252Bthe%252Bheat%252Bshock%252Bprotein%252B70%252B%252528Hsp70%252529%252Binhibitor%25252C%252BJG-98%26aulast%3DShao%26aufirst%3DHao%26date%3D2020%26volume%3D30%26issue%3D5%26spage%3D126954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tai  Wang</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Mark P.  Dunphy</span>, <span class="hlFld-ContribAuthor ">Adriana  Corben</span>, <span class="hlFld-ContribAuthor ">Shanu  Modi</span>, <span class="hlFld-ContribAuthor ">Monica L.  Guzman</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Gewirth</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Chaperome heterogeneity and its implications for cancer study and treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (6)
                                     , 2162-2179. <a href="https://doi.org/10.1074/jbc.REV118.002811" title="DOI URL">https://doi.org/10.1074/jbc.REV118.002811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.REV118.002811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.REV118.002811%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DChaperome%252Bheterogeneity%252Band%252Bits%252Bimplications%252Bfor%252Bcancer%252Bstudy%252Band%252Btreatment%26aulast%3DWang%26aufirst%3DTai%26date%3D2019%26volume%3D294%26issue%3D6%26spage%3D2162%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason E.  Gestwicki</span>, <span class="hlFld-ContribAuthor ">Hao  Shao</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors and chemical probes for molecular chaperone networks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (6)
                                     , 2151-2161. <a href="https://doi.org/10.1074/jbc.TM118.002813" title="DOI URL">https://doi.org/10.1074/jbc.TM118.002813</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.TM118.002813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.TM118.002813%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DInhibitors%252Band%252Bchemical%252Bprobes%252Bfor%252Bmolecular%252Bchaperone%252Bnetworks%26aulast%3DGestwicki%26aufirst%3DJason%2BE.%26date%3D2019%26volume%3D294%26issue%3D6%26spage%3D2151%26epage%3D2161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. N.  Aldobaev</span>, <span class="hlFld-ContribAuthor ">M. A.  Prezent</span>, <span class="hlFld-ContribAuthor ">I. V.  Zavarzin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N,N-dialkyl-1-(2-alkylthiopyrimidin-4-yl)piperidin- 4-amines as potential heat shock protein inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2018,</strong> <em>67 </em>
                                    (11)
                                     , 2127-2130. <a href="https://doi.org/10.1007/s11172-018-2339-5" title="DOI URL">https://doi.org/10.1007/s11172-018-2339-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-018-2339-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-018-2339-5%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DSynthesis%252Bof%252BN%25252CN-dialkyl-1-%2525282-alkylthiopyrimidin-4-yl%252529piperidin-%252B4-amines%252Bas%252Bpotential%252Bheat%252Bshock%252Bprotein%252Binhibitors%26aulast%3DAldobaev%26aufirst%3DV.%2BN.%26date%3D2018%26date%3D2018%26volume%3D67%26issue%3D11%26spage%3D2127%26epage%3D2130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabelle R.  Taylor</span>, <span class="hlFld-ContribAuthor ">Bryan M.  Dunyak</span>, <span class="hlFld-ContribAuthor ">Tomoko  Komiyama</span>, <span class="hlFld-ContribAuthor ">Hao  Shao</span>, <span class="hlFld-ContribAuthor ">Xu  Ran</span>, <span class="hlFld-ContribAuthor ">Victoria A.  Assimon</span>, <span class="hlFld-ContribAuthor ">Chakrapani  Kalyanaraman</span>, <span class="hlFld-ContribAuthor ">Jennifer N.  Rauch</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Erik R.P.  Zuiderweg</span>, <span class="hlFld-ContribAuthor ">Jason E.  Gestwicki</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput screen for inhibitors of protein–protein interactions in a reconstituted heat shock protein 70 (Hsp70) complex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (11)
                                     , 4014-4025. <a href="https://doi.org/10.1074/jbc.RA117.001575" title="DOI URL">https://doi.org/10.1074/jbc.RA117.001575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA117.001575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA117.001575%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DHigh-throughput%252Bscreen%252Bfor%252Binhibitors%252Bof%252Bprotein%2525E2%252580%252593protein%252Binteractions%252Bin%252Ba%252Breconstituted%252Bheat%252Bshock%252Bprotein%252B70%252B%252528Hsp70%252529%252Bcomplex%26aulast%3DTaylor%26aufirst%3DIsabelle%2BR.%26date%3D2018%26volume%3D293%26issue%3D11%26spage%3D4014%26epage%3D4025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitry V.  Sverchinsky</span>, <span class="hlFld-ContribAuthor ">Vladimir F.  Lazarev</span>, <span class="hlFld-ContribAuthor ">Pavel I.  Semenyuk</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Mitkevich</span>, <span class="hlFld-ContribAuthor ">Irina V.  Guzhova</span>, <span class="hlFld-ContribAuthor ">Boris A.  Margulis</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide fragments of Hsp70 modulate its chaperone activity and sensitize tumor cells to anti-cancer drugs. </span><span class="cited-content_cbyCitation_journal-name">FEBS Letters</span><span> <strong>2017,</strong> <em>591 </em>
                                    (24)
                                     , 4074-4082. <a href="https://doi.org/10.1002/1873-3468.12913" title="DOI URL">https://doi.org/10.1002/1873-3468.12913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/1873-3468.12913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F1873-3468.12913%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Letters%26atitle%3DPeptide%252Bfragments%252Bof%252BHsp70%252Bmodulate%252Bits%252Bchaperone%252Bactivity%252Band%252Bsensitize%252Btumor%252Bcells%252Bto%252Banti-cancer%252Bdrugs%26aulast%3DSverchinsky%26aufirst%3DDmitry%2BV.%26date%3D2017%26date%3D2017%26volume%3D591%26issue%3D24%26spage%3D4074%26epage%3D4082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luhong  Wang</span>, <span class="hlFld-ContribAuthor ">Jingyuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Yao  Yao</span>, <span class="hlFld-ContribAuthor ">Changyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Jianbin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Shu</span>, <span class="hlFld-ContribAuthor ">Xiuli  Sun</span>, <span class="hlFld-ContribAuthor ">Yanxia  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Hong  Yuan</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent binding design strategy: A prospective method for discovery of potent targeted anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 493-505. <a href="https://doi.org/10.1016/j.ejmech.2017.09.024" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252Bbinding%252Bdesign%252Bstrategy%25253A%252BA%252Bprospective%252Bmethod%252Bfor%252Bdiscovery%252Bof%252Bpotent%252Btargeted%252Banticancer%252Bagents%26aulast%3DWang%26aufirst%3DLuhong%26date%3D2017%26volume%3D142%26spage%3D493%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liza  Shrestha</span>, <span class="hlFld-ContribAuthor ">Hardik J.  Patel</span>, <span class="hlFld-ContribAuthor ">Yanlong  Kang</span>, <span class="hlFld-ContribAuthor ">Sahil  Sharma</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>, <span class="hlFld-ContribAuthor ">Tony  Taldone</span>. </span><span class="cited-content_cbyCitation_article-title">Copper mediated coupling of 2-(piperazine)-pyrimidine iodides with aryl thiols using Cu(I)thiophene-2-carboxylate. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (48)
                                     , 4525-4531. <a href="https://doi.org/10.1016/j.tetlet.2017.10.041" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.10.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.10.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.10.041%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DCopper%252Bmediated%252Bcoupling%252Bof%252B2-%252528piperazine%252529-pyrimidine%252Biodides%252Bwith%252Baryl%252Bthiols%252Busing%252BCu%252528I%252529thiophene-2-carboxylate%26aulast%3DShrestha%26aufirst%3DLiza%26date%3D2017%26volume%3D58%26issue%3D48%26spage%3D4525%26epage%3D4531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Sangeetha</span>, <span class="hlFld-ContribAuthor ">R.P.  Sasikala</span>, <span class="hlFld-ContribAuthor ">K.S.  Meena</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling, virtual screening and molecular docking of ATPase inhibitors of HSP70. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2017,</strong> <em>70 </em>, 164-174. <a href="https://doi.org/10.1016/j.compbiolchem.2017.05.011" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2017.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2017.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2017.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DPharmacophore%252Bmodeling%25252C%252Bvirtual%252Bscreening%252Band%252Bmolecular%252Bdocking%252Bof%252BATPase%252Binhibitors%252Bof%252BHSP70%26aulast%3DSangeetha%26aufirst%3DK.%26date%3D2017%26volume%3D70%26spage%3D164%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyong  Lu</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Designed covalent allosteric modulators: an emerging paradigm in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2017,</strong> <em>22 </em>
                                    (2)
                                     , 447-453. <a href="https://doi.org/10.1016/j.drudis.2016.11.013" title="DOI URL">https://doi.org/10.1016/j.drudis.2016.11.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2016.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2016.11.013%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DDesigned%252Bcovalent%252Ballosteric%252Bmodulators%25253A%252Ban%252Bemerging%252Bparadigm%252Bin%252Bdrug%252Bdiscovery%26aulast%3DLu%26aufirst%3DShaoyong%26date%3D2017%26volume%3D22%26issue%3D2%26spage%3D447%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Tai  Wang</span>, <span class="hlFld-ContribAuthor ">Pengrong  Yan</span>, <span class="hlFld-ContribAuthor ">Erica DaGama  Gomes</span>, <span class="hlFld-ContribAuthor ">Mark P. S.  Dunphy</span>, <span class="hlFld-ContribAuthor ">Nagavarakishore  Pillarsetty</span>, <span class="hlFld-ContribAuthor ">John  Koren</span>, <span class="hlFld-ContribAuthor ">John F.  Gerecitano</span>, <span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Hongliang  Zong</span>, <span class="hlFld-ContribAuthor ">Eloisi  Caldas-Lopes</span>, <span class="hlFld-ContribAuthor ">Mary  Alpaugh</span>, <span class="hlFld-ContribAuthor ">Adriana  Corben</span>, <span class="hlFld-ContribAuthor ">Matthew  Riolo</span>, <span class="hlFld-ContribAuthor ">Brad  Beattie</span>, <span class="hlFld-ContribAuthor ">Christina  Pressl</span>, <span class="hlFld-ContribAuthor ">Radu I.  Peter</span>, <span class="hlFld-ContribAuthor ">Chao  Xu</span>, <span class="hlFld-ContribAuthor ">Robert  Trondl</span>, <span class="hlFld-ContribAuthor ">Hardik J.  Patel</span>, <span class="hlFld-ContribAuthor ">Fumiko  Shimizu</span>, <span class="hlFld-ContribAuthor ">Alexander  Bolaender</span>, <span class="hlFld-ContribAuthor ">Chenghua  Yang</span>, <span class="hlFld-ContribAuthor ">Palak  Panchal</span>, <span class="hlFld-ContribAuthor ">Mohammad F.  Farooq</span>, <span class="hlFld-ContribAuthor ">Sarah  Kishinevsky</span>, <span class="hlFld-ContribAuthor ">Shanu  Modi</span>, <span class="hlFld-ContribAuthor ">Oscar  Lin</span>, <span class="hlFld-ContribAuthor ">Feixia  Chu</span>, <span class="hlFld-ContribAuthor ">Sujata  Patil</span>, <span class="hlFld-ContribAuthor ">Hediye  Erdjument-Bromage</span>, <span class="hlFld-ContribAuthor ">Pat  Zanzonico</span>, <span class="hlFld-ContribAuthor ">Clifford  Hudis</span>, <span class="hlFld-ContribAuthor ">Lorenz  Studer</span>, <span class="hlFld-ContribAuthor ">Gail J.  Roboz</span>, <span class="hlFld-ContribAuthor ">Ethel  Cesarman</span>, <span class="hlFld-ContribAuthor ">Leandro  Cerchietti</span>, <span class="hlFld-ContribAuthor ">Ross  Levine</span>, <span class="hlFld-ContribAuthor ">Ari  Melnick</span>, <span class="hlFld-ContribAuthor ">Steven M.  Larson</span>, <span class="hlFld-ContribAuthor ">Jason S.  Lewis</span>, <span class="hlFld-ContribAuthor ">Monica L.  Guzman</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">The epichaperome is an integrated chaperome network that facilitates tumour survival. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2016,</strong> <em>538 </em>
                                    (7625)
                                     , 397-401. <a href="https://doi.org/10.1038/nature19807" title="DOI URL">https://doi.org/10.1038/nature19807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nature19807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnature19807%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DThe%252Bepichaperome%252Bis%252Ban%252Bintegrated%252Bchaperome%252Bnetwork%252Bthat%252Bfacilitates%252Btumour%252Bsurvival%26aulast%3DRodina%26aufirst%3DAnna%26date%3D2016%26date%3D2016%26volume%3D538%26issue%3D7625%26spage%3D397%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit J.  Sabnis</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Guerriero</span>, <span class="hlFld-ContribAuthor ">Victor  Olivas</span>, <span class="hlFld-ContribAuthor ">Anin  Sayana</span>, <span class="hlFld-ContribAuthor ">Jonathan  Shue</span>, <span class="hlFld-ContribAuthor ">Jennifer  Flanagan</span>, <span class="hlFld-ContribAuthor ">Saurabh  Asthana</span>, <span class="hlFld-ContribAuthor ">Adrienne W.  Paton</span>, <span class="hlFld-ContribAuthor ">James C.  Paton</span>, <span class="hlFld-ContribAuthor ">Jason E.  Gestwicki</span>, <span class="hlFld-ContribAuthor ">Peter  Walter</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  Weissman</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Jeffrey L.  Brodsky</span>, <span class="hlFld-ContribAuthor ">Trever G.  Bivona</span>. </span><span class="cited-content_cbyCitation_article-title">Combined chemical–genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcoma. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2016,</strong> <em>113 </em>
                                    (32)
                                     , 9015-9020. <a href="https://doi.org/10.1073/pnas.1603883113" title="DOI URL">https://doi.org/10.1073/pnas.1603883113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1603883113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1603883113%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DCombined%252Bchemical%2525E2%252580%252593genetic%252Bapproach%252Bidentifies%252Bcytosolic%252BHSP70%252Bdependence%252Bin%252Brhabdomyosarcoma%26aulast%3DSabnis%26aufirst%3DAmit%2BJ.%26date%3D2016%26date%3D2016%26volume%3D113%26issue%3D32%26spage%3D9015%26epage%3D9020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias P.  Mayer</span>, <span class="hlFld-ContribAuthor ">Roman  Kityk</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the molecular mechanism of allostery in Hsp70s. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2015,</strong> <em>2 </em><a href="https://doi.org/10.3389/fmolb.2015.00058" title="DOI URL">https://doi.org/10.3389/fmolb.2015.00058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2015.00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2015.00058%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DInsights%252Binto%252Bthe%252Bmolecular%252Bmechanism%252Bof%252Ballostery%252Bin%252BHsp70s%26aulast%3DMayer%26aufirst%3DMatthias%2BP.%26date%3D2015%26date%3D2015%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Trendowski</span>. </span><span class="cited-content_cbyCitation_article-title">PU-H71: An improvement on nature's solutions to oncogenic Hsp90 addiction. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2015,</strong> <em>99 </em>, 202-216. <a href="https://doi.org/10.1016/j.phrs.2015.06.007" title="DOI URL">https://doi.org/10.1016/j.phrs.2015.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2015.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2015.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DPU-H71%25253A%252BAn%252Bimprovement%252Bon%252Bnature%252527s%252Bsolutions%252Bto%252Boncogenic%252BHsp90%252Baddiction%26aulast%3DTrendowski%26aufirst%3DMatthew%26date%3D2015%26volume%3D99%26spage%3D202%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristoffer R.  Brandvold</span>, <span class="hlFld-ContribAuthor ">Richard I.  Morimoto</span>. </span><span class="cited-content_cbyCitation_article-title">The Chemical Biology of Molecular Chaperones—Implications for Modulation of Proteostasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2015,</strong> <em>427 </em>
                                    (18)
                                     , 2931-2947. <a href="https://doi.org/10.1016/j.jmb.2015.05.010" title="DOI URL">https://doi.org/10.1016/j.jmb.2015.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2015.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2015.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DThe%252BChemical%252BBiology%252Bof%252BMolecular%252BChaperones%2525E2%252580%252594Implications%252Bfor%252BModulation%252Bof%252BProteostasis%26aulast%3DBrandvold%26aufirst%3DKristoffer%2BR.%26date%3D2015%26volume%3D427%26issue%3D18%26spage%3D2931%26epage%3D2947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah N.  Fontaine</span>, <span class="hlFld-ContribAuthor ">Mackenzie D.  Martin</span>, <span class="hlFld-ContribAuthor ">Elias  Akoury</span>, <span class="hlFld-ContribAuthor ">Victoria A.  Assimon</span>, <span class="hlFld-ContribAuthor ">Sergiy  Borysov</span>, <span class="hlFld-ContribAuthor ">Bryce A.  Nordhues</span>, <span class="hlFld-ContribAuthor ">Jonathan J.  Sabbagh</span>, <span class="hlFld-ContribAuthor ">Matt  Cockman</span>, <span class="hlFld-ContribAuthor ">Jason E.  Gestwicki</span>, <span class="hlFld-ContribAuthor ">Markus  Zweckstetter</span>, <span class="hlFld-ContribAuthor ">Chad A.  Dickey</span>. </span><span class="cited-content_cbyCitation_article-title">The active Hsc70/tau complex can be exploited to enhance tau turnover without damaging microtubule dynamics. </span><span class="cited-content_cbyCitation_journal-name">Human Molecular Genetics</span><span> <strong>2015,</strong> <em>24 </em>
                                    (14)
                                     , 3971-3981. <a href="https://doi.org/10.1093/hmg/ddv135" title="DOI URL">https://doi.org/10.1093/hmg/ddv135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/hmg/ddv135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fhmg%2Fddv135%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Molecular%2520Genetics%26atitle%3DThe%252Bactive%252BHsc70%25252Ftau%252Bcomplex%252Bcan%252Bbe%252Bexploited%252Bto%252Benhance%252Btau%252Bturnover%252Bwithout%252Bdamaging%252Bmicrotubule%252Bdynamics%26aulast%3DFontaine%26aufirst%3DSarah%2BN.%26date%3D2015%26date%3D2015%26volume%3D24%26issue%3D14%26spage%3D3971%26epage%3D3981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanqun  Zeng</span>, <span class="hlFld-ContribAuthor ">Ruiyuan  Cao</span>, <span class="hlFld-ContribAuthor ">Tianhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Song  Li</span>, <span class="hlFld-ContribAuthor ">Wu  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of piperidine derivatives as novel human heat shock protein 70 inhibitors for the treatment of drug-resistant tumors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 19-31. <a href="https://doi.org/10.1016/j.ejmech.2015.04.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.04.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.04.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bpiperidine%252Bderivatives%252Bas%252Bnovel%252Bhuman%252Bheat%252Bshock%252Bprotein%252B70%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bdrug-resistant%252Btumors%26aulast%3DZeng%26aufirst%3DYanqun%26date%3D2015%26volume%3D97%26spage%3D19%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah N.  Fontaine</span>, <span class="hlFld-ContribAuthor ">Jennifer N.  Rauch</span>, <span class="hlFld-ContribAuthor ">Bryce A.  Nordhues</span>, <span class="hlFld-ContribAuthor ">Victoria A.  Assimon</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Stothert</span>, <span class="hlFld-ContribAuthor ">Umesh K.  Jinwal</span>, <span class="hlFld-ContribAuthor ">Jonathan J.  Sabbagh</span>, <span class="hlFld-ContribAuthor ">Lyra  Chang</span>, <span class="hlFld-ContribAuthor ">Stanley M.  Stevens</span>, <span class="hlFld-ContribAuthor ">Erik R.P.  Zuiderweg</span>, <span class="hlFld-ContribAuthor ">Jason E.  Gestwicki</span>, <span class="hlFld-ContribAuthor ">Chad A.  Dickey</span>. </span><span class="cited-content_cbyCitation_article-title">Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2015,</strong> <em>290 </em>
                                    (21)
                                     , 13115-13127. <a href="https://doi.org/10.1074/jbc.M115.637595" title="DOI URL">https://doi.org/10.1074/jbc.M115.637595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M115.637595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M115.637595%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DIsoform-selective%252BGenetic%252BInhibition%252Bof%252BConstitutive%252BCytosolic%252BHsp70%252BActivity%252BPromotes%252BClient%252BTau%252BDegradation%252BUsing%252Ban%252BAltered%252BCo-chaperone%252BComplement%26aulast%3DFontaine%26aufirst%3DSarah%2BN.%26date%3D2015%26volume%3D290%26issue%3D21%26spage%3D13115%26epage%3D13127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaokai  Li</span>, <span class="hlFld-ContribAuthor ">Teresa  Colvin</span>, <span class="hlFld-ContribAuthor ">Jennifer N.  Rauch</span>, <span class="hlFld-ContribAuthor ">Diego  Acosta-Alvear</span>, <span class="hlFld-ContribAuthor ">Martin  Kampmann</span>, <span class="hlFld-ContribAuthor ">Bryan  Dunyak</span>, <span class="hlFld-ContribAuthor ">Byron  Hann</span>, <span class="hlFld-ContribAuthor ">Blake T.  Aftab</span>, <span class="hlFld-ContribAuthor ">Megan  Murnane</span>, <span class="hlFld-ContribAuthor ">Min  Cho</span>, <span class="hlFld-ContribAuthor ">Peter  Walter</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  Weissman</span>, <span class="hlFld-ContribAuthor ">Michael Y.  Sherman</span>, <span class="hlFld-ContribAuthor ">Jason E.  Gestwicki</span>. </span><span class="cited-content_cbyCitation_article-title">Validation of the Hsp70–Bag3 Protein–Protein Interaction as a Potential Therapeutic Target in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2015,</strong> <em>14 </em>
                                    (3)
                                     , 642-648. <a href="https://doi.org/10.1158/1535-7163.MCT-14-0650" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-14-0650</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-14-0650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-14-0650%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DValidation%252Bof%252Bthe%252BHsp70%2525E2%252580%252593Bag3%252BProtein%2525E2%252580%252593Protein%252BInteraction%252Bas%252Ba%252BPotential%252BTherapeutic%252BTarget%252Bin%252BCancer%26aulast%3DLi%26aufirst%3DXiaokai%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D3%26spage%3D642%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Manos-Turvey</span>, <span class="hlFld-ContribAuthor ">Jeffrey L.  Brodsky</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>. </span><span class="cited-content_cbyCitation_article-title">The Effect of Structure and Mechanism of the Hsp70 Chaperone on the Ability to Identify Chemical Modulators and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 81-129. <a href="https://doi.org/10.1007/7355_2015_90" title="DOI URL">https://doi.org/10.1007/7355_2015_90</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2015_90&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2015_90%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BEffect%252Bof%252BStructure%252Band%252BMechanism%252Bof%252Bthe%252BHsp70%252BChaperone%252Bon%252Bthe%252BAbility%252Bto%252BIdentify%252BChemical%252BModulators%252Band%252BTherapeutics%26aulast%3DManos-Turvey%26aufirst%3DAlexandra%26date%3D2015%26date%3D2015%26spage%3D81%26epage%3D129%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProtein%252BInhibitors%26aulast%3DMcAlpine%26aufirst%3DShelli%2BR.%26date%3D2016%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Budina-Kolomets</span>, <span class="hlFld-ContribAuthor ">Subhasree  Basu</span>, <span class="hlFld-ContribAuthor ">Lili  Belcastro</span>, <span class="hlFld-ContribAuthor ">Maureen E.  Murphy</span>. </span><span class="cited-content_cbyCitation_article-title">The Hsp70 Family of Heat Shock Proteins in Tumorigenesis: From Molecular Mechanisms to Therapeutic Opportunities. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 203-224. <a href="https://doi.org/10.1007/978-94-017-9421-3_10" title="DOI URL">https://doi.org/10.1007/978-94-017-9421-3_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-017-9421-3_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-017-9421-3_10%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BHsp70%252BFamily%252Bof%252BHeat%252BShock%252BProteins%252Bin%252BTumorigenesis%25253A%252BFrom%252BMolecular%252BMechanisms%252Bto%252BTherapeutic%252BOpportunities%26aulast%3DBudina-Kolomets%26aufirst%3DAnna%26date%3D2015%26date%3D2014%26spage%3D203%26epage%3D224%26pub%3DSpringer%2520Netherlands%26atitle%3DStress%252BResponse%252BPathways%252Bin%252BCancer%26aulast%3DWondrak%26aufirst%3DGeorg%2BT.%26date%3D2015%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. Quamrul  Hassan</span>, <span class="hlFld-ContribAuthor ">Christina A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Wenlai  Zhou</span>, <span class="hlFld-ContribAuthor ">Tim  Schuhmann</span>, <span class="hlFld-ContribAuthor ">Roman  Kityk</span>, <span class="hlFld-ContribAuthor ">D. Randal  Kipp</span>, <span class="hlFld-ContribAuthor ">Jason  Baird</span>, <span class="hlFld-ContribAuthor ">Jinyun  Chen</span>, <span class="hlFld-ContribAuthor ">Yaoyu  Chen</span>, <span class="hlFld-ContribAuthor ">Franklin  Chung</span>, <span class="hlFld-ContribAuthor ">Dominic  Hoepfner</span>, <span class="hlFld-ContribAuthor ">N. Rao  Movva</span>, <span class="hlFld-ContribAuthor ">Raymond  Pagliarini</span>, <span class="hlFld-ContribAuthor ">Frank  Petersen</span>, <span class="hlFld-ContribAuthor ">Christopher  Quinn</span>, <span class="hlFld-ContribAuthor ">Douglas  Quinn</span>, <span class="hlFld-ContribAuthor ">Ralph  Riedl</span>, <span class="hlFld-ContribAuthor ">Esther K.  Schmitt</span>, <span class="hlFld-ContribAuthor ">Anne  Schitter</span>, <span class="hlFld-ContribAuthor ">Travis  Stams</span>, <span class="hlFld-ContribAuthor ">Christian  Studer</span>, <span class="hlFld-ContribAuthor ">Pascal D.  Fortin</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Mayer</span>, <span class="hlFld-ContribAuthor ">Heather  Sadlish</span>. </span><span class="cited-content_cbyCitation_article-title">The Novolactone Natural Product Disrupts the Allosteric Regulation of Hsp70. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biology</span><span> <strong>2015,</strong> <em>22 </em>
                                    (1)
                                     , 87-97. <a href="https://doi.org/10.1016/j.chembiol.2014.11.007" title="DOI URL">https://doi.org/10.1016/j.chembiol.2014.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2014.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2014.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biology%26atitle%3DThe%252BNovolactone%252BNatural%252BProduct%252BDisrupts%252Bthe%252BAllosteric%252BRegulation%252Bof%252BHsp70%26aulast%3DHassan%26aufirst%3DA.%25C2%25A0Quamrul%26date%3D2015%26volume%3D22%26issue%3D1%26spage%3D87%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.-P.  Daguer</span>, <span class="hlFld-ContribAuthor ">C.  Zambaldo</span>, <span class="hlFld-ContribAuthor ">M.  Ciobanu</span>, <span class="hlFld-ContribAuthor ">P.  Morieux</span>, <span class="hlFld-ContribAuthor ">S.  Barluenga</span>, <span class="hlFld-ContribAuthor ">N.  Winssinger</span>. </span><span class="cited-content_cbyCitation_article-title">DNA display of fragment pairs as a tool for the discovery of novel biologically active small molecules. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     , 739-744. <a href="https://doi.org/10.1039/C4SC01654H" title="DOI URL">https://doi.org/10.1039/C4SC01654H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4SC01654H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4SC01654H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDNA%252Bdisplay%252Bof%252Bfragment%252Bpairs%252Bas%252Ba%252Btool%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Bbiologically%252Bactive%252Bsmall%252Bmolecules%26aulast%3DDaguer%26aufirst%3DJ.-P.%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D1%26spage%3D739%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Stefan O.  Ochiana</span>, <span class="hlFld-ContribAuthor ">Pallav D.  Patel</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Selective targeting of the stress chaperome as a therapeutic strategy. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2014,</strong> <em>35 </em>
                                    (11)
                                     , 592-603. <a href="https://doi.org/10.1016/j.tips.2014.09.001" title="DOI URL">https://doi.org/10.1016/j.tips.2014.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2014.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2014.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DSelective%252Btargeting%252Bof%252Bthe%252Bstress%252Bchaperome%252Bas%252Ba%252Btherapeutic%252Bstrategy%26aulast%3DTaldone%26aufirst%3DTony%26date%3D2014%26volume%3D35%26issue%3D11%26spage%3D592%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Feng  Ma</span>, <span class="hlFld-ContribAuthor ">Hai-Kui  Yang</span>, <span class="hlFld-ContribAuthor ">Meng-Jin  Hu</span>, <span class="hlFld-ContribAuthor ">Qian  Li</span>, <span class="hlFld-ContribAuthor ">Tian-Zhu  Ma</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhen  Zhou</span>, <span class="hlFld-ContribAuthor ">Rui-Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  You</span>, <span class="hlFld-ContribAuthor ">Pei-Liang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis and antiproliferative activity of novel 2,4-diaminopyrimidine derivatives bearing piperidine and piperazine moieties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>84 </em>, 127-134. <a href="https://doi.org/10.1016/j.ejmech.2014.07.017" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOne-pot%252Bsynthesis%252Band%252Bantiproliferative%252Bactivity%252Bof%252Bnovel%252B2%25252C4-diaminopyrimidine%252Bderivatives%252Bbearing%252Bpiperidine%252Band%252Bpiperazine%252Bmoieties%26aulast%3DMa%26aufirst%3DWei-Feng%26date%3D2014%26volume%3D84%26spage%3D127%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radhey Mohan  Singh</span>, <span class="hlFld-ContribAuthor ">Kishor Chandra  Bharadwaj</span>, <span class="hlFld-ContribAuthor ">Dharmendra Kumar  Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">Morita–Baylis–Hillman reaction of acrylamide with isatin derivatives. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>10 </em>, 2975-2980. <a href="https://doi.org/10.3762/bjoc.10.315" title="DOI URL">https://doi.org/10.3762/bjoc.10.315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.10.315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.10.315%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMorita%2525E2%252580%252593Baylis%2525E2%252580%252593Hillman%252Breaction%252Bof%252Bacrylamide%252Bwith%252Bisatin%252Bderivatives%26aulast%3DSingh%26aufirst%3DRadhey%2BMohan%26date%3D2014%26date%3D2014%26volume%3D10%26spage%3D2975%26epage%3D2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of reported potential Hsp70 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Rational design of the allosteric pocket ligands. (a,b) The homology-modeled hHsp70 structure led to the identification of a novel allosteric pocket (shown in green) located in the N-terminal domain of human Hsp70.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This pocket contains a potentially reactive cysteine residue (position shown in red lettering in panel a) and is located outside the ATP-binding site (shown in red in panel b). (c) The geometry of the N-terminal allosteric pocket of hHsp70 as predicted by SiteMap (shown in yellow) and residues lining the pocket and their relative location (depicted as colored circles) are presented. Ligands based on the 2,5′-thiopyrimidine and 5-(phenylthio)pyrimidine chemical scaffolds were designed to fit into the allosteric pocket. They adopt the conformation required for a proper fit and position functionalities toward the shown pocket residues. An acrylamide positioned toward Cys267 was also incorporated into these scaffolds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (PMB)Cl, NaH, DMF, 0 °C to rt; (b) NIS, MeCN, rt; (c) 4,6-diamino-2-mercaptopyrimidine or 4-amino-2-mercaptopyrimidine, neocuproine, CuI, K<sub>2</sub>CO<sub>3</sub>, DMSO, 120–130 °C; (d) Ac<sub>2</sub>O, DMAP, 110–120 °C; (e) TFA, CHCl<sub>3</sub>, 62 °C; (f) HF/pyridine, NaNO<sub>2</sub>, 0 °C; (g) amine, DMF, 90 °C; (h) NaOH, H<sub>2</sub>O, MeOH, 60 °C; (i) acryloyl chloride, Et<sub>3</sub>N, dioxane, rt.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOMe/MeOH, 90 °C, then NaOH, 60 °C; (b) acryloyl chloride, Et<sub>3</sub>N, dioxane, rt; (c) TFA, CHCl<sub>3</sub>, 62 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-methylpiperazine or morpholine, DMF, 90 °C; (b) NIS, TFA, CH<sub>3</sub>CN, rt; (c) 3-aminothiophenol or 4-amino-2-mercaptopyrimidine, neocuproine, CuI, K<sub>2</sub>CO<sub>3</sub>, DMF, 110–130 °C; (d) acid chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Known Hsp70 functions used to design the biological testing of the Hsp70 inhibitors in cancer cells. Hsp90 in concert with Hsp70 maintains the transforming capacity of several oncoproteins whose aberrant activity leads to increased cell proliferation and survival. The function of the Hsp90 protein complex requires the HSP-organizing protein (HOP), involved in the formation of the active chaperone complex. Altering the formation of the Hsp90–HOP–Hsp70 complex leads to degradation of the oncoprotein via a proteasome-mediated pathway and is associated with cell growth inhibition and/or cell death. To confirm an Hsp70-mediated mechanism, it is expected that compounds will be active at similar concentrations in this battery of assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Designed ligands interact specifically with Hsp70 in cancer cells. (a) Streptavidin beads were incubated with the indicated concentrations of <b>44b</b>, <b>45b</b>, and <span class="smallcaps smallerCapital">d</span>-biotin, the unbound agent was washed off, and the resulting beads carrying <b>44b</b>, <b>45b</b>, or <span class="smallcaps smallerCapital">d</span>-biotin were probed with SKBr3 cell extracts (500 μg). Hsp70 isolated on the beads was probed by Western blot (WB). A representative blot is presented (top). Blots were quantified by densitometry and values, in relative luminescence units, graphed against the concentration of added biotinylated Hsp70 inhibitor (bottom). Results from three independent experiments were graphed to determine the relative binding affinity (<i>K</i><sub>d</sub>) of <b>44b</b> and <b>45b</b> using equations as implemented in the GraphPad Prism software. Key: points, mean; bars, SD. (b) Cells were treated with the indicated concentrations of <b>44b</b> for 6 h prior to lysing and precipitation of protein complexes on streptavidin beads. Beads were washed with high-salt (1 M NaCl) buffer before elution of proteins on a denaturing gel and silver staining. BB70 is an antibody specific for Hsp70. This antibody also recognizes Grp78 and Grp75, the endoplasmic reticulum and the mitochondrial Hsp70 paralogues, respectively. (c) Protein complexes were isolated as indicated in (b) in cells pretreated with <b>17a</b>. CP = chemical precipitation. (d) Analysis of the Hsp70–HOP complex. SKBr3 cells were treated for 24 h with vehicle or indicated concentrations of <b>20a</b>. Upon cell lysing, Hsp70 complexes were isolated with an anti-Hsp70 antibody (IP BB70) and analyzed by WB. Specificity of binding was tested with a control IgG. Gels were quantified by densitometry, values normalized to the control (vehicle only treated cells), and data graphed against the concentration of <b>20a</b>. Error bars represent the SEM (<i>n</i> = 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding interactions of hHsp70 with derivative <b>17a</b>, as predicted by Glide (Schrodinger LLC, New York). Hydrogen bonds are shown as dotted red lines, and the interaction distance is shown by dotted purple lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/medium/jm-2013-01551n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Derivative <b>17a</b> (at 10 μM) was tested in the scanMAX screen (Ambit) against 402 kinases. The TREE<i>spot</i> interaction map for <b>17a</b> is presented. Only c-Met (red dot on the kinase tree) appears as a potential low-affinity kinase hit of <b>17a</b>. KINOME<i>scan</i>’s selectivity score (<i>S</i>) is a quantitative measure of compound selectivity. It is calculated by dividing the number of kinases that bind to the compound by the total number of distinct kinases tested, excluding mutant variants. <i>S</i>(35) = (number of nonmutant kinases with %Ctrl < 35)/(number of nonmutant kinases tested).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401551n/20150218/images/large/jm-2013-01551n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401551n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i104">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Daugaard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jäättelä, M.</span><span> </span><span class="NLM_article-title">The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">3702</span><span class="NLM_x">–</span> <span class="NLM_lpage">3710</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=3702-3710&author=M.+Daugaardauthor=M.+Rohdeauthor=M.+J%C3%A4%C3%A4ttel%C3%A4&title=The+heat+shock+protein+70+family%3A+highly+homologous+proteins+with+overlapping+and+distinct+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaugaard%26aufirst%3DM.%26aulast%3DRohde%26aufirst%3DM.%26aulast%3DJ%25C3%25A4%25C3%25A4ttel%25C3%25A4%26aufirst%3DM.%26atitle%3DThe%2520heat%2520shock%2520protein%252070%2520family%253A%2520highly%2520homologous%2520proteins%2520with%2520overlapping%2520and%2520distinct%2520functions%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D3702%26epage%3D3710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Brodsky, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Hsp70 molecular chaperones: emerging roles in human disease and identification of small molecule modulators</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.2174%2F156802606777811997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=16842158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1215-1225&author=J.+F.+Brodskyauthor=G.+Chiosis&title=Hsp70+molecular+chaperones%3A+emerging+roles+in+human+disease+and+identification+of+small+molecule+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp70 molecular chaperones: emerging roles in human disease and identification of small molecule modulators</span></div><div class="casAuthors">Brodsky, Jeffrey L.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1215-1225</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mol. chaperones are best known for their ability to aid in the solubilization of mis-folded proteins, and as a result play essential roles in protein folding, degrdn., and transport.  However, many mol. chaperones also play essential roles in signal transduction cascades.  For example, Hsp70 mol. chaperones are a highly conserved, abundant class of chaperones that are found in every species and in nearly every cellular compartment in eukaryotes.  In addn. to their well-established roles in facilitating protein folding and in the targeting of proteins to organelles and to proteolytic machines, Hsp70s are anti-apoptotic and inhibition of Hsp70 function in some cases is sufficient to induce tumor cell death.  Hsp70 function is also vital for the replication of viruses.  Based on these data, small mol. Hsp70 modulators might, in principle, be used for the treatment of specific cancers, infections, and protein conformational diseases.  In this review, we summarize the structural and functional characteristics of Hsp70 chaperones, and then discuss their roles in cellular physiol.  Finally, we will review the recent discovery of small mols. that alter Hsp70 expression and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKvQuXC1mQE7Vg90H21EOLACvtfcHk0lgdIzvIbGwOJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLs%253D&md5=8d71a06d57fd9ac349e31cddad49d452</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F156802606777811997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777811997%26sid%3Dliteratum%253Aachs%26aulast%3DBrodsky%26aufirst%3DJ.%2BF.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHsp70%2520molecular%2520chaperones%253A%2520emerging%2520roles%2520in%2520human%2520disease%2520and%2520identification%2520of%2520small%2520molecule%2520modulators%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1215%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lanneau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solary, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontenay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, C.</span><span> </span><span class="NLM_article-title">Heat shock proteins: essential proteins for apoptosis regulation</span> <span class="citation_source-journal">J. Cell Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1111%2Fj.1582-4934.2008.00273.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=18266962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlCrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=743-761&author=D.+Lanneauauthor=M.+Brunetauthor=E.+Frisanauthor=E.+Solaryauthor=M.+Fontenayauthor=C.+Garrido&title=Heat+shock+proteins%3A+essential+proteins+for+apoptosis+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock proteins: essential proteins for apoptosis regulation</span></div><div class="casAuthors">Lanneau, D.; Brunet, M.; Frisan, E.; Solary, E.; Fontenay, M.; Garrido, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">743-761</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Many different external and intrinsic apoptotic stimuli induce the accumulation in cells of a set of proteins known as stress or heat-shock proteins (HSPs).  HSPs are conserved proteins present in both prokaryotes and eukaryotes.  These proteins play an essential role as mol. chaperones by assisting the correct folding of nascent and stress-accumulated misfolded proteins, and by preventing their aggregation.  HSPs have a protective function, i.e., they allow cells to survive to otherwise lethal conditions.  Various mechanisms have been proposed to account for the cytoprotective functions of HSPs.  Several of these proteins have been demonstrated to directly interact with components of the cell signaling pathways, e.g., those of the tightly regulated caspase-dependent programmed cell death machinery, upstream, downstream, and at the mitochondrial level.  HSPs can also affect the caspase-independent apoptosis-like process by interacting with apoptogenic factors such as apoptosis-inducing factor (AIF) or by acting at the lysosome level.  Here, the authors describe the different key apoptotic proteins interacting with HSPs and the consequences of these interactions in cell survival, proliferation, and apoptotic processes.  The authors' purpose is illustrated by emerging strategies in targeting these protective proteins to treat hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF4Fhw_RO4p7Vg90H21EOLACvtfcHk0ljWxVWz9l4tlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlCrt70%253D&md5=d8b5c1c6411c5499268ba1a3eedf97c0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00273.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00273.x%26sid%3Dliteratum%253Aachs%26aulast%3DLanneau%26aufirst%3DD.%26aulast%3DBrunet%26aufirst%3DM.%26aulast%3DFrisan%26aufirst%3DE.%26aulast%3DSolary%26aufirst%3DE.%26aulast%3DFontenay%26aufirst%3DM.%26aulast%3DGarrido%26aufirst%3DC.%26atitle%3DHeat%2520shock%2520proteins%253A%2520essential%2520proteins%2520for%2520apoptosis%2520regulation%26jtitle%3DJ.%2520Cell%2520Mol.%2520Med.%26date%3D2008%26volume%3D12%26spage%3D743%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Powers, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=250-262&author=M.+V.+Powersauthor=P.+A.+Clarkeauthor=P.+Workman&title=Dual+targeting+of+HSC70+and+HSP72+inhibits+HSP90+function+and+induces+tumor-specific+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DDual%2520targeting%2520of%2520HSC70%2520and%2520HSP72%2520inhibits%2520HSP90%2520function%2520and%2520induces%2520tumor-specific%2520apoptosis%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D14%26spage%3D250%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mayer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukau, B.</span><span> </span><span class="NLM_article-title">Hsp70 chaperones: cellular functions and molecular mechanism</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1007%2Fs00018-004-4464-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=15770419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlymt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2005&pages=670-684&author=M.+P.+Mayerauthor=B.+Bukau&title=Hsp70+chaperones%3A+cellular+functions+and+molecular+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp70 chaperones: Cellular functions and molecular mechanism</span></div><div class="casAuthors">Mayer, M. P.; Bukau, B.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">670-684</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Hsp70 proteins are central components of the cellular network of mol. chaperones and folding catalysts.  They assist a large variety of protein folding processes in the cell by transient assocn. of their substrate binding domain with short hydrophobic peptide segments within their substrate proteins.  The substrate binding and release cycle is driven by the switching of Hsp70 between the low-affinity ATP bound state and the high-affinity ADP bound state.  Thus, ATP binding and hydrolysis are essential in vitro and in vivo for the chaperone activity of Hsp70 proteins.  This ATPase cycle is controlled by co-chaperones of the family of J-domain proteins, which target Hsp70s to their substrates, and by nucleotide exchange factors, which det. the lifetime of the Hsp70-substrate complex.  Addnl. co-chaperones fine-tune this chaperone cycle.  For specific tasks, the Hsp70 cycle is coupled to the action of other chaperones, such as Hsp90 and Hsp100.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsdr6juDha1rVg90H21EOLACvtfcHk0ljWxVWz9l4tlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlymt78%253D&md5=c12378f4e13b2241521b3abe09d8f88b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs00018-004-4464-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-004-4464-6%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%2BP.%26aulast%3DBukau%26aufirst%3DB.%26atitle%3DHsp70%2520chaperones%253A%2520cellular%2520functions%2520and%2520molecular%2520mechanism%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2005%26volume%3D62%26spage%3D670%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Young, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agashe, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">Pathways of chaperone-mediated protein folding in the cytosol</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnrm1492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=15459659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVSlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=781-791&author=J.+C.+Youngauthor=V.+R.+Agasheauthor=K.+Siegersauthor=F.+U.+Hartl&title=Pathways+of+chaperone-mediated+protein+folding+in+the+cytosol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways of chaperone-mediated protein folding in the cytosol</span></div><div class="casAuthors">Young, Jason C.; Agashe, Vishwas R.; Siegers, Katja; Hartl, F. Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">781-791</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cells are faced with the task of folding thousands of different polypeptides into a wide range of conformations.  For many proteins, the folding process requires the action of mol. chaperones.  In the cytosol of prokaryotic and eukaryotic cells, mol. chaperones of different structural classes form a network of pathways that can handle substrate polypeptides from the point of initial synthesis on ribosomes to the final stages of folding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozOmZCjGhXsbVg90H21EOLACvtfcHk0lghvGBBm4LDGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVSlsrg%253D&md5=e5b25a79128866bd17f7915dd6f42c6d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm1492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1492%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DJ.%2BC.%26aulast%3DAgashe%26aufirst%3DV.%2BR.%26aulast%3DSiegers%26aufirst%3DK.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DPathways%2520of%2520chaperone-mediated%2520protein%2520folding%2520in%2520the%2520cytosol%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D781%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Evans, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Heat shock protein 70 (hsp70) as an emerging drug target</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4585</span><span class="NLM_x">–</span> <span class="NLM_lpage">4602</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100054f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4585-4602&author=C.+G.+Evansauthor=L.+Changauthor=J.+E.+Gestwicki&title=Heat+shock+protein+70+%28hsp70%29+as+an+emerging+drug+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target</span></div><div class="casAuthors">Evans, Christopher G.; Chang, Lyra; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4585-4602</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5hrQMA77XsrVg90H21EOLACvtfcHk0livKW4vbkII8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejsLc%253D&md5=b87bdc9b76e66d62c130a162037387b5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm100054f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100054f%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DC.%2BG.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DHeat%2520shock%2520protein%252070%2520%2528hsp70%2529%2520as%2520an%2520emerging%2520drug%2520target%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4585%26epage%3D4602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Patury, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Pharmacological targeting of the Hsp70 chaperone</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.2174%2F156802609789895674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=19860737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFakur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1337-1351&author=S.+Paturyauthor=Y.+Miyataauthor=J.+E.+Gestwicki&title=Pharmacological+targeting+of+the+Hsp70+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological targeting of the Hsp70 chaperone</span></div><div class="casAuthors">Patury, Srikanth; Miyata, Yoshinari; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1337-1351</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat shock protein 70 (Hsp70), acts at multiple steps in a protein's life cycle, including during the processes of folding, trafficking, remodeling and degrdn.  To accomplish these various tasks, the activity of Hsp70 is shaped by a host of co-chaperones, which bind to the core chaperone and influence its functions.  Genetic studies have strongly linked Hsp70 and its co-chaperones to numerous diseases, including cancer, neurodegeneration and microbial pathogenesis, yet the potential of this chaperone as a therapeutic target remains largely underexplored.  Here, we review the current state of Hsp70 as a drug target, with a special emphasis on the important challenges and opportunities imposed by its co-chaperones, protein-protein interactions and allostery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPBOUYJuccBbVg90H21EOLACvtfcHk0livKW4vbkII8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFakur8%253D&md5=7fb9ff641b0fc4b82c8a94ffee822c64</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F156802609789895674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789895674%26sid%3Dliteratum%253Aachs%26aulast%3DPatury%26aufirst%3DS.%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DPharmacological%2520targeting%2520of%2520the%2520Hsp70%2520chaperone%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1337%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Leu, J. I.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimkina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D. L.</span><span> </span><span class="NLM_article-title">A small molecule inhibitor of inducible heat shock protein 70</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=15-27&author=J.+I.-J.+Leuauthor=J.+Pimkinaauthor=A.+Frankauthor=M.+E.+Murphyauthor=D.+L.+George&title=A+small+molecule+inhibitor+of+inducible+heat+shock+protein+70"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeu%26aufirst%3DJ.%2BI.-J.%26aulast%3DPimkina%26aufirst%3DJ.%26aulast%3DFrank%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DM.%2BE.%26aulast%3DGeorge%26aufirst%3DD.%2BL.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520inducible%2520heat%2520shock%2520protein%252070%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D36%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Leu, J. I.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimkina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D. L.</span><span> </span><span class="NLM_article-title">HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1158%2F1541-7786.MCR-11-0019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=21636681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVOktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=936-947&author=J.+I.-J.+Leuauthor=J.+Pimkinaauthor=P.+Pandeyauthor=M.+E.+Murphyauthor=D.+L.+George&title=HSP70+inhibition+by+the+small-molecule+2-phenylethynesulfonamide+impairs+protein+clearance+pathways+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">HSP70 Inhibition by the Small-Molecule 2-Phenylethynesulfonamide Impairs Protein Clearance Pathways in Tumor Cells</span></div><div class="casAuthors">Leu, J. I.-Ju; Pimkina, Julia; Pandey, Pooja; Murphy, Maureen E.; George, Donna L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">936-947</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The evolutionarily conserved stress-inducible HSP70 mol. chaperone plays a central role in maintaining protein quality control in response to various forms of stress.  Constitutively elevated HSP70 expression is a characteristic of many tumor cells and contributes to their survival.  We recently identified the small-mol. 2-phenylethyenesulfonamide (PES) as a novel HSP70 inhibitor.  Here, we present evidence that PES-mediated inhibition of HSP70 family proteins in tumor cells results in an impairment of the two major protein degrdn. systems, namely, the autophagy-lysosome system and the proteasome pathway.  HSP70 family proteins work closely with the HSP90 mol. chaperone to maintain the stability and activities of their many client proteins, and PES causes a disruption in the HSP70/HSP90 chaperone system.  As a consequence, many cellular proteins, including known HSP70/HSP90 substrates, accumulate in detergent-insol. cell fractions, indicative of aggregation and functional inactivation.  Overall, PES simultaneously disrupts several cancer crit. survival pathways, supporting the idea of targeting HSP70 as a potential approach for cancer therapeutics.  Mol Cancer Res; 9(7); 936-47.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXnDyVjlbD1LVg90H21EOLACvtfcHk0livKW4vbkII8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVOktbw%253D&md5=36e6fd9093b96ff6c04914a86f277e4f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-11-0019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-11-0019%26sid%3Dliteratum%253Aachs%26aulast%3DLeu%26aufirst%3DJ.%2BI.-J.%26aulast%3DPimkina%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DP.%26aulast%3DMurphy%26aufirst%3DM.%2BE.%26aulast%3DGeorge%26aufirst%3DD.%2BL.%26atitle%3DHSP70%2520inhibition%2520by%2520the%2520small-molecule%25202-phenylethynesulfonamide%2520impairs%2520protein%2520clearance%2520pathways%2520in%2520tumor%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2011%26volume%3D9%26spage%3D936%26epage%3D947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Braunstein, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coplan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrico, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodsky, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batuman, O.</span><span> </span><span class="NLM_article-title">Antimyeloma effects of the heat shock protein 70 molecular chaperone inhibitor MAL3-101</span> <span class="citation_source-journal">J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">ID 232037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=ID+232037&author=M.+J.+Braunsteinauthor=S.+S.+Scottauthor=C.+M.+Scottauthor=S.+Behrmanauthor=P.+Walterauthor=P.+Wipfauthor=J.+D.+Coplanauthor=W.+Chricoauthor=D.+Josephauthor=J.+L.+Brodskyauthor=O.+Batuman&title=Antimyeloma+effects+of+the+heat+shock+protein+70+molecular+chaperone+inhibitor+MAL3-101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBraunstein%26aufirst%3DM.%2BJ.%26aulast%3DScott%26aufirst%3DS.%2BS.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DBehrman%26aufirst%3DS.%26aulast%3DWalter%26aufirst%3DP.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DCoplan%26aufirst%3DJ.%2BD.%26aulast%3DChrico%26aufirst%3DW.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DBrodsky%26aufirst%3DJ.%2BL.%26aulast%3DBatuman%26aufirst%3DO.%26atitle%3DAntimyeloma%2520effects%2520of%2520the%2520heat%2520shock%2520protein%252070%2520molecular%2520chaperone%2520inhibitor%2520MAL3-101%26jtitle%3DJ.%2520Oncol.%26date%3D2011%26volume%3D2011%26spage%3DID%2520232037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertelsen, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuade, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderweg, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Chemical screens against a reconstituted multiprotein complex: myricetin blocks DnaJ regulation of DnaK through an allosteric mechanism</span> <span class="citation_source-journal">Chem Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1016%2Fj.chembiol.2010.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=21338918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Kjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=210-221&author=L.+Changauthor=Y.+Miyataauthor=P.+M.+Ungauthor=E.+B.+Bertelsenauthor=T.+J.+McQuadeauthor=H.+A.+Carlsonauthor=E.+R.+Zuiderwegauthor=J.+E.+Gestwicki&title=Chemical+screens+against+a+reconstituted+multiprotein+complex%3A+myricetin+blocks+DnaJ+regulation+of+DnaK+through+an+allosteric+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Screens against a Reconstituted Multiprotein Complex: Myricetin Blocks DnaJ Regulation of DnaK through an Allosteric Mechanism</span></div><div class="casAuthors">Chang, Lyra; Miyata, Yoshinari; Ung, Peter M. U.; Bertelsen, Eric B.; McQuade, Thomas J.; Carlson, Heather A.; Zuiderweg, Erik R. P.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-221</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">DnaK is a mol. chaperone responsible for multiple aspects of bacterial proteostasis.  The intrinsically slow ATPase activity of DnaK is stimulated by its co-chaperone, DnaJ, and these proteins often work in concert.  To identify inhibitors the authors screened plant-derived exts. against a reconstituted mixt. of DnaK and DnaJ.  This approach resulted in the identification of flavonoids, including myricetin, which inhibited activity by up to 75%.  Interestingly, myricetin prevented DnaJ-mediated stimulation of ATPase activity, with minimal impact on either DnaK's intrinsic turnover rate or its stimulation by another co-chaperone, GrpE.  Using NMR, the authors found that myricetin binds DnaK at an unanticipated site between the IB and IIB subdomains and that it allosterically blocked binding of DnaK to DnaJ.  Together, these results highlight a "gray box" screening approach, which might facilitate the identification of inhibitors of other protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99yN2zfPqm7Vg90H21EOLACvtfcHk0ljaivdFp36-qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Kjtrc%253D&md5=597bc82a96fc30c3fafc6948db320eae</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DUng%26aufirst%3DP.%2BM.%26aulast%3DBertelsen%26aufirst%3DE.%2BB.%26aulast%3DMcQuade%26aufirst%3DT.%2BJ.%26aulast%3DCarlson%26aufirst%3DH.%2BA.%26aulast%3DZuiderweg%26aufirst%3DE.%2BR.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DChemical%2520screens%2520against%2520a%2520reconstituted%2520multiprotein%2520complex%253A%2520myricetin%2520blocks%2520DnaJ%2520regulation%2520of%2520DnaK%2520through%2520an%2520allosteric%2520mechanism%26jtitle%3DChem%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D210%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rousaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jinwal, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderweg, E. R.</span><span> </span><span class="NLM_article-title">Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2011&pages=614-632&author=A.+Rousakiauthor=Y.+Miyataauthor=U.+K.+Jinwalauthor=C.+A.+Dickeyauthor=J.+E.+Gestwickiauthor=E.+R.+Zuiderweg&title=Allosteric+drugs%3A+the+interaction+of+antitumor+compound+MKT-077+with+human+Hsp70+chaperones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRousaki%26aufirst%3DA.%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DJinwal%26aufirst%3DU.%2BK.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26aulast%3DZuiderweg%26aufirst%3DE.%2BR.%26atitle%3DAllosteric%2520drugs%253A%2520the%2520interaction%2520of%2520antitumor%2520compound%2520MKT-077%2520with%2520human%2520Hsp70%2520chaperones%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D411%26spage%3D614%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Cho, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baek, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, I.</span><span> </span><span class="NLM_article-title">A small molecule that binds to an ATPase domain of Hsc70 promotes membrane trafficking of mutant cystic fibrosis transmembrane conductance regulator</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">20267</span><span class="NLM_x">–</span> <span class="NLM_lpage">20276</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja206762p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=20267-20276&author=H.+J.+Choauthor=H.+Y.+Geeauthor=K.+H.+Baekauthor=S.+K.+Koauthor=J.+M.+Parkauthor=H.+Leeauthor=N.+D.+Kimauthor=M.+G.+Leeauthor=I.+Shin&title=A+small+molecule+that+binds+to+an+ATPase+domain+of+Hsc70+promotes+membrane+trafficking+of+mutant+cystic+fibrosis+transmembrane+conductance+regulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja206762p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja206762p%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DGee%26aufirst%3DH.%2BY.%26aulast%3DBaek%26aufirst%3DK.%2BH.%26aulast%3DKo%26aufirst%3DS.%2BK.%26aulast%3DPark%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DShin%26aufirst%3DI.%26atitle%3DA%2520small%2520molecule%2520that%2520binds%2520to%2520an%2520ATPase%2520domain%2520of%2520Hsc70%2520promotes%2520membrane%2520trafficking%2520of%2520mutant%2520cystic%2520fibrosis%2520transmembrane%2520conductance%2520regulator%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D20267%26epage%3D20276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Williams, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, I.</span><span> </span><span class="NLM_article-title">An apoptosis-inducing small molecule that binds to heat shock protein 70</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">7466</span><span class="NLM_x">–</span> <span class="NLM_lpage">7469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=7466-7469&author=D.+R.+Williamsauthor=S.+K.+Koauthor=S.+Parkauthor=M.+R.+Leeauthor=I.+Shin&title=An+apoptosis-inducing+small+molecule+that+binds+to+heat+shock+protein+70"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BR.%26aulast%3DKo%26aufirst%3DS.%2BK.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DShin%26aufirst%3DI.%26atitle%3DAn%2520apoptosis-inducing%2520small%2520molecule%2520that%2520binds%2520to%2520heat%2520shock%2520protein%252070%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D7466%26epage%3D7469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kawakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shishido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. B.</span><span> </span><span class="NLM_article-title">Structure–activity of novel rhodacyanine dyes as antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970590k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=130-142&author=M.+Kawakamiauthor=K.+Koyaauthor=T.+Ukaiauthor=N.+Tatsutaauthor=A.+Ikegawaauthor=K.+Ogawaauthor=T.+Shishidoauthor=L.+B.+Chen&title=Structure%E2%80%93activity+of+novel+rhodacyanine+dyes+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm970590k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970590k%26sid%3Dliteratum%253Aachs%26aulast%3DKawakami%26aufirst%3DM.%26aulast%3DKoya%26aufirst%3DK.%26aulast%3DUkai%26aufirst%3DT.%26aulast%3DTatsuta%26aufirst%3DN.%26aulast%3DIkegawa%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DShishido%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%2BB.%26atitle%3DStructure%25E2%2580%2593activity%2520of%2520novel%2520rhodacyanine%2520dyes%2520as%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D130%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kawakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shishido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. B.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel rhodacyanine dyes that exhibit antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3151</span><span class="NLM_x">–</span> <span class="NLM_lpage">3160</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9702692" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3151-3160&author=M.+Kawakamiauthor=K.+Koyaauthor=T.+Ukaiauthor=N.+Tatsutaauthor=A.+Ikegawaauthor=K.+Ogawaauthor=T.+Shishidoauthor=L.+B.+Chen&title=Synthesis+and+evaluation+of+novel+rhodacyanine+dyes+that+exhibit+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm9702692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9702692%26sid%3Dliteratum%253Aachs%26aulast%3DKawakami%26aufirst%3DM.%26aulast%3DKoya%26aufirst%3DK.%26aulast%3DUkai%26aufirst%3DT.%26aulast%3DTatsuta%26aufirst%3DN.%26aulast%3DIkegawa%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DShishido%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%2BB.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520rhodacyanine%2520dyes%2520that%2520exhibit%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3151%26epage%3D3160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokurno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macias, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A. J.</span><span> </span><span class="NLM_article-title">Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1510</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801627a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1arsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1510-1513&author=D.+S.+Williamsonauthor=J.+Borgognoniauthor=A.+Clayauthor=Z.+Danielsauthor=P.+Dokurnoauthor=M.+J.+Drysdaleauthor=N.+Foloppeauthor=G.+L.+Francisauthor=C.+J.+Grahamauthor=R.+Howesauthor=A.+T.+Maciasauthor=J.+B.+Murrayauthor=R.+Parsonsauthor=T.+Shawauthor=A.+E.+Surgenorauthor=L.+Terryauthor=Y.+Wangauthor=M.+Woodauthor=A.+J.+Massey&title=Novel+adenosine-derived+inhibitors+of+70+kDa+heat+shock+protein%2C+discovered+through+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design</span></div><div class="casAuthors">Williamson, Douglas S.; Borgognoni, Jenifer; Clay, Alexandra; Daniels, Zoe; Dokurno, Pawel; Drysdale, Martin J.; Foloppe, Nicolas; Francis, Geraint L.; Graham, Christopher J.; Howes, Rob; Macias, Alba T.; Murray, James B.; Parsons, Rachel; Shaw, Terry; Surgenor, Allan E.; Terry, Lindsey; Wang, Yikang; Wood, Mike; Massey, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1510-1513</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and synthesis of novel adenosine-derived inhibitors of HSP70, guided by modeling and X-ray crystallog. structures of these compds. in complex with HSC70/BAG-1, is described.  Examples exhibited submicromolar affinity for HSP70, were highly selective over HSP90, and some displayed potency against HCT116 cells.  Exposure of I to HCT116 cells caused significant redn. in cellular levels of Raf-1 and Her2 at concns. similar to that which caused cell growth arrest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7sPdbJciUk7Vg90H21EOLACvtfcHk0liSNaew-kS3RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1arsbg%253D&md5=714b981545d1aa8db6627a252b3da8cc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm801627a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801627a%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DClay%26aufirst%3DA.%26aulast%3DDaniels%26aufirst%3DZ.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFrancis%26aufirst%3DG.%2BL.%26aulast%3DGraham%26aufirst%3DC.%2BJ.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DMacias%26aufirst%3DA.%2BT.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26aulast%3DTerry%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DMassey%26aufirst%3DA.%2BJ.%26atitle%3DNovel%2520adenosine-derived%2520inhibitors%2520of%252070%2520kDa%2520heat%2520shock%2520protein%252C%2520discovered%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1510%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Jhaveri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1823</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=742-755&author=K.+Jhaveriauthor=T.+Taldoneauthor=S.+Modiauthor=G.+Chiosis&title=Advances+in+the+clinical+development+of+heat+shock+protein+90+%28Hsp90%29+inhibitors+in+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAdvances%2520in%2520the%2520clinical%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1823%26spage%3D742%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Massey, A. J.</span><span> </span><span class="NLM_article-title">ATPases as drug targets: insights from heat shock proteins 70 and 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7280</span><span class="NLM_x">–</span> <span class="NLM_lpage">7286</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100342z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7280-7286&author=A.+J.+Massey&title=ATPases+as+drug+targets%3A+insights+from+heat+shock+proteins+70+and+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">ATPases as Drug Targets: Insights from Heat Shock Proteins 70 and 90</span></div><div class="casAuthors">Massey, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7280-7286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouskN9BSeSLLVg90H21EOLACvtfcHk0liSNaew-kS3RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVGgsrY%253D&md5=1fb082e98a0e666b2276cb7dc1e38c2a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm100342z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100342z%26sid%3Dliteratum%253Aachs%26aulast%3DMassey%26aufirst%3DA.%2BJ.%26atitle%3DATPases%2520as%2520drug%2520targets%253A%2520insights%2520from%2520heat%2520shock%2520proteins%252070%2520and%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7280%26epage%3D7286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Massey, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokurno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macias, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffroy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dopson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span> </span><span class="NLM_article-title">A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1007%2Fs00280-009-1194-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=20012863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXns1SisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=535-545&author=A.+J.+Masseyauthor=D.+S.+Williamsonauthor=H.+Browneauthor=J.+B.+Murrayauthor=P.+Dokurnoauthor=T.+Shawauthor=A.+T.+Maciasauthor=Z.+Danielsauthor=S.+Geoffroyauthor=M.+Dopsonauthor=P.+Lavanauthor=N.+Matassovaauthor=G.+L.+Francisauthor=C.+J.+Grahamauthor=R.+Parsonsauthor=Y.+Wangauthor=A.+Padfieldauthor=M.+Comerauthor=M.+J.+Drysdaleauthor=M.+Wood&title=A+novel%2C+small+molecule+inhibitor+of+Hsc70%2FHsp70+potentiates+Hsp90+inhibitor+induced+apoptosis+in+HCT116+colon+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells</span></div><div class="casAuthors">Massey, Andrew J.; Williamson, Douglas S.; Browne, Helen; Murray, James B.; Dokurno, Pawel; Shaw, Terry; Macias, Alba T.; Daniels, Zoe; Geoffroy, Stephanie; Dopson, Melanie; Lavan, Paul; Matassova, Natalia; Francis, Geraint L.; Graham, Christopher J.; Parsons, Rachel; Wang, Yikang; Padfield, Antony; Comer, Mike; Drysdale, Martin J.; Wood, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">535-545</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: The anti-apoptotic function of the 70 kDa family of heat shock proteins and their role in cancer is well documented.  Dual targeting of Hsc70 and Hsp70 with siRNA induces proteasome-dependent degrdn. of Hsp90 client proteins and extensive tumor specific apoptosis as well as the potentiation of tumor cell apoptosis following pharmacol. Hsp90 inhibition.  Methods: We have previously described the discovery and synthesis of novel adenosine-derived inhibitors of the 70 kDa family of heat shock proteins; the first inhibitors described to target the ATPase binding domain.  The in vitro activity of VER-155008 was evaluated in HCT116, HT29, BT474 and MDA-MB-468 carcinoma cell lines.  Cell proliferation, cell apoptosis and caspase 3/7 activity was detd. for VER-155008 in the absence or presence of small mol. Hsp90 inhibitors.  Results: VER-155008 inhibited the proliferation of human breast and colon cancer cell lines with GI50s in the range 5.3-14.4 μM, and induced Hsp90 client protein degrdn. in both HCT116 and BT474 cells.  As a single agent, VER-155008 induced caspase-3/7 dependent apoptosis in BT474 cells and non-caspase dependent cell death in HCT116 cells.  VER-155008 potentiated the apoptotic potential of a small mol. Hsp90 inhibitor in HCT116 but not HT29 or MDA-MB-468 cells.  In vivo, VER-155008 demonstrated rapid metab. and clearance, along with tumor levels below the predicted pharmacol. active level.  Conclusion: These data suggest that small mol. inhibitors of Hsc70/Hsp70 phenotypically mimic the cellular mode of action of a small mol. Hsp90 inhibitor and can potentiate the apoptotic potential of a small mol. Hsp90 inhibitor in certain cell lines.  The factors detg. whether or not cells apoptose in response to Hsp90 inhibition or the combination of Hsp90 plus Hsc70/Hsp70 inhibition remain to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodJSKJxiDK87Vg90H21EOLACvtfcHk0limIgJBlhyo9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXns1SisbY%253D&md5=754638ba62eb7779978f15326042451c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00280-009-1194-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-009-1194-3%26sid%3Dliteratum%253Aachs%26aulast%3DMassey%26aufirst%3DA.%2BJ.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DBrowne%26aufirst%3DH.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DMacias%26aufirst%3DA.%2BT.%26aulast%3DDaniels%26aufirst%3DZ.%26aulast%3DGeoffroy%26aufirst%3DS.%26aulast%3DDopson%26aufirst%3DM.%26aulast%3DLavan%26aufirst%3DP.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DFrancis%26aufirst%3DG.%2BL.%26aulast%3DGraham%26aufirst%3DC.%2BJ.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPadfield%26aufirst%3DA.%26aulast%3DComer%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DWood%26aufirst%3DM.%26atitle%3DA%2520novel%252C%2520small%2520molecule%2520inhibitor%2520of%2520Hsc70%252FHsp70%2520potentiates%2520Hsp90%2520inhibitor%2520induced%2520apoptosis%2520in%2520HCT116%2520colon%2520carcinoma%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2010%26volume%3D66%26spage%3D535%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baaklini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharaj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirico, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talele, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Identification of an allosteric pocket on human Hsp70 reveals a mode of inhibition of this therapeutically important protein</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1469</span><span class="NLM_x">–</span> <span class="NLM_lpage">1480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1016%2Fj.chembiol.2013.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=24239008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsl2js7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1469-1480&author=A.+Rodinaauthor=P.+D.+Patelauthor=Y.+Kangauthor=Y.+Patelauthor=I.+Baakliniauthor=M.+J.+H.+Wongauthor=T.+Taldoneauthor=P.+Yanauthor=C.+Yangauthor=R.+Maharajauthor=A.+Gozmanauthor=M.+R.+Patelauthor=H.+J.+Patelauthor=W.+Chiricoauthor=H.+Erdjument-Bromageauthor=T.+T.+Taleleauthor=J.+C.+Youngauthor=G.+Chiosis&title=Identification+of+an+allosteric+pocket+on+human+Hsp70+reveals+a+mode+of+inhibition+of+this+therapeutically+important+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Allosteric Pocket on Human Hsp70 Reveals a Mode of Inhibition of This Therapeutically Important Protein</span></div><div class="casAuthors">Rodina, Anna; Patel, Pallav D.; Kang, Yanlong; Patel, Yogita; Baaklini, Imad; Wong, Michael J. H.; Taldone, Tony; Yan, Pengrong; Yang, Chenghua; Maharaj, Ronnie; Gozman, Alexander; Patel, Maulik R.; Patel, Hardik J.; Chirico, William; Erdjument-Bromage, Hediye; Talele, Tanaji T.; Young, Jason C.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1469-1480</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Hsp70s are important cancer chaperones that act upstream of Hsp90 and exhibit independent anti-apoptotic activities.  To develop chem. tools for the study of human Hsp70, we developed a homol. model that unveils a previously unknown allosteric site located in the nucleotide binding domain of Hsp70.  Combining structure-based design and phenotypic testing, we discovered a previously unknown inhibitor of this site, YK5.  In cancer cells, this compd. is a potent and selective binder of the cytosolic but not the organellar human Hsp70s and has biol. activity partly by interfering with the formation of active oncogenic Hsp70/Hsp90/client protein complexes.  YK5 is a small mol. inhibitor rationally designed to interact with an allosteric pocket of Hsp70 and represents a previously unknown chem. tool to investigate cellular mechanisms assocd. with Hsp70.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIWNzS6oXrObVg90H21EOLACvtfcHk0limIgJBlhyo9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsl2js7jN&md5=3d87791cfc4be81fb78159124a83b926</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DY.%26aulast%3DBaaklini%26aufirst%3DI.%26aulast%3DWong%26aufirst%3DM.%2BJ.%2BH.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DMaharaj%26aufirst%3DR.%26aulast%3DGozman%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DChirico%26aufirst%3DW.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTalele%26aufirst%3DT.%2BT.%26aulast%3DYoung%26aufirst%3DJ.%2BC.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520an%2520allosteric%2520pocket%2520on%2520human%2520Hsp70%2520reveals%2520a%2520mode%2520of%2520inhibition%2520of%2520this%2520therapeutically%2520important%2520protein%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1469%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Taldone, T.; Kang, Y.; Patel, H. J.; Patel, M. R.; Patel, P. D.; Rodina, A.; Patel, Y.; Gozman, A.; Maharaj, R.; Clement, C. C.; Lu, A.; Young, J. C.; Chiosis, G.</span><span> </span><span class="NLM_article-title">Heat shock protein 70 inhibitors. 2. 2,5′-thiodipyrimidines, 5-(phenylthio)pyrimidines, 2-(pyridin-3-ylthio)pyrimidines, and 3-(phenylthio)pyridines as reversible binders to an allosteric site on heat shock protein 70</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/jm401552y</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm401552y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+Taldone&author=Y.+Kang&author=H.+J.+Patel&author=M.+R.+Patel&author=P.+D.+Patel&author=A.+Rodina&author=Y.+Patel&author=A.+Gozman&author=R.+Maharaj&author=C.+C.+Clement&author=A.+Lu&author=J.+C.+Young&author=G.+Chiosis&title=Heat+shock+protein+70+inhibitors.+2.+2%2C5%E2%80%B2-thiodipyrimidines%2C+5-%28phenylthio%29pyrimidines%2C+2-%28pyridin-3-ylthio%29pyrimidines%2C+and+3-%28phenylthio%29pyridines+as+reversible+binders+to+an+allosteric+site+on+heat+shock+protein+70&doi=10.1021%2Fjm401552y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm401552y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401552y%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26atitle%3DHeat%2520shock%2520protein%252070%2520inhibitors.%25202.%25202%252C5%25E2%2580%25B2-thiodipyrimidines%252C%25205-%2528phenylthio%2529pyrimidines%252C%25202-%2528pyridin-3-ylthio%2529pyrimidines%252C%2520and%25203-%2528phenylthio%2529pyridines%2520as%2520reversible%2520binders%2520to%2520an%2520allosteric%2520site%2520on%2520heat%2520shock%2520protein%252070%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26doi%3D10.1021%2Fjm401552y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Sriram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osipiuk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span> </span><span class="NLM_article-title">Human Hsp70 molecular chaperone binds two calcium ions within the ATPase domain</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=403-414&author=M.+Sriramauthor=J.+Osipiukauthor=B.+Freemanauthor=R.+Morimotoauthor=A.+Joachimiak&title=Human+Hsp70+molecular+chaperone+binds+two+calcium+ions+within+the+ATPase+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DOsipiuk%26aufirst%3DJ.%26aulast%3DFreeman%26aufirst%3DB.%26aulast%3DMorimoto%26aufirst%3DR.%26aulast%3DJoachimiak%26aufirst%3DA.%26atitle%3DHuman%2520Hsp70%2520molecular%2520chaperone%2520binds%2520two%2520calcium%2520ions%2520within%2520the%2520ATPase%2520domain%26jtitle%3DStructure%26date%3D1997%26volume%3D5%26spage%3D403%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Stevens, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellecchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderweg, E. R.</span><span> </span><span class="NLM_article-title">The solution structure of the bacterial HSP70 chaperone protein domain DnaK (393–507) in complex with the peptide NRLLLTG</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1110%2Fps.03269103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=14573869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXoslelu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=2588-2596&author=S.+Y.+Stevensauthor=S.+Caiauthor=M.+Pellecchiaauthor=E.+R.+Zuiderweg&title=The+solution+structure+of+the+bacterial+HSP70+chaperone+protein+domain+DnaK+%28393%E2%80%93507%29+in+complex+with+the+peptide+NRLLLTG"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The solution structure of the bacterial HSP70 chaperone protein domain DnaK(393-507) in complex with the peptide NRLLLTG</span></div><div class="casAuthors">Stevens, Shawn Y.; Cai, Sheng; Pellecchia, Maurizio; Zuiderweg, Erik R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2588-2596</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The Hsp70 family of mol. chaperones participates in a no. of cellular processes, including binding to nascent polypeptide chains and assistance in protein (re)folding and degrdn.  We present the soln. structure of the substrate binding domain (residues 393-507) of the Escherichia coli Hsp70, DnaK, that is bound to the peptide NRLLLTG and compare it to the crystal structure of DnaK(389-607) bound to the same peptide.  The construct discussed here does not contain the α-helical domain that characterizes earlier published peptide-bound structures of the Hsp70.  It is established that removing the α-helical domain in its entirety does not affect the primary interactions or structure of the DnaK(393-507) in complex with the peptide NRLLLTG.  In particular, the arch that protects the substrate-binding cleft is also formed in the absence of the helical lid.  15N-relaxation measurements show that the peptide-bound form of DnaK(393-507) is relatively rigid.  As compared to the peptide-free state, the peptide-bound state of the domain shows distinct, widespread, and contiguous differences in structure extending toward areas previously defined as important to the allosteric regulation of the Hsp70 chaperones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0OXfHhOWlMLVg90H21EOLACvtfcHk0lgzQ3o_7IcsOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXoslelu74%253D&md5=d57cd363bddd9082a1c7c26ab99b1dba</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1110%2Fps.03269103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.03269103%26sid%3Dliteratum%253Aachs%26aulast%3DStevens%26aufirst%3DS.%2BY.%26aulast%3DCai%26aufirst%3DS.%26aulast%3DPellecchia%26aufirst%3DM.%26aulast%3DZuiderweg%26aufirst%3DE.%2BR.%26atitle%3DThe%2520solution%2520structure%2520of%2520the%2520bacterial%2520HSP70%2520chaperone%2520protein%2520domain%2520DnaK%2520%2528393%25E2%2580%2593507%2529%2520in%2520complex%2520with%2520the%2520peptide%2520NRLLLTG%26jtitle%3DProtein%2520Sci.%26date%3D2003%26volume%3D12%26spage%3D2588%26epage%3D2596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Worrall, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span> </span><span class="NLM_article-title">Crystal structure of the C-terminal three-helix bundle subdomain of C. elegans Hsp70</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=105-110&author=L.+J.+Worrallauthor=M.+D.+Walkinshaw&title=Crystal+structure+of+the+C-terminal+three-helix+bundle+subdomain+of+C.+elegans+Hsp70"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWorrall%26aufirst%3DL.%2BJ.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26atitle%3DCrystal%2520structure%2520of%2520the%2520C-terminal%2520three-helix%2520bundle%2520subdomain%2520of%2520C.%2520elegans%2520Hsp70%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D357%26spage%3D105%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Wisniewska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotenyova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, H.</span><span> </span><span class="NLM_article-title">Crystal structures of the ATPase domains of four human Hsp70 isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B′, and HSPA5/BiP/GRP78</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e8625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e8625&author=M.+Wisniewskaauthor=T.+Karlbergauthor=L.+Lehtioauthor=I.+Johanssonauthor=T.+Kotenyovaauthor=M.+Mocheauthor=H.+Schuler&title=Crystal+structures+of+the+ATPase+domains+of+four+human+Hsp70+isoforms%3A+HSPA1L%2FHsp70-hom%2C+HSPA2%2FHsp70-2%2C+HSPA6%2FHsp70B%E2%80%B2%2C+and+HSPA5%2FBiP%2FGRP78"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWisniewska%26aufirst%3DM.%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DJohansson%26aufirst%3DI.%26aulast%3DKotenyova%26aufirst%3DT.%26aulast%3DMoche%26aufirst%3DM.%26aulast%3DSchuler%26aufirst%3DH.%26atitle%3DCrystal%2520structures%2520of%2520the%2520ATPase%2520domains%2520of%2520four%2520human%2520Hsp70%2520isoforms%253A%2520HSPA1L%252FHsp70-hom%252C%2520HSPA2%252FHsp70-2%252C%2520HSPA6%252FHsp70B%25E2%2580%25B2%252C%2520and%2520HSPA5%252FBiP%252FGRP78%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De8625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurochkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertelsen, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderweg, E. R.</span><span> </span><span class="NLM_article-title">Allostery in Hsp70 chaperones is transduced by subdomain rotations</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1016%2Fj.jmb.2009.01.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=19361428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVCrsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=475-490&author=A.+Bhattacharyaauthor=A.+V.+Kurochkinauthor=G.+N.+Yipauthor=Y.+Zhangauthor=E.+B.+Bertelsenauthor=E.+R.+Zuiderweg&title=Allostery+in+Hsp70+chaperones+is+transduced+by+subdomain+rotations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Allostery in Hsp70 Chaperones Is Transduced by Subdomain Rotations</span></div><div class="casAuthors">Bhattacharya, Akash; Kurochkin, Alexander V.; Yip, Grover N. B.; Zhang, Yongbo; Bertelsen, Eric B.; Zuiderweg, Erik R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-490</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Hsp70s (heat shock protein 70 kDa) are central to protein folding, refolding, and trafficking in organisms ranging from archaea to Homo sapiens under both normal and stressed cellular conditions.  Hsp70s are comprised of a nucleotide-binding domain (NBD) and a substrate-binding domain (SBD).  The nucleotide binding site in the NBD and the substrate binding site in the SBD are allosterically linked: ADP binding promotes substrate binding, while ATP binding promotes substrate release.  Hsp70s have been linked to inhibition of apoptosis (i.e., cancer) and diseases assocd. with protein misfolding such as Alzheimer's, Parkinson's, and Huntington's.  It has long been a goal to characterize the nature of allosteric coupling in these proteins.  However, earlier studies of the isolated NBD could not show any difference in overall conformation between the ATP state and the ADP state.  Hence the question: How is the state of the nucleotide communicated between NBD and SBD Here we report a soln. NMR study of the 44-kDa NBD of Hsp70 from Thermus thermophilus in the ADP and AMPPNP states.  Using the soln. NMR methods of residual dipolar coupling anal., we det. that significant rotations occur for different subdomains of the NBD upon exchange of nucleotide.  These rotations modulate access to the nucleotide binding cleft in the absence of a nucleotide exchange factor.  Moreover, the rotations cause a change in the accessibility of a hydrophobic surface cleft remote from the nucleotide binding site, which previously has been identified as essential to allosteric communication between NBD and SBD.  We propose that it is this change in the NBD surface cleft that constitutes the allosteric signal that can be recognized by the SBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDgfOozqB_ALVg90H21EOLACvtfcHk0lgWJAY-kDAXnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVCrsL4%253D&md5=dc693ae61ac52cf59cf0df5dbb370375</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.01.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.01.062%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DKurochkin%26aufirst%3DA.%2BV.%26aulast%3DYip%26aufirst%3DG.%2BN.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBertelsen%26aufirst%3DE.%2BB.%26aulast%3DZuiderweg%26aufirst%3DE.%2BR.%26atitle%3DAllostery%2520in%2520Hsp70%2520chaperones%2520is%2520transduced%2520by%2520subdomain%2520rotations%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26spage%3D475%26epage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Woo, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafer, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, R.</span><span> </span><span class="NLM_article-title">ATP-induced conformational changes in Hsp70: molecular dynamics and experimental validation of an in silico predicted conformation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">11470</span><span class="NLM_x">–</span> <span class="NLM_lpage">11477</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi901256y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=11470-11477&author=H.+J.+Wooauthor=J.+Jiangauthor=E.+M.+Laferauthor=R.+Sousa&title=ATP-induced+conformational+changes+in+Hsp70%3A+molecular+dynamics+and+experimental+validation+of+an+in+silico+predicted+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi901256y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi901256y%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DH.%2BJ.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DLafer%26aufirst%3DE.%2BM.%26aulast%3DSousa%26aufirst%3DR.%26atitle%3DATP-induced%2520conformational%2520changes%2520in%2520Hsp70%253A%2520molecular%2520dynamics%2520and%2520experimental%2520validation%2520of%2520an%2520in%2520silico%2520predicted%2520conformation%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D11470%26epage%3D11477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirico, W. J.</span><span> </span><span class="NLM_article-title">N-Ethylmaleimide inactivates a nucleotide-free Hsp70 molecular chaperone</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">29937</span><span class="NLM_x">–</span> <span class="NLM_lpage">29944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=29937-29944&author=Q.+Liuauthor=E.+J.+Levyauthor=W.+J.+Chirico&title=N-Ethylmaleimide+inactivates+a+nucleotide-free+Hsp70+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLevy%26aufirst%3DE.%2BJ.%26aulast%3DChirico%26aufirst%3DW.%2BJ.%26atitle%3DN-Ethylmaleimide%2520inactivates%2520a%2520nucleotide-free%2520Hsp70%2520molecular%2520chaperone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D29937%26epage%3D29944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+Hsp90+confers+tumour+selectivity+on+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0lhueXMOheb0Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520Hsp90%2520confers%2520tumour%2520selectivity%2520on%2520Hsp90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchietti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes-DaGama, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas-Lopes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alpaugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillarsetty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnchembio.670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=21946277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1anurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=818-826&author=K.+Moulickauthor=J.+H.+Ahnauthor=H.+Zongauthor=A.+Rodinaauthor=L.+Cerchiettiauthor=E.+M.+Gomes-DaGamaauthor=E.+Caldas-Lopesauthor=K.+Beebeauthor=F.+Pernaauthor=K.+Hatziauthor=L.+P.+Vuauthor=X.+Zhaoauthor=D.+Zatorskaauthor=T.+Taldoneauthor=P.+Smith-Jonesauthor=M.+Alpaughauthor=S.+S.+Grossauthor=N.+Pillarsettyauthor=T.+Kuauthor=J.+S.+Lewisauthor=S.+M.+Larsonauthor=R.+Levineauthor=H.+Erdjument-Bromageauthor=M.+L.+Guzmanauthor=S.+D.+Nimerauthor=A.+Melnickauthor=L.+Neckersauthor=G.+Chiosis&title=Affinity-based+proteomics+reveal+cancer-specific+networks+coordinated+by+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90</span></div><div class="casAuthors">Moulick, Kamalika; Ahn, James H.; Zong, Hongliang; Rodina, Anna; Cerchietti, Leandro; Gomes DaGama, Erica M.; Caldas-Lopes, Eloisi; Beebe, Kristin; Perna, Fabiana; Hatzi, Katerina; Vu, Ly P.; Zhao, Xinyang; Zatorska, Danuta; Taldone, Tony; Smith-Jones, Peter; Alpaugh, Mary; Gross, Steven S.; Pillarsetty, Nagavarakishore; Ku, Thomas; Lewis, Jason S.; Larson, Steven M.; Levine, Ross; Erdjument-Bromage, Hediye; Guzman, Monica L.; Nimer, Stephen D.; Melnick, Ari; Neckers, Len; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-826</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Most cancers were characterized by multiple mol. alterations, but identification of the key proteins involved in these signaling pathways is currently beyond reach.  The inhibitor PU-H71 preferentially targets tumor-enriched Hsp90 complexes and affinity captures Hsp90-dependent oncogenic client proteins.  The authors used PU-H71 affinity capture to design a proteomic approach that, when combined with bioinformatic pathway anal., identifies dysregulated signaling networks and key oncoproteins in chronic myeloid leukemia.  The identified interactome overlaps with the well-characterized altered proteome in this cancer, indicating that this method can provide global insights into the biol. of individual tumors, including primary patient specimens.  In addn., this approach can be used to identify previously uncharacterized oncoproteins and mechanisms, potentially leading to new targeted therapies.  Further the abundance of the PU-H71-enriched Hsp90 species, which is not dictated by Hsp90 expression alone, is predictive of the cell's sensitivity to Hsp90 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXTlQWF_MFU7Vg90H21EOLACvtfcHk0lhueXMOheb0Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1anurbN&md5=d62e663a2e054f3715a3a6e2d5e2c10e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.670%26sid%3Dliteratum%253Aachs%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DZong%26aufirst%3DH.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DGomes-DaGama%26aufirst%3DE.%2BM.%26aulast%3DCaldas-Lopes%26aufirst%3DE.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DPerna%26aufirst%3DF.%26aulast%3DHatzi%26aufirst%3DK.%26aulast%3DVu%26aufirst%3DL.%2BP.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DSmith-Jones%26aufirst%3DP.%26aulast%3DAlpaugh%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DS.%2BS.%26aulast%3DPillarsetty%26aufirst%3DN.%26aulast%3DKu%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DLevine%26aufirst%3DR.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAffinity-based%2520proteomics%2520reveal%2520cancer-specific%2520networks%2520coordinated%2520by%2520Hsp90%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D818%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Beebe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollapour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scroggins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zierer, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.18632%2Foncotarget.1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=23867252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1065-1074&author=K.+Beebeauthor=M.+Mollapourauthor=B.+Scrogginsauthor=C.+Prodromouauthor=W.+Xuauthor=M.+Tokitaauthor=T.+Taldoneauthor=L.+Pullenauthor=B.+K.+Ziererauthor=M.+J.+Leeauthor=J.+Trepelauthor=J.+Buchnerauthor=D.+Bolonauthor=G.+Chiosisauthor=L.+Neckers&title=Posttranslational+modification+and+conformational+state+of+heat+shock+protein+90+differentially+affect+binding+of+chemically+diverse+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span></div><div class="casAuthors">Beebe Kristin; Mollapour Mehdi; Scroggins Bradley; Prodromou Chrisostomos; Xu Wanping; Tokita Mari; Taldone Tony; Pullen Lester; Zierer Bettina K; Lee Min-Jung; Trepel Jane; Buchner Johannes; Bolon Daniel; Chiosis Gabriela; Neckers Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1065-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an essential molecular chaperone in eukaryotes that facilitates the conformational maturation and function of a diverse protein clientele, including aberrant and/or over-expressed proteins that are involved in cancer growth and survival.  A role for Hsp90 in supporting the protein homeostasis of cancer cells has buoyed interest in the utility of Hsp90 inhibitors as anti-cancer drugs.  Despite the fact that all clinically evaluated Hsp90 inhibitors target an identical nucleotide-binding pocket in the N domain of the chaperone, the precise determinants that affect drug binding in the cellular environment remain unclear, and it is possible that chemically distinct inhibitors may not share similar binding preferences.  Here we demonstrate that two chemically unrelated Hsp90 inhibitors, the benzoquinone ansamycin geldanamycin and the purine analog PU-H71, select for overlapping but not identical subpopulations of total cellular Hsp90, even though both inhibitors bind to an amino terminal nucleotide pocket and prevent N domain dimerization.  Our data also suggest that PU-H71 is able to access a broader range of N domain undimerized Hsp90 conformations than is geldanamycin and is less affected by Hsp90 phosphorylation, consistent with its broader and more potent anti-tumor activity.  A more complete understanding of the impact of the cellular milieu on small molecule inhibitor binding to Hsp90 should facilitate their more effective use in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLZ-jT50Ygfa91pGlMMoT5fW6udTcc2eZ6Pvc7FFBTP7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D&md5=1db8c9dca9517cd39a1b911107869582</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1099%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DScroggins%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DTokita%26aufirst%3DM.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPullen%26aufirst%3DL.%26aulast%3DZierer%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26aulast%3DBolon%26aufirst%3DD.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DPosttranslational%2520modification%2520and%2520conformational%2520state%2520of%2520heat%2520shock%2520protein%252090%2520differentially%2520affect%2520binding%2520of%2520chemically%2520diverse%2520small%2520molecule%2520inhibitors%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26spage%3D1065%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1113</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1196%2Fannals.1391.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=17513464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2007&pages=202-216&author=P.+Workmanauthor=F.+Burrowsauthor=L.+Neckersauthor=N.+Rosen&title=Drugging+the+cancer+chaperone+HSP90%3A+combinatorial+therapeutic+exploitation+of+oncogene+addiction+and+tumor+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging the cancer chaperone HSP90: combinatorial therapeutic expolitation on oncogene addiction and tumor stress</span></div><div class="casAuthors">Workman, Paul; Burrows, Francis; Neckers, Len; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Stress Responses in Biology and Medicine</span>),
    <span class="NLM_cas:pages">202-216</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone HSP90 has emerged as an exciting target for cancer treatment.  We review the potential advantages of HSP90 inhibitors, particularly the simultaneous combinatorial depletion of multiple oncogenic "client" proteins, leading to blockade of many cancer-causing pathways and the antagonism of all of the hallmark pathol. traits of malignancy.  Cancer selectivity is achieved by exploiting cancer "dependencies," including oncogene addiction and the stressed state of malignant cells.  The multiple downstream effects of HSP90 inhibitors should make the development of resistance more difficult than with agents having more restricted effects.  We review the various classes of HSP90 inhibitor that have been developed, including the natural products geldanamycin and radicicol and also the purine scaffold and pyrazole/isoxazole class of synthetic small mol. inhibitors.  A first-in-class HSP90 drug, the geldanamycin analog 17-AAG, has provided proof of concept for HSP90 inhibition in patients at well tolerated doses and therapeutic activity has been seen.  Other inhibitors show promise in preclin. and clin. development.  Opportunities and challenges for HSP90 inhibitors are discussed, including use in combination with other agents.  Most of the current HSP90 inhibitors act by blocking the essential nucleotide binding and ATPase activity required for chaperone function.  Potential new approaches are discussed, for example, interference with cochaperone binding and function in the superchaperone complex.  Biomarkers for use with HSP90 inhibitors are described.  We stress how basic and translational research has been mutually beneficial and indicate future directions to enhance our understanding of mol. chaperones and their exploitation in cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_I-DGevqj7Vg90H21EOLACvtfcHk0lh5rYfv7OmOqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF&md5=a537c5d947847c6b3cdf613968214623</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1196%2Fannals.1391.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1391.012%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DDrugging%2520the%2520cancer%2520chaperone%2520HSP90%253A%2520combinatorial%2520therapeutic%2520exploitation%2520of%2520oncogene%2520addiction%2520and%2520tumor%2520stress%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2007%26volume%3D1113%26spage%3D202%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Caldas-Lopes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchietti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanchina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mab, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varticovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">8368</span><span class="NLM_x">–</span> <span class="NLM_lpage">8373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=8368-8373&author=E.+Caldas-Lopesauthor=L.+Cerchiettiauthor=J.+H.+Ahnauthor=C.+C.+Clementauthor=A.+I.+Roblesauthor=A.+Rodinaauthor=K.+Moulickauthor=T.+Taldoneauthor=A.+Gozmanauthor=Y.+Guoauthor=N.+Wuauthor=E.+Stanchinaauthor=J.+Whiteauthor=S.+S.+Grossauthor=Y.+Mabauthor=L.+Varticovskiauthor=A.+Melnickauthor=G.+Chiosis&title=Hsp90+inhibitor+PU-H71%2C+a+multimodal+inhibitor+of+malignancy%2C+induces+complete+responses+in+triple-negative+breast+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaldas-Lopes%26aufirst%3DE.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DRobles%26aufirst%3DA.%2BI.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DGozman%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DStanchina%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DS.%2BS.%26aulast%3DMab%26aufirst%3DY.%26aulast%3DVarticovski%26aufirst%3DL.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHsp90%2520inhibitor%2520PU-H71%252C%2520a%2520multimodal%2520inhibitor%2520of%2520malignancy%252C%2520induces%2520complete%2520responses%2520in%2520triple-negative%2520breast%2520cancer%2520models%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D106%26spage%3D8368%26epage%3D8373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0508078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=381-390&author=H.+Heauthor=D.+Zatorskaauthor=J.+Kimauthor=J.+Aguirreauthor=L.+Llaugerauthor=Y.+Sheauthor=N.+Wuauthor=R.+M.+Immorminoauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Identification+of+potent+water+soluble+purine-scaffold+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90</span></div><div class="casAuthors">He, Huazhong; Zatorska, Danuta; Kim, Joungnam; Aguirre, Julia; Llauger, Laura; She, Yuhong; Wu, Nian; Immormino, Robert M.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways.  Its inactivation may result in targeting multiple mol. alterations and, thus, in reverting the transformed phenotype.  The PU-class, a purine-scaffold Hsp90 inhibitor series, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer.  Here, a series of this class was synthesized and evaluated as inhibitors of the chaperone.  The structure-activity relationship and selectivity for tumor Hsp90 of compds. within the series is presented.  The study identifies water sol. derivs. (>5 mM in PBS pH 7.4) of nanomolar potency (IC50 ∼ 50 nM) in cellular and animal models of cancer.  Binding affinities of these compds. for Hsp90 correlate well with their biol. activities.  When administered in vivo to mice bearing MDA-MB-468 human breast cancer xenografted tumors, these agents result in pharmacol. relevant concns. and, accordingly, in modulation of Hsp90-client proteins in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwHp1Wo_iW7Vg90H21EOLACvtfcHk0liYKWBCL0HUtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF&md5=3bd02ca5bc0a147e9cffa58968433917</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0508078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508078%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potent%2520water%2520soluble%2520purine-scaffold%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D381%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Inhibition of heat shock protein Hsp90-pp60<sup>v-src</sup> heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">8324</span><span class="NLM_x">–</span> <span class="NLM_lpage">8328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1073%2Fpnas.91.18.8324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=8078881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8324-8328&author=L.+Whitesellauthor=E.+G.+Mimnaughauthor=B.+De+Costaauthor=C.+E.+Myersauthor=L.+M.+Neckers&title=Inhibition+of+heat+shock+protein+Hsp90-pp60v-src+heteroprotein+complex+formation+by+benzoquinone+ansamycins%3A+essential+role+for+stress+proteins+in+oncogenic+transformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span></div><div class="casAuthors">Whitesell, Luke; Mimnaugh, Edward G.; De Costa, Brian; Myers, Charles E.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8324-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The mol. mechanisms by which oncogenic tyrosine kinases induce cellular transformation are unclear.  Herbimycin A, geldanamycin, and certain other benzoquinone ansamycins display an unusual capacity to revert tyrosine kinase-induced oncogenic transformation.  As an approach to the study of v-src-mediated transformation, the authors examd. ansamycin action in transformed cells and found that drug-induced reversion could be achieved without direct inhibition of src phosphorylating activity.  To identify mechanisms other than kinase inhibition for drug-mediated reversion, the authors prepd. a solid phase-immobilized geldanamycin deriv. and affinity pptd. the mol. targets with which the drug interacted.  In a range of cell lines, immobilized geldanamycin bound elements of a major class of heat shock protein (HSP90) in a stable and pharmacol. specific manner.  Consistent with these binding data, the authors found that sol. geldanamycin and herbimycin A inhibited specifically the formation of a previously described src-HSP90 heteroprotein complex.  A related benzoquinone ansamycin that failed to revert transformed cells did not inhibit the formation of this complex.  These results demonstrate that HSP participation in multimol. complex formation is required for src-mediated transformation and can provide a target for drug modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTW8DJOglQLVg90H21EOLACvtfcHk0liYKWBCL0HUtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D&md5=18f1cad01698df44adaa05ef3da9f850</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8324%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DMimnaugh%26aufirst%3DE.%2BG.%26aulast%3DDe%2BCosta%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DC.%2BE.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%2520Hsp90-pp60v-src%2520heteroprotein%2520complex%2520formation%2520by%2520benzoquinone%2520ansamycins%253A%2520essential%2520role%2520for%2520stress%2520proteins%2520in%2520oncogenic%2520transformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D8324%26epage%3D8328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huezo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spampinato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modrich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1016%2Fj.chembiol.2004.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=15217612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=787-797&author=M.+Vilenchikauthor=D.+Solitauthor=A.+Bassoauthor=H.+Huezoauthor=B.+Lucasauthor=H.+Heauthor=N.+Rosenauthor=C.+Spampinatoauthor=P.+Modrichauthor=G.+Chiosis&title=Targeting+wide-range+oncogenic+transformation+via+PU24FCl%2C+a+specific+inhibitor+of+tumor+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Wide-Range Oncogenic Transformation via PU24FCl, a Specific Inhibitor of Tumor Hsp90</span></div><div class="casAuthors">Vilenchik, Maria; Solit, David; Basso, Andrea; Huezo, Henri; Lucas, Brian; He, Huazhong; Rosen, Neal; Spampinato, Claudia; Modrich, Paul; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">787-797</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Agents that inhibit Hsp90 function hold significant promise in cancer therapy.  Here we present PU24FCl, a representative of the first class of designed Hsp90 inhibitors.  By specifically and potently inhibiting tumor Hsp90, PU24FCl exhibits wide-ranging anti-cancer activities that occur at similar doses in all tested tumor types.  Normal cells are 10- to 50-fold more resistant to these effects.  Its Hsp90 inhibition results in multiple antitumor-specific effects, such as degrdn. of Hsp90-client proteins involved in cell growth, survival, and specific transformation, inhibition of cancer cell growth, delay of cell cycle progression, induction of morphol. and functional changes, and apoptosis.  In concordance with its higher affinity for tumor Hsp90, in vivo PU24FCl accumulates in tumors while being rapidly cleared from normal tissue.  Concns. achieved in vivo in tumors lead to single-agent antitumor activity at non-toxic doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHKaguPFd5FLVg90H21EOLACvtfcHk0liYKWBCL0HUtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrg%253D&md5=1bf99fe18a0a212c770fa731c197e60c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DSolit%26aufirst%3DD.%26aulast%3DBasso%26aufirst%3DA.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DSpampinato%26aufirst%3DC.%26aulast%3DModrich%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DTargeting%2520wide-range%2520oncogenic%2520transformation%2520via%2520PU24FCl%252C%2520a%2520specific%2520inhibitor%2520of%2520tumor%2520Hsp90%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D787%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Synthesis of a red-shifted fluorescence polarization probe for Hsp90</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4515</span><span class="NLM_x">–</span> <span class="NLM_lpage">4518</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4515-4518&author=K.+Moulickauthor=C.+C.+Clementauthor=J.+Aguirreauthor=J.+Kimauthor=Y.+Kangauthor=S.+Feltsauthor=G.+Chiosis&title=Synthesis+of+a+red-shifted+fluorescence+polarization+probe+for+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520a%2520red-shifted%2520fluorescence%2520polarization%2520probe%2520for%2520Hsp90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4515%26epage%3D4518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lélias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lgCA9RNysPXHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lhPmk2ooKF5qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Hurwitz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scullin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L.</span><span> </span><span class="NLM_article-title">Afatinib treatment in advanced non-small cell lung cancer</span> <span class="citation_source-journal">Lung Cancer: Targets Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=47-57&author=J.+L.+Hurwitzauthor=P.+Scullinauthor=L.+Campbell&title=Afatinib+treatment+in+advanced+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Afatinib treatment in advanced non-small cell lung cancer</span></div><div class="casAuthors">Hurwitz, Jane L.; Scullin, Paula; Campbell, Lynn</div><div class="citationInfo"><span class="NLM_cas:title">Lung Cancer: Targets and Therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-57</span>CODEN:
                <span class="NLM_cas:coden">LCTTBI</span>;
        ISSN:<span class="NLM_cas:issn">1179-2728</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite some recent advances in the management of advanced non-small cell lung cancer (NSCLC), prognosis for these patients remains poor.  Small mol. epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have however provided a new therapeutic option in this disease setting and EGFR mutation testing is now routine practice for newly diagnosed NSCLC patients.  A proportion of patients will not respond to first-generation EGFR-TKIs however and those who do will ultimately develop resistance and disease relapse.  Next-generation EGFR-TKIs which inhibit multiple members of the EGFR family are being developed in order to increase sensitivity and overcome resistance to existing agents.  Afatinib (BIBW 2992) is an oral, irreversible inhibitor of EGFR and HER2 tyrosine kinases and is the most advanced of these agents in clin. development.  Pre-clin. and early-phase clin. trials have demonstrated a favorable safety profile as a single agent and in combination with other anti-cancer agents, and provide evidence of clin. activity in advanced NSCLC.  The LUX-Lung trials suggest that for selected patients, afatinib offers symptomatic improvement and prolonged progression-free survival, although this has not yet translated into improved overall survival.  This article aims to review the use of EGFR-TKIs in the management of advanced NSCLC and the mechanisms underlying resistance to these agents.  We will discuss the current pre-clin. and clin. data regarding afatinib, its potential to overcome resistance to firstgeneration TKIs and its emerging role in advanced NSCLC treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR6NVwLl4z9bVg90H21EOLACvtfcHk0lhPmk2ooKF5qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCm&md5=e0890492e1de41c1fee5e541e08cbb21</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DJ.%2BL.%26aulast%3DScullin%26aufirst%3DP.%26aulast%3DCampbell%26aufirst%3DL.%26atitle%3DAfatinib%2520treatment%2520in%2520advanced%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DLung%2520Cancer%253A%2520Targets%2520Ther.%26date%3D2011%26volume%3D2%26spage%3D47%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Burstein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirix, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paridaens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badwe, R.</span><span> </span><span class="NLM_article-title">Neratinib, an irreversible ErbB Receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1200%2FJCO.2009.25.8707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=20142587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFSqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=1301-1307&author=H.+J.+Bursteinauthor=Y.+Sunauthor=L.+Y.+Dirixauthor=Z.+Jiangauthor=R.+Paridaensauthor=A.+R.+Tanauthor=A.+Awadaauthor=A.+Ranadeauthor=S.+Jiaoauthor=G.+Schwartzauthor=R.+Abbasauthor=C.+Powellauthor=K.+Turnbullauthor=J.+Vermetteauthor=C.+Zacharchukauthor=R.+Badwe&title=Neratinib%2C+an+irreversible+ErbB+Receptor+tyrosine+kinase+inhibitor%2C+in+patients+with+advanced+ErbB2-positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer</span></div><div class="casAuthors">Burstein, Harold J.; Sun, Yan; Dirix, Luc Y.; Jiang, Zefei; Paridaens, Robert; Tan, Antoinette R.; Awada, Ahmad; Ranade, Anantbhushan; Jiao, Shunchang; Schwartz, Gary; Abbas, Richat; Powell, Christine; Turnbull, Kathleen; Vermette, Jennifer; Zacharchuk, Charles; Badwe, Rajendra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1301-1307</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Neratinib is an oral, irreversible pan-ErbB receptor tyrosine kinase inhibitor.  The efficacy and safety of neratinib were evaluated in two cohorts of patients with advanced ErbB2-pos. breast cancer-those with and those without prior trastuzumab treatment-in an open-label, multicenter, phase II trial.  Patients in the two cohorts (prior trastuzumab, n = 66; no prior trastuzumab, n = 70) received oral neratinib 240 mg once daily.  The primary end point was the 16-wk progression-free survival (PFS) rate for the evaluable population (prior trastuzumab, n = 63; no prior trastuzumab, n = 64), as assessed by independent review.  The 16-wk PFS rates were 59% for patients with prior trastuzumab treatment and 78% for patients with no prior trastuzumab treatment.  Median PFS was 22.3 and 39.6 wk, resp.  Objective response rates were 24% among patients with prior trastuzumab treatment and 56% in the trastuzumab-naive cohort.  The most common adverse events were diarrhea, nausea, vomiting, and fatigue.  Diarrhea was the most frequent grades 3 to 4 adverse event, occurring in 30% of patients with prior trastuzumab treatment and in 13% of patients with no prior trastuzumab treatment, which prompted dose redns. in 29% and 4% of patients, resp., but treatment discontinuation in only one patient.  No neratinib-related, grades 3 or 4 cardiotoxicity was reported.  Oral neratinib showed substantial clin. activity and was reasonably well tolerated among both heavily pretreated and trastuzumab-naive patients who had advanced, ErbB2-pos. breast cancer.  Diarrhea was the most common adverse effect but was manageable with antidiarrheal agents and dose modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqbEv1WYAZUbVg90H21EOLACvtfcHk0lhPmk2ooKF5qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFSqtbs%253D&md5=11b07ce171753c7499b50d52786859e8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.25.8707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.25.8707%26sid%3Dliteratum%253Aachs%26aulast%3DBurstein%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DParidaens%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DA.%2BR.%26aulast%3DAwada%26aufirst%3DA.%26aulast%3DRanade%26aufirst%3DA.%26aulast%3DJiao%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DG.%26aulast%3DAbbas%26aufirst%3DR.%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DTurnbull%26aufirst%3DK.%26aulast%3DVermette%26aufirst%3DJ.%26aulast%3DZacharchuk%26aufirst%3DC.%26aulast%3DBadwe%26aufirst%3DR.%26atitle%3DNeratinib%252C%2520an%2520irreversible%2520ErbB%2520Receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520patients%2520with%2520advanced%2520ErbB2-positive%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D1301%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Sequist, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besse, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitlitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freyman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananthakrishnan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J.-C.</span><span> </span><span class="NLM_article-title">Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3076</span><span class="NLM_x">–</span> <span class="NLM_lpage">3083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1200%2FJCO.2009.27.9414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=20479403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlaju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=3076-3083&author=L.+V.+Sequistauthor=B.+Besseauthor=T.+J.+Lynchauthor=V.+A.+Millerauthor=K.+K.+Wongauthor=B.+Gitlitzauthor=K.+Eatonauthor=C.+Zacharchukauthor=A.+Freymanauthor=C.+Powellauthor=R.+Ananthakrishnanauthor=S.+Quinnauthor=J.-C.+Soria&title=Neratinib%2C+an+irreversible+pan-ErbB+receptor+tyrosine+kinase+inhibitor%3A+results+of+a+phase+II+trial+in+patients+with+advanced+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Neratinib, an irreversible Pan-ErbB, receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer</span></div><div class="casAuthors">Sequist, Lecia V.; Besse, Benjamin; Lynch, Thomas J.; Miller, Vincent A.; Wong, Kwok K.; Gitlitz, Barbara; Eaton, Keith; Zacharchuk, Charles; Freyman, Amy; Powell, Christine; Ananthakrishnan, Revathi; Quinn, Susan; Soria, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3076-3083</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have had a significant impact on non-small-cell lung cancer (NSCLC) outcomes, particularly for patients with EGFR mutations.  Resistance emerges after 9 to 12 mo, primarily mediated by the T790M resistance mutation.  We studied neratinib, an irreversible pan-ErbB TKI that may overcome T790M.  Patients with advanced NSCLC underwent EGFR sequencing of available tumor tissue at enrollment.  Those with ≥ 12 wk of prior TKI therapy were placed in arm A if they were EGFR mutation pos. or arm B if they were wild-type.  Arm C included TKI-naive patients with adenocarcinoma and light smoking histories (≤ 20 pack-years).  All patients received daily oral neratinib, initially at 320 mg but subsequently reduced to 240 mg because of excessive diarrhea.  The primary end point was objective response rate (RR).  167 Patients were treated: 91 in arm A, 48 in arm B, and 28 in arm C.  Diarrhea was the most common toxicity; grade 3 incidence was 50% at 320 mg but improved to 25% after dose redn.  The RR was 3% in arm A and zero in arms B and C.  No patients with known T790M responded.  Notably, three of four patients with an exon 18 G719X EGFR mutation had a partial response and the fourth had stable disease lasting 40 wk.  Neratinib had low activity in patients with prior benefit from TKIs and in TKI-naive patients, potentially because of insufficient bioavailability from diarrhea-imposed dose limitation.  Responses were seen in patients with the rare G719X EGFR mutation, highlighting the importance of obtaining comprehensive genetic information on trials of targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Z3gsvbWbOrVg90H21EOLACvtfcHk0lj6fn-vZP9y5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlaju7c%253D&md5=460e088e58919bbfcf8c153772f157b0</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.27.9414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.27.9414%26sid%3Dliteratum%253Aachs%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DBesse%26aufirst%3DB.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DMiller%26aufirst%3DV.%2BA.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DGitlitz%26aufirst%3DB.%26aulast%3DEaton%26aufirst%3DK.%26aulast%3DZacharchuk%26aufirst%3DC.%26aulast%3DFreyman%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DAnanthakrishnan%26aufirst%3DR.%26aulast%3DQuinn%26aufirst%3DS.%26aulast%3DSoria%26aufirst%3DJ.-C.%26atitle%3DNeratinib%252C%2520an%2520irreversible%2520pan-ErbB%2520receptor%2520tyrosine%2520kinase%2520inhibitor%253A%2520results%2520of%2520a%2520phase%2520II%2520trial%2520in%2520patients%2520with%2520advanced%2520non-small-cell%2520lung%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D3076%26epage%3D3083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ou, S.-H. I.</span><span> </span><span class="NLM_article-title">Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1016%2Fj.critrevonc.2011.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=22257651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A280%3ADC%252BC38vgs1GrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=407-421&author=S.-H.+I.+Ou&title=Second-generation+irreversible+epidermal+growth+factor+receptor+%28EGFR%29+tyrosine+kinase+inhibitors+%28TKIs%29%3A+a+better+mousetrap%3F+A+review+of+the+clinical+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence</span></div><div class="casAuthors">Ou Sai-Hong Ignatius</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The discovery of activating epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) in 2004 heralded the era of molecular targeted therapy in NSCLC.  First-generation small molecule, reversible tyrosine kinase inhibitors (TKIs) of EGFR, gefitinib and erlotinib, had been approved for second- or third-line treatment of NSCLC prior to the knowledge of these mutations.  However, resistance to gefitinib and erlotinib invariably develops after prolonged clinical use.  Two second-generation irreversible EGFR TKIs, afatinib (BIBW 2992) and dacomitinib (PF-00299804), that can potentially overcome the majority of these resistances are in late stage clinical development.  Here I will review the clinical data of EGFR TKIs and discuss the appropriate future role of afatinib and dacomitinib in NSCLC: whether as replacement of erlotinib or gefitinib or only after erlotinib or gefitinib failure and whether different subgroups would benefit from different approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQB3Zud0oX1WCM8MEzWGjS9fW6udTcc2eZ5FOfoK0k_c7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vgs1GrsA%253D%253D&md5=df9e3f1fe1c2bb8f328f925725024d40</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2011.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2011.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DS.-H.%2BI.%26atitle%3DSecond-generation%2520irreversible%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520tyrosine%2520kinase%2520inhibitors%2520%2528TKIs%2529%253A%2520a%2520better%2520mousetrap%253F%2520A%2520review%2520of%2520the%2520clinical%2520evidence%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2012%26volume%3D83%26spage%3D407%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kwak, E.</span><span> </span><span class="NLM_article-title">The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancer</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1498</span><span class="NLM_x">–</span> <span class="NLM_lpage">1507</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=1498-1507&author=E.+Kwak&title=The+role+of+irreversible+HER+family+inhibition+in+the+treatment+of+patients+with+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DE.%26atitle%3DThe%2520role%2520of%2520irreversible%2520HER%2520family%2520inhibition%2520in%2520the%2520treatment%2520of%2520patients%2520with%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DOncologist%26date%3D2011%26volume%3D16%26spage%3D1498%26epage%3D1507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vejda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotzmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte-Hermann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikulits, W.</span><span> </span><span class="NLM_article-title">Concomitant determination of absolute values of cellular protein amounts, synthesis rates, and turnover rates by quantitative proteome profiling</span> <span class="citation_source-journal">Mol. Cell Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1074%2Fmcp.M200026-MCP200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=12239281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFKls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=528-537&author=C.+Gernerauthor=S.+Vejdaauthor=D.+Gelbmannauthor=E.+Bayerauthor=J.+Gotzmannauthor=R.+Schulte-Hermannauthor=W.+Mikulits&title=Concomitant+determination+of+absolute+values+of+cellular+protein+amounts%2C+synthesis+rates%2C+and+turnover+rates+by+quantitative+proteome+profiling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Concomitant determination of absolute values of cellular protein amounts, synthesis rates, and turnover rates by quantitative proteome profiling</span></div><div class="casAuthors">Gerner, Christopher; Vejda, Susanne; Gelbmann, Dieter; Bayer, Editha; Gotzmann, Josef; Schulte-Hermann, Rolf; Mikulits, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Proteomics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">528-537</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9476</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Two-dimensional gel electrophoresis of protein fractions isolated from 35S-radiolabeled cells provides qual. information on intracellular amts. 35S incorporation rates, protein modifications, and subcellular localizations of up to thousands of individual proteins.  In this study we extended proteome profiling to provide quant. data on synthesis rates of individual proteins.  We combined fluorescence detection of radiolabeled proteins with SYPRO ruby staining and subsequent autoradiog. of the same gels, thereby quantifying protein amts. and 35S incorporation.  To calibrate calcn. of abs. synthesis rates, we detd. the amt. and autoradiograph intensity of radiolabeled haptoglobin secreted by interleukin-6 pretreated HepG2 cells.  This allowed us to obtain a std. calibration value for 35S incorporation per autoradiograph intensity unit.  This value was used to measure protein synthesis rates during time course expts. of heat-shocked U937 cells.  We measured the increasing amts. of hsp70 and calcd. it by integration of the detd. hsp70 synthesis rates over time.  Similar results were obtained by both methods, validating our standardization procedure.  Based on the assumption that the synthesis rate of proteins in a steady state of cell metab. would essentially compensate protein degrdn., we calcd. biol. half-lives of proteins from protein amts. and synthesis rates detd. from two-dimensional gels.  Calcd. protein half-lives were found close to those detd. by pulse-chase expts., thus validating this new method.  In conclusion, we devised a method to assess quant. proteome profiles covering detn. of individual amts., synthesis, and turnover rates of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNRfQd0ATwzLVg90H21EOLACvtfcHk0lhLphqX2_RJWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFKls7s%253D&md5=afb267deb43e63fbad45fdcc09deda42</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M200026-MCP200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M200026-MCP200%26sid%3Dliteratum%253Aachs%26aulast%3DGerner%26aufirst%3DC.%26aulast%3DVejda%26aufirst%3DS.%26aulast%3DGelbmann%26aufirst%3DD.%26aulast%3DBayer%26aufirst%3DE.%26aulast%3DGotzmann%26aufirst%3DJ.%26aulast%3DSchulte-Hermann%26aufirst%3DR.%26aulast%3DMikulits%26aufirst%3DW.%26atitle%3DConcomitant%2520determination%2520of%2520absolute%2520values%2520of%2520cellular%2520protein%2520amounts%252C%2520synthesis%2520rates%252C%2520and%2520turnover%2520rates%2520by%2520quantitative%2520proteome%2520profiling%26jtitle%3DMol.%2520Cell%2520Proteomics%26date%3D2002%26volume%3D1%26spage%3D528%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0lhLphqX2_RJWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">High-throughput screening fluorescence polarization assay for tumor-specific Hsp90</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1177%2F1087057107306067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=17942784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12rs7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=915-924&author=Y.+Duauthor=K.+Moulickauthor=A.+Rodinaauthor=J.+Aguirreauthor=S.+Feltsauthor=R.+Dingledineauthor=H.+Fuauthor=G.+Chiosis&title=High-throughput+screening+fluorescence+polarization+assay+for+tumor-specific+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening fluorescence polarization assay for tumor-specific Hsp90</span></div><div class="casAuthors">Du, Yuhong; Moulick, Kamalika; Rodina, Anna; Aguirre, Julia; Felts, Sara; Dingledine, Raymond; Fu, Haian; Chiosis, Gabriella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">915-924</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that has emerged as an important target in cancer and several other diseases, such as neurodegenerative diseases, nerve injuries, inflammation, and infection.  Discovery of novel agents that inhibit Hsp90 and have druglike properties is therefore a major focus in several academic and industrial labs.  In this study, the authors describe the development and optimization in a 384-well format of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization, which measures competitive binding of red-shifted fluorescently labeled geldanamycin (GM-cy3B) to Hsp90 found in the NCI-N417 small-cell lung carcinoma cells.  The authors demonstrate that GM-cy3B binds with high affinity and specificity to cellular Hsp90.  The assay results in excellent signal-to-noise ratios (>10) and Z' values (>0.75) at tracer concns. greater than 4 nM and 1 μg/well of total NCI-N417 protein, indicating a robust assay.  It also equilibrates after 5 h of incubation at room temp. and remains stable for up to 24 h.  Furthermore, it is a simple mix-and-read format that is cost-effective and uses only low amts. of fluorophore and cell lysates.  A study using more than 15,000 compds. from the National Institutes of Health Mol. Libraries Screening Center Network was performed to validate its performance in a high-throughput screening format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8tjbDItT49rVg90H21EOLACvtfcHk0lgo80XUUYUysQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12rs7rO&md5=e47f199e1c11d828056f6007d3f38eab</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1177%2F1087057107306067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057107306067%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DDingledine%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHigh-throughput%2520screening%2520fluorescence%2520polarization%2520assay%2520for%2520tumor-specific%2520Hsp90%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2007%26volume%3D12%26spage%3D915%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massague, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodsky, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystal, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm401551n&amp;key=10.1038%2Fnchembio.2007.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm401551n&amp;key=17603540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm401551n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFaru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=498-507&author=A.+Rodinaauthor=M.+Vilenchikauthor=K.+Moulickauthor=J.+Aguirreauthor=J.+Kimauthor=A.+Chiangauthor=J.+Litzauthor=C.+C.+Clementauthor=Y.+Kangauthor=Y.+Sheauthor=N.+Wuauthor=S.+Feltsauthor=P.+Wipfauthor=J.+Massagueauthor=X.+Jiangauthor=J.+L.+Brodskyauthor=G.+W.+Krystalauthor=G.+Chiosis&title=Selective+compounds+define+Hsp90+as+a+major+inhibitor+of+apoptosis+in+small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer</span></div><div class="casAuthors">Rodina, Anna; Vilenchik, Maria; Moulick, Kamalika; Aguirre, Julia; Kim, Joungnam; Chiang, Anne; Litz, Julie; Clement, Cristina C.; Kang, Yanlong; She, Yuhong; Wu, Nian; Felts, Sara; Wipf, Peter; Massague, Joan; Jiang, Xuejun; Brodsky, Jeffrey L.; Krystal, Geoffrey W.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">498-507</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The heat shock protein 90 (Hsp90) has a crit. role in malignant transformation.  Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood.  By using selective compds., the authors the authors have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90.  Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled.  These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZlX5SIced7Vg90H21EOLACvtfcHk0lgo80XUUYUysQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFaru78%253D&md5=79f2a09bca626726b09895f80c40f001</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2007.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2007.10%26sid%3Dliteratum%253Aachs%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DA.%26aulast%3DLitz%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DMassague%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DBrodsky%26aufirst%3DJ.%2BL.%26aulast%3DKrystal%26aufirst%3DG.%2BW.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DSelective%2520compounds%2520define%2520Hsp90%2520as%2520a%2520major%2520inhibitor%2520of%2520apoptosis%2520in%2520small-cell%2520lung%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D498%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1S3X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1S3X','PDB','1S3X'); return false;">PDB: 1S3X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KHO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KHO','PDB','2KHO'); return false;">PDB: 2KHO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P32" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P32','PDB','2P32'); return false;">PDB: 2P32</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i96"><a href="/doi/suppl/10.1021/jm401551n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_20033"></div></div></div></div></div><hr /></hr><p class="last">Description of the synthesis of compounds <b>44a</b>,<b>b</b> and <b>45a</b>,<b>b</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401551n/suppl_file/jm401551n_si_001.pdf">jm401551n_si_001.pdf (272.82 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID codes of crystal structures used as a starting point for building the homology model are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1S3X">1S3X</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KHO">2KHO</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P32">2P32</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401551n&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-4%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm401551n" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401551n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991e1e994dd1cb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
